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Complex Regional Pain Syndrome (CRPS) is a debilitating pain condition of 
unknown aetiology, usually occurring post-traumatically. Early diagnosis of 
CRPS remains a challenge with adverse implications on rehabilitation and 
recovery. The main goals of my research were to help develop clinically useful 
bedside tests as well as objective biomarkers to improve the early diagnosis 
of CRPS.  
 
The first research project in this thesis, ‘Novel signs in CRPS and their 
diagnostic clinical utility’ was a prospective observational cohort study which 
defined the four novel signs (finger misperception, abnormal hand laterality, 
astereognosis and abnormal body scheme report) in CRPS, examined their 
prevalence in CRPS and other chronic pain conditions and assessed their 
diagnostic utility (Sensitivity, Specificity, Predictive values and Likelihood 
ratios) for identifying patients at risk of CRPS within a Fracture cohort. This 
study demonstrates that novel signs are present in the majority of CRPS 
patients and can be reliably detected following simple training. They are 
practical and have significant clinical utility in diagnosing persistent pain in a 
fracture group. They can be used to identify patients at high risk of developing 
chronic pain post-fracture thereby allowing targeted early intervention. 
 
Cortical reorganisation, defined as structural and functional changes within 
the cerebral cortex, is implicated in many chronic pain conditions including 
CRPS.  The second research project in this thesis ‘Cortical reorganisation and 
finger misperception in CRPS- a high density electroencephalogram study’ 
was a prospective case control design study which investigated the EEG 
parameters suggestive of cortical reorganisation in CRPS patients by studying 
the somatosensory ERPs (Event Related Potentials) elicited on painless 
finger stimulation. There was no significant difference in the GFP (Global Field 
Power) latency in the patient group compared to healthy subjects or between 
affected and unaffected sides of the patient group suggesting there was no 
impairment of somatosensory conduction from the periphery to the 
somatosensory cortex. However, GFP amplitude corresponding to P300 was 
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significantly higher in the patient affected side compared to the healthy 
subjects suggesting cognitive dysfunction possibly related to increased 
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Chapter 1: Complex Regional Pain Syndrome (CRPS) 
– an   overview 
 
1.1 Definition 
Complex Regional Pain syndrome (CRPS) is a debilitating pain condition that 
usually arises after trauma to a limb. It is characterised by dis-proportionate 
pain, swelling, vasomotor, sudomotor, trophic and motor changes. CRPS is 
classified as Type 1 if a definite nerve lesion cannot be identified and Type 2 if 
there is a definite nerve lesion (Harden et al. 2007). 
 
Symptoms and signs of CRPS can vary in severity and duration. Pain is the 
predominant symptom of CRPS and is seemingly disproportionate in degree 
or time to the usual course of any known inciting event. It is usually triggered 
by a fracture, soft tissue injury or surgery, although spontaneous onset has 
also been described in a small minority of patients. The pain is regional i.e.; 
not in a specific dermatome or nerve territory (Marinus et al. 2011; Birklein, 
Neill, et al. 2015). 
 
Initially there is swelling of the affected part although with time this may 
subside. Oedema can result from inflammation and/or autonomic changes. 
Vasomotor changes can cause colour changes of the skin (redness or 
purplish/bluish discolouration) and changes in skin temperature. In most 
cases skin is warm to touch initially although in some it can be cold at 
presentation or change from warm to cold (Marinus et al. 2011; Birklein, Neill, 
et al. 2015). 
 
Sudomotor changes (abnormal sweating) of the affected limb can also occur. 
Trophic changes recognised in CRPS include increased or decreased growth 
of hair and nail as well as skin atrophy. Movement difficulties are reported by 
almost all patients usually due to pain but can also be due to contractures in 
late stages. Some patients also develop central motor features such as 




Traditionally, experts considered that there are 3 sequential stages of CRPS 
as described below (Bonica 1953). 
Stage 1 is characterised by burning, throbbing pain; sensitivity to touch or 
cold; and localized oedema. The distribution of the pain is not compatible with 
a single peripheral nerve, trunk, or root lesion. Vasomotor disturbances occur 
with variable intensity, producing altered colour and temperature. The 
radiograph is usually normal but may show patchy demineralization. 
Stage 2 is marked by progression of the soft tissue edema, thickening of the 
skin and articular soft tissues, muscle wasting, and the development of 
brawny skin. This may last for three to six months. 
Stage 3 is most severe and is characterized by limitation of movement, 
contractures of the digits, waxy trophic skin changes, and brittle, ridged nails. 
Bone radiography reveals severe demineralization. 
Evidence for the sequential development of these 3 stages, however is 
lacking and hence this concept is not currently accepted by many CRPS 
experts(Harden et al. 2013; Bruehl et al. 2002). 
 
It is clinically useful to think of CRPS in terms of early, late & recovery phases. 
Vasomotor and sudomotor features of CRPS (discolouration, temperature 
disturbance, altered sweating, and oedema) tend to be most common in early 
CRPS and have the greatest likelihood of resolving(Bean et al. 2014). Early 
CRPS has much better prognosis than the late stage and most cases improve 
or stabilize early after disease onset, while later improvement is less 
common(Goebel 2011). Motor symptoms such as weakness, stiffness, and 
limited range of motion are the symptoms most likely to persist in the late 
phase. Body perception disturbances are also reported more commonly in the 
late phase (Bailey et al. 2013). A formally accepted definition of recovery 
phase is still lacking. However, a recent study found that from patients' 
perspective, recovery means, in order of priority, as relief from: their CRPS-
related pain, generalised pain, movement restriction, reliance on medication, 
and stiffness(Llewellyn et al. 2018). 
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1.2 Historical perspective 
The earliest documented clinical description of CRPS is probably by the 16th 
century French surgeon, Ambroise Pare (Figure 1.1). He reported that King 
Charles IX developed persistent arm pain and muscle contractures following 
blood-letting procedures undertaken for treatment of small pox (Dommerholt 
2004). 
 
  Figure 1.1: Ambroise Pare (1510-1590) 
 
 
Silas Weir Mitchell (Figure 1.2), an American physician, in his book "Gunshot 
wounds and other Injuries of nerves", described American civil war (1861-65) 
veterans suffering from a burning pain which persisted long after the removal 
of the bullets. He attributed this to the consequences of nerve injury and 
named it "causalgia" coined from the Greek terms ‘kausis’ (fire) and ‘algos’ 
(pain). Mitchell observed: "In our early experience of nerve wounds, we met 
with a small number of men who were suffering from a pain which they 
described as ‘burning’, or as ‘mustard red hot’, or as a ‘red hot file rasping the 
skin’. In all of these patients and many later cases, this pain was an associate 
of the glossy skin…..The part itself is not alone subject to an intense burning 
sensation, but becomes exquisitely hyperaesthetic so that a touch or tap of 




 Figure 1.2: Silas Weir Mitchell (1829-1914) 
 
 
Paul Sudeck (Figure 1.3), a German surgeon described the radiographic 
changes of patchy osteopenia (spotty decalcification) in some patients with 
this condition in 1900 and ascribed them to an exaggerated process of 
inflammation and healing (Plewes 1956). The terms ‘Sudeck’s atrophy 
(Morbus Sudeck)’ and ‘post-traumatic osteodystrophy’ became popular 
especially in Europe to describe this condition.  
  Figure 1.3: Paul Sudeck (1866-1945) 
 
Rene Leriche (Figure 1.4), a French surgeon, was the first to recognise the 
importance of sympathetic nervous system in maintenance of chronic pain 
and reported pain relief in a patient after extensive periarterial sympathectomy 
(Leriche 1928). 
 




James Evans, an American physician, coined the term ‘reflex sympathetic 
dystrophy’(Evans 1946). He suggested that afferent activity triggered by 
trauma set up a spinal cord reflex that, in turn, stimulated sympathetic efferent 
activity. This vicious circle induced arterial vasospasm and tissue ischemia 
that increased capillary filtration pressure with resultant oedema and swelling.   
This concept was adopted and popularised by John Bonica in his classic 
textbook ‘The management of pain’ (Bonica 1953) and dominated medical 
thinking throughout the latter half of the 20th century.  
 
The recognition that only some and not all patients respond to 
sympathectomy has led some to question the relevance of sympathetic 
nervous system as a therapeutic target and an underlying pathology (Stanton-
Hicks 2000). The multitude of names (Table 1a) with imprecise classifications 
had led to confusion and misunderstanding in both research and clinical 
management of this complex condition.  
 
 
Table 1a: Previous names for CRPS in the literature 
 


















1.3 Diagnostic Criteria 
 
In 1993, a task force was set up by International Association for Study of Pain 
(IASP) to review nomenclature and devise diagnostic criteria. The consensus 
conference in Florida in 1994 adopted CRPS as the preferred terminology 
(Stanton-Hicks et al. 1995) and proposed the IASP diagnostic criteria ( Table 
1b). CRPS was further subdivided into Type 1 (without a definite peripheral 
nerve injury) and Type 2 (with a definite peripheral nerve injury).  
 
 
Table 1b: IASP diagnostic criteria for CRPS* (1994) 
 
1.The presence of an initial noxious event, or a cause for immobilisation # 
2. Continuing pain, allodynia or hyperalgesia in which the pain is disproportionate to 
any known inciting event  
3. Evidence at some time of oedema, changes in skin blood flow or abnormal 
sudomotor activity in the region of pain (can be a sign or symptom) 
4. This diagnosis is excluded by the presence of other conditions that would 
otherwise  account for the degree of pain and dysfunction 
 
* if seen without major nerve damage, diagnose CRPS type 1, otherwise type 2 
# not required for diagnosis; 5-10% will not have this. Must meet criteria 2, 3&4 for 
diagnosis 
 
The internal validity of IASP criteria was assessed by Harden and colleagues 
in a study of 123 patients fulfilling the IASP diagnostic criteria for CRPS.  Data 
on CRPS-related signs and symptoms was obtained using a standardized 
sign/symptom checklist. Principal Components factor Analysis was used to 
detect statistical groupings of signs/symptoms (factors). Although a separate 
pain/sensation criterion was supported, vasomotor symptoms formed a factor 
distinct from a sudomotor/oedema factor. Changes in range of motion, motor 
dysfunction, and trophic changes, which are not included in the IASP criteria, 
formed a distinct fourth factor. Scores on the pain/sensation factor correlated 
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positively with pain duration (P<0. 001), but there was a negative correlation 
between the sudomotor/edema factor scores and pain duration (P<0.05). The 
motor/trophic factor predicted positive responses to sympathetic block 
(P<0.05). These results suggested that the internal validity of the IASP/CRPS 
criteria could be improved by separating vasomotor signs/symptoms from 
sudomotor dysfunction and oedema. Results also indicated that motor and 
trophic changes may be incorporated in the IASP criteria as a distinct 
component (Harden et al. 1999). 
 
External validity of diagnostic criteria refers to their usefulness for 
distinguishing between patients on the basis of some external reference or 
‘gold standard’. External validity of the IASP criteria were examined by Bruehl 
and colleagues in a study of series of 117 CRPS patients and 43 patients 
diagnosed with non-CRPS (diabetic neuropathy, polyneuropathy, post 
herpetic neuralgia and radiculopathy) neuropathic pain (Bruehl et al. 1999). 
Multiple discriminant function analyses were used to test the ability of the 
IASP diagnostic criteria to discriminate between CRPS patients and those 
experiencing non-CRPS neuropathic pain. IASP criteria and decision rules 
discriminated significantly between groups (P <0.001). However, although 
sensitivity was quite high (0.98), specificity was poor (0.36), and a positive 
diagnosis of CRPS was likely to be correct in as few as 40% of cases. A 
decision rule, requiring at least two sign categories and four symptom 
categories to be positive optimized diagnostic efficiency, with a diagnosis of 
CRPS likely to be accurate in up to 84% of cases, and a diagnosis of non-
CRPS neuropathic pain likely to be accurate in up to 88% of cases.  
 
The poor specificity of IASP diagnostic criteria can potentially lead to over 
diagnosis. One reason for poor specificity was the assumption that signs and 
symptoms of vasomotor, sudomotor, and oedema-related changes provide 
redundant diagnostic information; that is, the presence of any one of these is 
sufficient to meet criterion 3.  Diagnosis based solely on patient-reported 
historical symptoms was permitted as per the IASP criteria and this also likely 
contributed to overdiagnosis. Failure to include motor/trophic signs and 
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symptoms in the IASP criteria also lead to important diagnostically 
discriminatory information being ignored (Harden et al. 2007).  
 
An IASP consensus workshop was held in Budapest in 2003 to address the 
lack of specificity in the original IASP diagnostic criteria. Their 
recommendations were informed by the results of the validation studies 
(Harden et al. 1999; Bruehl et al. 1999) of IASP criteria described above. 
They approved and codified empirically validated, statistically derived 
revisions of the IASP criteria for CRPS and this is referred to as the ‘Budapest 
criteria’ (Tables 1c & 1d). The Budapest clinical diagnostic criteria retain the 
sensitivity of the IASP criteria, but improve the specificity (0.68) (Harden et al. 
2007). 
 
Tables 1c & 1d (Budapest diagnostic criteria for CRPS) 
1. Continuing pain, which is disproportionate to any inciting event  
2. Must report at least one symptom in ≥3 symptom categories. 
Table 1C - Symptom categories in CRPS 
Sensory Reports of hyperesthesia and/or allodynia 
Vasomotor Reports of temperature asymmetry and/or skin colour changes and/or   skin colour 
asymmetry 
Sudomotor/ Oedema Reports of oedema and/or sweating changes and/or sweating asymmetry 
Motor/Trophic Reports of decreased range of motion and/or motor dysfunction (weakness, tremor, 
dystonia) and/or trophic changes (hair, nail, skin) 
3. Must display at least 1 sign at time of evaluation in ≥2 signs categories  
Table 1D - Signs categories in CRPS 
Sensory Evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or 
temperature sensation and/or deep somatic pressure and/or joint movement) 
Vasomotor Evidence of temperature asymmetry (>1°C) and/or skin colour changes and/or 
asymmetry 
Sudomotor/ Oedema Evidence of oedema and/or sweating changes and/or sweating asymmetry 
Motor/Trophic Evidence of decreased range of motion and/or motor dysfunction (weakness, 
tremor, dystonia) and/or trophic changes (hair, nail, skin) 
 4. There is no other diagnosis that better explains the signs and symptoms 
 
*For research criteria there must be at least 1 symptom in all 4 symptom 




Although the precise aetiology of CRPS remains unknown, there is evidence 
for pathophysiology being multifactorial in nature. In particular, aberrant 
inflammation (including neurogenic inflammation), vasomotor dysfunction and 
maladaptive neuroplasticity are the key mechanisms implicated and clinical 
heterogeneity stems from the inter-individual variation in the degree of 
activation of these pathways after tissue injury (Marinus et al. 2011). 
 
Initial step in the pathophysiology usually involves post-traumatic 
inflammation. Inflammatory cytokines are released from the keratinocytes in 
the skin, endothelium and other damaged tissues by activation of innate 
immunity (Birklein & Dimova 2017). A skin biopsy study of 55 CRPS patients 
(Birklein, Drummond, et al. 2015) found that keratinocytes were activated in 
the affected skin, resulting in proliferation, epidermal thickening, and 
upregulated TNF-α and IL-6 expression in early CRPS. On the other hand, in 
chronic CRPS there was reduced keratinocyte proliferation with epidermal 
thinning. This study also found that acute CRPS (but not chronic CRPS) 
patients also had increased mast cell accumulation in the affected skin. 
 
The inflammatory cytokines in turn excite the nociceptors leading to long term 
peripheral sensitization. Action potentials resulting from stimulation of 
nociceptive C-fibres travel centrally but also invade peripheral nerve terminals 
via axonal reflex or dorsal root reflex. This results in the release of 
neuropeptides (mainly Calcitonin gene–related peptide and substance P) from 
the cytokine-sensitized nociceptors (neurogenic inflammation) and cause 
vasodilation and protein extravasation resulting in redness, warmth, and 
oedema (Borchers & Gershwin 2014).  
 
CRPS patients are also found to have elevated levels of the pro-inflammatory 
cytokines IL-1β & IL-6 in their cerebrospinal fluid, as well as reduced levels of 
the anti-inflammatory cytokines IL-4 and IL-10 suggesting an important role 




Neuroinflammation can also spread either anterograde or retrograde, via 
axonal projections and establish neuroinflammatory tracks within the neural 
axis. Neuroinflammation spreading to second-order synapses in supraspinal 
centres can then potentially destabilize feedback circuits involved in 
proprioception, nociception, and autonomic functions, in CRPS (Cooper & 
Clark 2013). 
 
Further evidence for the role of adaptive immunity comes from the detection 
of agonistic serum auto-antibodies against adrenergic and cholinergic 
receptors in some CRPS patients (Kohr et al. 2011; Dubuis et al. 2014).  Two 
small studies (Goebel et al. 2010; Goebel et al. 2002) also suggested that 
treatment with low dose intravenous immunoglobulin (IVIG) may improve pain 
symptoms in CRPS implicating a role for auto-immunity; however a recent 
larger study failed to confirm the efficacy of IVIG in moderate to severe CRPS 
of 1-5 years duration (Goebel et al. 2017). 
 
Vasomotor dysfunction is commonly noted in CRPS. The affected limb is 
usually warmer than the unaffected limb in early stages and then switches to 
being colder in later stages. However, in 20% of cases the affected limb is 
cold from the start. This temperature changes suggests a temporal shift in 
vasoconstrictor neuron activity. CRPS is associated with a unilateral inhibition 
of cutaneous sympathetic vasoconstrictor neurons, which leads to a warmer 
limb in the acute stage in majority of cases (Marinus et al. 2011).  
 
In addition to affecting peripheral circulation, the sympathetic nervous system 
is also thought to play a role in pain (sympathetically maintained pain). 
Peripheral nociceptors develop catecholamine sensitivity as a result of 
decreased activity of cutaneous sympathetic vasoconstrictor neurons (Baron 
et al. 1999). However, meta-analyses of trials (O’Connell et al. 2016) have 
failed to show that local anaesthetic sympathetic blocks are effective in 
reducing pain in CRPS leading some experts to question the importance of 




Maladaptive neuroplasticity is another key mechanism implicated in CRPS 
(Marinus et al. 2011). Structural and functional changes within the central 
nervous system cause central sensitization. Disinhibition of spinal and 
trigeminal nociceptive neurons and facilitation of nociceptive activity by 
excitatory neurons that project from the rostroventral medulla are thought to 
be the main mechanisms of central sensitization(Vera-Portocarrero et al. 
2006). Activation and upregulation of glutamate receptors causes spinal 
nociceptive neurons to become hyper- responsive to peripheral input (Kuner 
2010) and inhibition of glutamergic NMDA receptors by intravenous infusion of 
ketamine has been shown to be effective in treating pain in some CRPS 
patients (Azari et al. 2012). Cortical reorganisation has been reported in 
somatosensory and motor cortices in CRPS (Di Pietro et al. 2013b; Di Pietro 
et al. 2013a) and these are discussed in detail in chapter 4 of this thesis.  
 
Body perception disturbances (for example, finger misperception, 
astereognosis, ‘not feeling as if affected limb belongs to them’, distorted 
mental image of affected part)  are also reported in CRPS and can contribute 
to pain (Lewis et al. 2007; Förderreuther et al. 2004; Cohen et al. 2013; Galer 
& Jensen 1999). The underlying mechanisms including the role for executive 
functions of fronto-parietal networks as well as the “salience network” 
including anterior insula and midcingulate cortex with reference to the 
“Hierarchical Predictive Coding” accounts of perception are discussed in detail 















CRPS is almost as common as rheumatoid arthritis and six times as common 
as multiple sclerosis. A Dutch community-based retrospective cohort study 
(de Mos et al. 2007) estimated the incidence as 26/100,000 life-years. The 
peak incidence was found to be between the ages of 61 and 70 years. The 
incidence rate in this study is four times that reported in a previous population 
based study done in Olmsted county, USA (Sandroni et al. 2003).  
This difference in reported incidence between the two studies is likely to be 
due to differences in case definition and validation. For example, Sandroni 
and colleagues applied strict IASP CRPS criteria on electronic medical 
records data whereas the Dutch study did not require that all cases should 
fulfil diagnostic criteria; they retained all cases on the basis of a reconfirmed 
diagnosis of CRPS by general practitioner or specialist.  The differences in 
population characteristics such as ethnicity, socio-economic factors and 
incidence of fractures may also partly explain the observed difference. 
Both studies found that females were around four times more likely than 
males to be affected and that upper limbs were more commonly affected than 
lower limbs with no side preference. Fracture was the most common 
precipitating event accounting for around 40% of cases. 
 
70-80% report significant recovery within 1 year of disease onset (Sandroni et 
al. 2003). However, if the disease persists for more than 1 year, the prognosis 
is considerably worse.  In a study by de Mos and colleagues, 102 CRPS 
patients were assessed at an average of six years (range 2 – 11 years) after 
disease onset (de Mos et al. 2009). In this group, 15% reported the CRPS as 
still progressive with no improvement in symptoms and overall, 30 % of 









1.6 Diagnostic issues in CRPS 
 
UK CRPS guidelines recommend prompt diagnosis and early treatment to 
avoid secondary physical problems associated with disuse of the affected limb 
and the psychological consequences of living with undiagnosed chronic pain 
(Turner-Stokes & Goebel 2011). However, diagnosing CRPS early is a 
challenge. It is estimated that CRPS patients have an average delay in 
diagnosis of 6 months after symptom onset (Shenker et al. 2014). 
 
Currently, the diagnosis of CRPS is a clinical one based upon the presence of 
dis-proportionate pain associated with vasomotor, sudomotor, trophic and 
motor changes. However, the signs vary with time and many patients may not 
fulfil the strict diagnostic criteria. The current diagnostic criteria define 
established and more severe CRPS but may not capture earlier or lesser 
presentations (Dutton & Littlejohn 2015). Delayed diagnosis also results from 
lack of awareness of diagnostic criteria for CRPS among healthcare 
providers. In particular, failure to notice subtle signs of autonomic dysfunction 
may be an important contributing factor for the missing CRPS diagnosis 
(Lunden et al. 2016). 
 
Current imaging modalities of thermography (TG), triple phase bone scan 
(TPBS) and contrast-magnetic resonance imaging (MRI) have poor sensitivity 
(TG-29%, TPBS-14% and MRI-13%) and low positive predictive value (TG-
17%, TPBS-53%, MRI-31%) and are unable to reliably differentiate normal 
post-traumatic changes from CRPS (Schürmann et al. 2007). 
 
In summary, the pathophysiology of CRPS suggests central neurological 
mechanisms dominate for patients with chronic symptoms and these may well 
be associated with novel clinical signs. The early detection of these signs may 











Clinical signs such as finger misperception, impaired hand laterality 
recognition, astereognosis and abnormal body scheme have been reported in 
patients with CRPS (Förderreuther et al. 2004; Moseley 2004). The CRPS 
patients may also report unusual symptoms such as ‘feeling of foreignness’ 
and wish to amputate the affected limb (autotomy wish)(Galer & Jensen 1999; 
Lewis et al. 2007). 
Although these signs and symptoms have been known to be present in CRPS 
for some years, they have not been included in the current diagnostic or 
classification criteria(Harden 2010). Hence we have labelled them novel 
clinical signs and the current understanding of the factors underlying these 
neurocognitive dysfunctions are discussed in detail below. 
 
2.2 Finger misperception 
 
Finger misperception is defined as an impaired ability to identify fingers 
correctly with eyes closed when tactile stimuli is applied to the fingers.  
This has been previously reported in some patients with CRPS.  
For example, in a study by Förderruether and colleagues (Förderreuther et al. 
2004), 73 CRPS patients were tested for the ability to name the fingers 
touched with a cotton swab on the dorsal side of the first segment. They 
ensured prior to the test that the touch stimuli were clearly and readily felt on 
both hands. The unaffected hand was examined first. The fingers were fully 
extended and slightly spread, if possible. Each finger was stimulated twice in 
random order. All patients were instructed not to move the fingers during the 
investigation in order to exclude additional sensory input. The results for the 
affected and the unaffected hand were compared by a Chi-square test. The 
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ability to identify the fingers of the affected hand compared with those of the 
contralateral hand was impaired in 37 (48%) patients. In contrast, the ability to 
identify fingers on the unaffected hand compared with the contralateral hand 
was impaired in only five (6.5%) patients. This difference was highly 
significant (χ2 =33.5, df = 1, p = 0.0001). Impaired identification of the fingers 
was not related to the affected side of CRPS (right hand affected, n = 19; left 
hand affected, n =18). This study authors also reported that all patients 
stressed that their difficulties naming the fingers could not be explained by 
reduced perception of the cotton swab.  
 
2.3 Impaired hand laterality recognition 
Hand laterality recognition task tests the ability of a subject to judge the 
handedness of visually presented stimuli (images of hands shown in a variety 
of postures and orientations) and indicate whether they perceive a right or left 
hand. The task engages kinaesthetic and sensorimotor processes and is 
considered a standard example of motor imagery (Coslett et al. 2010; 
Moseley 2004; Boonstra et al. 2012). 
 
Motor imagery is the mental rehearsal of an action without movement 
(Jeannerod 1995). Functional neuroimaging studies have demonstrated that 
same brain structures are involved in action as well imagining the same action 
(Grèzes & Decety 2001). A motor imagery task such as recognising the 
laterality of pictured image of a hand as either left or right requires the mental 
rotation of the image of one’s own hand to match that of the picture (Parsons 
1987). This neurocognitive ability is reported to be impaired in chronic pain 
conditions including CRPS. For example, in a study of 18 CRPS patients and 
age matched controls (Moseley 2004), CRPS patients had delayed hand 
laterality recognition on the affected side which was related to symptom 
duration and to the pain that would be evoked by executing the movement.  
 
Reinersmann and colleagues (Reinersmann et al. 2010) reported significantly 
delayed reaction times in both CRPS and phantom limb pain patients in a 
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study of 12 CRPS patients, 12 phantom limb pain patients and 38 healthy 
subjects. They found that the impairment was present in both affected and 
unaffected sides and that this was independent of attentional performance. 
 
Coslett and colleagues (Coslett et al. 2010) reported a study in which 19 
patients with chronic musculoskeletal or radiculopathic arm or shoulder pain, 
24 subjects with chronic pain not involving the arm or shoulder and 41 normal 
controls were asked to indicate if a line drawing was a right or left hand. 
Relative to normal and pain control subjects, arm or shoulder pain subjects 
were significantly slower for stimuli that required greater amplitude rotations. 
This interaction between group and rotation suggests that the differences 
between controls and arm or shoulder pain subjects are not simply a non-
specific effect of pain or its treatment.  For the arm or shoulder pain subjects 
only there was a correlation between degree of slowing and the rating of 
severity of pain with movement but not the non-specific pain rating. This study 





Astereognosis is defined as the inability to identify an object by touch only 
without visual input despite having intact cutaneous sensation; and this 
usually results from damage to the cortical regions important for haptic input 
integration (Amick 2011). Classically, this is reported in patients who have had 
stroke mainly affecting the parietal lobe (Connell et al. 2008; Knecht et al. 
1996). Roland in a study of 93 patients showed that damage to anterior part of 
the middle third of  postcentral gyrus caused impairment of astereognosis 
contralateral to the lesion (Roland 1976).  
 
Astereognosis has also been reported in some patients with CRPS. For 
example, Cohen and colleagues (Cohen et al. 2013) reported that in a study 
of 22 CRPS patients, 14 (64%) had astereognosis. 
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2.5 Abnormal body scheme report 
 
Body scheme is the dynamic real time representation of one’s own body in 
space; and it represents centrally the body’s spatial properties including limb 
segment lengths, their hierarchical arrangement, the configuration of the 
segments in space and the shape of the body surface (Haggard & Wolpert 
2005). 
 
Body scheme is generated by the proprioceptive, somatosensory, vestibular 
and other sensory inputs.  This representation is also integrated with motor 
systems for control of action and normally this integration is automatic and 
seamless. Sensory deprivation can result in impairment of even routine 
movements such as reaching towards an object or balancing on a chair as 
noted in patients with sensory neuropathy underlying the importance of body 
scheme in guiding movement (Schwoebel et al. 2001). Neuropsychological 
evidence also suggests that parietal cortex is the neural substrate for the body 
scheme as it appears to be involved in monitoring the sensory and motor 
information required for accurate real and imagined movements (Sirigu et al. 
1996). 
 
Body scheme is sensitive to central insults that affect motor performance such 
as motor cortex lesions and basal ganglia dysfunctions (Dominey et al. 1995). 
It is also affected by peripheral factors such as pain as demonstrated by a 
study of patients with chronic unilateral arm pain (Schwoebel et al. 2001). 
 
Abnormal body scheme has also been reported in CRPS patients and has 
been proposed as a contributor to pain in this condition (Lewis et al. 2007; 
Lewis & McCabe 2010; Lewis & Schweinhardt 2012; Galer et al. 1995; Galer 
& Jensen 1999).  
 
Galer and colleagues used the term ‘neglect–like’ to describe some of the 
body perception disturbances in CRPS as they were thought to be similar to 
the post-stroke neurological neglect (Galer et al. 1995). For example, some 
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CRPS patients perceive their own affected limb to be ‘foreign’ and not 
belonging to them and this was dubbed ‘cognitive neglect’. Similarly, some 
CRPS patients may need to focus mental and visual attention in order to 
move their affected limb and this was referred to as ‘motor neglect’. 
 
Galen and Jensen (Galer & Jensen 1999) did a questionnaire survey of CRPS 
patients to determine the frequency of ‘neglect-like’ symptoms. 242 patients 
(10%) returned the questionnaire and 224 patients were included in the 
analysis. 84% (188/224) endorsed at least one of the four neglect-like 
symptom statement and 47% (105/224) endorsed both motor and cognitive 
neglect statements. The main limitation of this study was that the subjects 
were members of a national patient support group who claimed to have CRPS 
and direct confirmation of their diagnosis by physical examination was not 
made. The other limitation was the extremely low response rate and inherent 
selection bias as subjects who had symptoms were more likely to respond.  
Nevertheless, this study suggests that these symptoms are important in a 
subset of CRPS patients. 
 
Lewis and colleagues (Lewis et al. 2007) undertook a qualitative study using 
semi-structured interviews of 27 patients with CRPS and reported that 
patients revealed bizarre perceptions of affected body parts and that some 
patients expressed a desire to amputate the affected part despite the prospect 
of further pain and functional loss. There was a mismatch experienced 
between the sensation of the limb and how it looked. Anatomical parts of the 
CRPS limb were erased in mental representations of the affected area. Pain 
generated a raised consciousness of the limb yet there was a lack of 
awareness as to its position. These feelings were about the CRPS limb only 
as the remaining unaffected body was felt to be normal. These findings from 
this study suggest that there is a complex interaction between pain, 
disturbances in body perception and central remapping.  
 
In a study of 22 CRPS patients (Lewis & Schweinhardt 2012), body 
perception disturbance was found to positively correlate with pain (those in 
greater pain had more extensive body perception disturbance) and two-point 
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discrimination thresholds (those with greater body perception disturbance had 
worse tactile acuity). This study also showed that those with longer disease 
duration had significantly greater body perception disturbance. 
 
The Bath CRPS Body Perception Disturbance Scale has been developed by 
Lewis & colleagues and this tool provides a comprehensive assessment of the 
extent of body perception disturbance and helps to monitor changes in body 
perception over time (Lewis & McCabe 2010). The original English version of 
this scale has also been translated and validated in German speaking CRPS 

























2.6 Neurocognitive and neuroplastic mechanisms of 
novel clinical signs  
 
The constellation of novel clinical signs in CRPS is reminiscent of 
neurocognitive dysfunctions seen in patients with parietal lobe lesions in 
Gerstmann syndrome (Gerstmann 1940). Austrian neurologist, Josef 
Gerstmann reported patients with the tetrad of finger agnosia, agraphia 
(difficulty in writing), acalculia (difficulty in performing calculations) and left to 
right confusion. Finger agnosia was considered a disturbance of orientation 
and consisted of failure of the patient to recognise, show and name the 
fingers of either hand in the presence of normal vision and tactile sensation. 
Gerstmann suggested that these symptoms constitute a syndromal entity and 
are because of a defect in a common functional denominator and localized it 
to the dominant parietal lobe.  
 
Neuropsychological studies during open brain surgery have confirmed a 
relation between the Gerstmann tetrad and left parietal cortex and have, 
demonstrated a certain degree of proximity and overlap of those cortical sites 
where electrical stimulation can elicit these symptoms (Morris et al. 1984).   
 
Rusconi and colleagues (Rusconi et al. 2009) used  f-MRI and diffusion tensor 
imaging in healthy subjects to seek out the common cortical substrate 
accounting for the tetrad. They construed a functional activation paradigm that 
mirrored each of the four clinical deficits in Gerstmann syndrome and 
determined cortical activation patterns. They then applied fibre tracking to 
diffusion tensor images and used cortical activation foci in the four functional 
domains as seed regions. None of the subjects showed parietal overlap of 
cortical activation patterns from the four cognitive domains. However, in every 
subject, the parietal activation patterns across all four domains consistently 
connected to a small region of subcortical parietal white matter at a location 
that is congruent with the lesion in a well-documented case of pure 
Gerstmann syndrome. This study suggests that pure form of Gerstmann 
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syndrome might arise from disconnection, via a lesion, to separate but co-
localized fibre tracts in the subcortical parietal white matter. Indeed, it has 
been suggested that these findings arise from cortical changes within the 
parietal lobe in CRPS patients as well (Cohen et al. 2013). 
 
Plasticity in cortical representations of the affected limb, manifesting as a 
reversible shrinkage of the somatosensory cortex has been reported  in CRPS 
(Maihöfner et al. 2003; Maihöfner et al. 2004; Pleger et al. 2006; Di Pietro et 
al. 2013b; Vartiainen et al. 2008; Juottonen et al. 2002). A shrinkage in the 
Penfield’s homunculus (Penfield & Boldrey 1937) provide a plausible 
explanation for many of the perceptual disturbances seen in CRPS. Cortical 
reorganization may disrupt the internal body map and impair performance on 
the tasks requiring the identification of somatosensory information and coding 
of body posture. However, the evidence supporting this hypothesis has some 
limitations as discussed below. 
 
Firstly, there is a high risk of bias (due to unclear sampling methods and 
unblinded analysis of outcomes)  in many of the studies as reported in a 
meta-analysis by Di Pietro and colleagues (Di Pietro et al. 2013b). In order to 
address this, data from a more recent fMRI study (Di Pietro et al. 2015) was 
analyzed blind to the group (CRPS patients or healthy controls) and hand 
(affected or unaffected). Contrary to previous findings, CRPS was associated 
with an enlarged representation of the healthy hand, not a smaller 
representation of the affected hand.  
 
A methodological limitation of EEG/MEG, is that the reported spatial changes 
in somatosensory responses in comparing thumb and little finger (in the 
region of 5 mm on average) are comparable to or smaller than the estimated 
spatial resolution and accuracy of the best available source modelling 
methods with MEG and EEG based on simulated data (Darvas et al. 2005; 
Yao & Dewald 2005), which must therefore be considered optimistic when 
applied to clinical data (Kuttikat et al. 2016). With clinical data, the accuracy of 
the source model may be affected by unknown/unmodelled concurrent neural 
responses such as those involved with top-down modulation from higher-
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order cortical regions. Subject motion during recording/scanning, which is 
more likely in patients with more severe symptoms, can reduce data quality 
and introduce artefactual effects that may underestimate the observational 
parameters. The introduction of “noise” from the above sources risks biasing 
results, especially in studies with small samples sizes (Kuttikat et al. 2016). 
 
Intact somatosensory awareness depends also on the late cognitive stages of 
neuronal processing (Auksztulewicz et al. 2012; Adhikari et al. 2014) and 
neurological disturbances of the body scheme can be caused by the frontal 
lobe abnormalities (Weijers et al. 2013). Perceptual disturbances in some 
patients with CRPS may in fact point to disturbed cognitive-executive 
functioning. Somatosensory perception dependency on the executive 
functions of fronto-parietal networks as well as the “salience network” 
including anterior insula and mid-cingulate cortex has been investigated 
based on “Hierarchical Predictive Coding (HPC)” accounts of perception(Rao 
& Ballard 1999; Friston 2005; Friston 2008). 
 
Hierarchical predictive coding accounts of perception originate from the work 
of Hermann von Helmholtz (Helmholtz 1962) who proposed that the brain 
does not represent sensations per se, but rather models the causes of those 
sensations. Because these causes cannot be perceived directly, they must be 
inferred from sensory data.  
However, the problem is that sensations can potentially have multiple causes 
that interact and the brain must deal with this inherent uncertainty in the 
causes of sensory impressions to generate perceptions and guide actions 
(Friston 2003). One solution to this problem is for the brain’s model of the 
environment to contain prior expectations about how causes interact.  
 
HPC models (Clark 2013) depict that top-down expectancy-related 
information is used to predict and “explain away” the sensory inputs, leaving 
residual “prediction errors.” These prediction errors then propagate 
information forward within the system – they report the “surprise” induced by a 
mismatch between sensory signals and predictions of those signals and serve 
to update the brain’s virtual model of the causes of those sensations so as to 
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improve the reliability of predictions. Such errors can occur at multiple levels 
of a processing hierarchy, such that higher-level systems generate predictions 
about the inputs to lower-level systems based on modelling the causal 
structure of the world. This scheme is attractive due to being computationally 
efficient (i.e., it reflects computations that neurons could feasibly produce) and 
providing a structure reminiscent of cortical circuits (Kuttikat et al. 2016).  
 
Optimal perception and behaviour depends on minimizing prediction error. 
This can either be achieved by changing the brain’s predictions to explain 
sensory input by perception and learning or by actively changing sensory 
input to fulfil the brain’s predictions. In the latter case, the agent can 
selectively sample the sensory inputs that it expects. This is known as active 
inference (Friston 2003). Selective sampling of sensory data in order to 
confirm expectations may help to explain why expectations, as formed by 
prior experiences, have been known to modify sensory perception, including 
the perception of pain. Pain expectancies can trigger anticipatory neural 
responses that result in changes in perception, emotion, and behaviour 
(Ploghaus et al. 1999; Brown et al. 2008; Clark et al. 2008; Kong et al. 2013; 
Seidel et al. 2015). Such changes are adaptive for avoiding acute injury but 
are potentially maladaptive in chronic pain conditions.  
 
There is also evidence that key nodes of the frontoparietal and salience 
networks, the dorsolateral prefrontal cortex and anterior insula cortex show 
aberrant responses during anticipation of pain that are common across 
chronic pain populations suffering both nociceptive and non-nociceptive 
(unexplained) pain (Brown et al. 2014).  
 
Interestingly, greater spectral power in the EEG in the low-frequency delta (<4 
Hz) and theta (4–9 Hz) ranges, localized to both somatosensory and ventral 
PFC, have been found in CRPS patients compared to control subjects 
(Walton et al. 2010) in a similar region to that showing grey matter atrophy in 
patients with CRPS (Geha et al. 2008) and that appears to be important for 
the top-down self-regulation of pain (Woo et al. 2015). This suggests that the 
somatosensory processing abnormalities in CRPS are mediated by the long-
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range and low-frequency entrainment across frontal and somatosensory 
cortices, representing the influence of high-level predictions on 
somatosensory perception. This view is also supported by f-MRI evidence of 
greater functional connectivity patterns between the post-central gyrus and 
prefrontal, cingulate and thalamic regions to cold allodynia in paediatric 
patients with CRPS (Linnman et al. 2013) compared to healthy controls. 
 
Modelling techniques such as Dynamic Causal Modelling (DCM) can be used 
to investigate somatosensory forward (bottom-up) and backward (top-down) 
connections in body misperceptions. DCM allows the study of neuronal 
architecture underlying observed electromagnetic signals (from EEG and 
MEG) and the effective connectivity between its sources (David et al. 2006).  
 
DCM has been applied to EEG data to assess evidence for feedforward, 
feedback, and recurrent processing between S1 and S2 in a somatosensory 
detection task (Auksztulewicz et al. 2012) – also see Figure 2.1. Recurrent 
processing within the somatosensory system, dominated by an enhanced S1–
S2 connection, underlies somatosensory detection and awareness. This is 
consistent with dominant neural models of consciousness suggesting that 
reportable perceptual experiences depend on (1) sufficient early sensory 
processing, (2) wide distribution of sensory representations within the 
executive functions, and (3) recurrent interactions between sensory and 
frontal brain regions (Lamme 2006; Dehaene & Changeux 2011). If so, any 
reported perceptual abnormality may be caused not only by disturbed sensory 
processing but also by disturbed executive functions, or abnormal interaction 
between the sensory and executive regions of the brain. Abnormalities in such 
recurrent connections may underlie body misperceptions in CRPS (Kuttikat et 
al. 2016).  
 
Anterior insula cortex plays an important role in the anticipation of pain (Porro 
et al. 2002; Wager et al. 2004; Brown & Jones 2008; Palermo et al. 2014) and 
mediating the effect of expectations on pain (Koyama et al. 2005; Atlas et al. 
2010). The insula is a centre of salience processing across multiple sensory, 
emotional, and cognitive domains (Uddin 2014). The anterior insula is thought 
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to be crucial for the hierarchical processing of bodily information, integrating 
afferent thalamic and sensory inputs with top-down control signals arising in 
the prefrontal and cingulate cortex (Seth et al. 2011; Seth 2013). The right 
anterior insula is highly interconnected with primary somatosensory areas 
such as posterior insula and somatosensory cortex (Cerliani et al. 2012; 
Chang et al. 2013) and anticipates the sensory and affective consequences of 
pain and touch (Lovero et al. 2009). The anterior insula also projects to the 
amygdala, forming a network contributing to emotional salience(Seeley et al. 
2007). Functional connectivity between the insula and amygdala is thought to 
be related to levels of pain-related fear and is dampened by effective 
psychological treatment in paediatric patients with CRPS (Simons et al. 2014).  
 
Observations of the centrality of the insula in salience processing have led 
researchers to investigate the role of recurrent connections between the 
insula and somatosensory cortex in somatosensory perception. DCM has 
revealed that unexpected somatosensory stimuli increase the strength of 
forward connections along a caudal to rostral hierarchy – projecting from 
thalamic and somatosensory regions toward insula, cingulate and prefrontal 
cortices – reflecting the role of forward connection in conveying prediction 
error (Allen et al. 2016). The anterior insula, however, was the only region to 
show increased backwards connectivity to the somatosensory cortex, 
augmenting a reciprocal exchange of neuronal signals. These results suggest 
that the anterior insula acts as a hub for regulating somatosensory responses 
in a top-down manner (Figure 2.1). 
 
It has been proposed that the anterior insula and midcingulate cortex form a 
“salience network” (Seeley et al. 2007). Salience and attention has been 
linked to the “precision” (reliability/degree of certainty) of sensory inputs 
(Feldman & Friston 2010). Within the HPC framework, attention serves the 
function of balancing top-down and bottom-up influences on perception 
according to their respective precision weights (Figure 2.1). In HPC, precision  
enhances the influence of ascending prediction errors via the regulation of 
post-synaptic cortical gain (Moran et al. 2013). By this means, attention (via 
the salience network) can drive learning and appropriate plasticity. By 
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extension of this logic, a lack of precision/attention to a particular limb, i.e., 
cognitive neglect, may result in a relative loss of cortical function akin to 
disuse, a hypothetical explanation for cortical changes in patients with CRPS 
in cases in which no other neuropathology can be observed. A useful 
illustration of how this might work in relation to CRPS neglect-like symptoms 
is the rubber hand illusion (RHI). The RHI refers to the illusory sense of 
ownership of a plastic hand, which is induced by synchronous tactile 
stimulation of the fake and the participant’s real (but hidden) hand. In order for 
the brain to assign the experience of ownership to the artificial hand, certain 
sensory evidence must be suppressed, namely proprioceptive evidence that 
the two hands are in different positions (Zeller et al. 2015). In HPC, this 
corresponds to a reduction in the precision/attention afforded to sensory 
prediction errors (Feldman & Friston 2010). As evidence in favour of this 
account, an ERP study (Zeller et al. 2015) identified an attenuation of 
somatosensory-evoked responses in frontal electrodes that corresponded to 
cortical sources in the (contralateral) perirolandic area and the parietal lobe. In 
the absence of an illusion but in the presence of a (perceived) artificial hand, 
responses were larger in primary somatosensory cortex and inferior parietal 
lobule. This is consistent with a hypothetical reduction in gain mediated by 
superficial pyramidal cells in order to resolve the multisensory conflicts arising 
under the illusion. Should similar multisensory conflicts arise in a patient with 
CRPS, as implied by the success of mirror therapy in some patients (McCabe 
et al. 2003), the brain may naturally attempt to resolve these conflicts by 
attenuating somatosensory predictions errors, with the consequence of driving 





Figure 2.1 (A) Neural networks and their effective connections underlying 
somatosensory perception-Figure adapted from (Kuttikat et al. 2016).  
Frontoparietal executive networks are likely to mediate perceptual predictions while 
the salience network (aIC and MCC) mediate the effect of predictions on the 
perception of tactile and pain stimuli, with the aIC acting as a “hub” controlling the 
balance between bottom-up and top-down information.  
PFC, prefrontal cortex; IPC, Inferior parietal cortex; MCC, Midcingulate cortex; aIC, 
Anterior insular cortex; iS2, Ipsilateral secondary somatosensory cortex; cS2, 
Contralateral secondary somatosensory cortex; cS1, Contralateral primary 
somatosensory cortex.  
 
(B) Variables hypothesized to influence the neurocognitive phenotype of CRPS, 
based on a hierarchical predictive coding (HPC) account of parameters describing the 
computational function of each neural network. The integrity of somatosensory 
neurons could be potentially influenced both by neurological factors (e.g., 
neuroinflammation leading to neuronal atrophy) and neurocognitive factors (i.e., 
changes in neural plasticity related to attention and learning). Resulting changes in 
signal quality from early cortical processing could change the precision weights 
attributed to sensory inputs and thereby the gain on prediction errors, a process 
balanced by the relative precision weights on top-down predictions. According to 
HPC models, this balance affects the extent to which predictions are updated 
according to sensory inputs (thereby determining the acuity of tactile perceptions) and 
also affects the content and influence of top-down predictions as mediated by 
anticipatory neural activity prior to expected tactile or nociceptive stimuli. Finally, 
evidence for neuronal atrophy in the executive and salience networks in CRPS lends 
to the hypothesis of long-term changes in neuroplasticity related to the weighting of 











Diagnosis of CRPS remains sub-optimal and this has an adverse effect on the 
effective management of this chronic debilitating pain condition. Several novel 
clinical signs have been reported anecdotally in CRPS, although their clinical 
diagnostic utility is not well defined. We undertook this prospective 
observational cohort study to provide diagnostic clinical utility (sensitivity, 
specificity, predictive values and likelihood ratios) of these novel signs in 
CRPS. 
 
3.2 Central hypothesis and objectives 
We investigated the following central hypothesis in our study: 
 ‘’The prevalence of novel clinical signs will be significantly higher in patients 
with CRPS compared to patients with other chronic pain conditions’’.  
The main objectives were to define and validate these novel signs, assess 
their prevalence in chronic pain conditions, and finally to assess their 
diagnostic clinical utility (sensitivity, specificity, predictive values and likelihood 




3.3.1 Study design: This was a clinically based prospective cohort study. 
3.3.2 Study setting: The study was done in the following clinical areas of 




3.3.3 Inclusion criteria: 
1.Patients with chronic unilateral upper and/or lower limb CRPS will have 
had the condition for at least 6 months and meet the IASP (International 
Association for the Study of Pain) research criteria for CRPS (Harden et al. 
2007) below. 
 Continuing pain which is disproportionate to any inciting event. 
 Report at least one symptom in each of the four following categories 
 Display at least one sign in two or more of the following categories 
o Sensory: hyperaesthesia 
o Vasomotor: temperature asymmetry, and/or skin colour changes 
and/or skin colour asymmetry 
o Sudomotor: oedema and/or sweating changes and/or sweating 
asymmetry. 
o Motor/trophic: Decreased range of motion and/or motor 
dysfunction (weakness, tremor, dystonia) and/or trophic 
changes (hair, nail, skin). 
2. Patients with rheumatoid arthritis will meet the American Rheumatology 
Association’s classification criteria (4 from 7 criteria) (Arnett et al. 1988): 
 Morning stiffness around joints for at least 1 hour (more than 6 weeks) 
 3 or more swollen joints (doctor-observed, reported to be more than 6 
weeks) 
 Proximal interphalangeal, metacarpal or wrist joints (more than 6 
weeks) 
 Symmetrical swelling (more than 6 weeks) 
 Rheumatoid nodules 
 Rheumatoid factor (blood test) 
 Radiographic evidence of erosions and/or periarticular osteopaenia 
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3. Patients with fibromyalgia will meet the American College of 
Rheumatology 1990 classification criteria  (Wolfe et al. 1990) as unexplained 
pain that is: 
 Chronic  
 Widespread (bilateral, axial, above and below waist)  
 Associated with at least 11 of 18 pre-specified tender points 
4. Patients with chronic low back pain will meet the European Commission 
Research Directorate Guidelines (Airaksinen et al. 2006) 
 Pain and discomfort localised below the costal margin and above the 
inferior gluteal folds 
 With or without referred leg pain 
 Which has persisted for at least 12 weeks 
5. Patients with upper or lower limb fracture requiring plaster-of-Paris casting  
6. Healthy controls were recruited from the members of staff of Cambridge 
University Hospitals NHS Foundation Trust and the students of University of 
Cambridge, Clinical School of Medicine. 
3.3.4 Exclusion criteria: 
Patients with a neurological condition that is likely to confound the tests such 
as peripheral neuropathy, carpal tunnel syndrome, multiple sclerosis, stroke 
and Parkinson’s disease were excluded from the study. 
Patients unable to give full informed consent, such as those under 16 years 
and those unable to make competent decisions were also excluded. 
3.3.5 Study procedures: 
At the initial visit, the following baseline data were collected in all patients: 
date of diagnosis, age, sex, past medical history, medication, body part 
affected (if CRPS or fracture), hand dominance and history of dyslexia. For 
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fracture patients, additional data regarding date of fracture and date of casting 
were collected. All patients completed the following five questionnaires 
assessing pain severity, physical function, body perception disturbance and 
emotional state. (Appendix 5). 
1. Brief Pain Inventory – BPI (Cleeland & Ryan 1994) 
This is a widely used well-validated questionnaire (Cleeland & Ryan 1994; 
Tan et al. 2004) for all chronic pain conditions with numerical value scores 
from 0 (no pain) to 10 (pain as bad as you can imagine) in several domains 
(maximal pain, minimal pain, average pain) commenting from the last 24 
hours and also current pain. Using similar scales of 0 (does not interfere) to 
10 (interferes completely), patients are also asked to rate the extent to which 
their pain interferes with 7 quality of-life domains that include general activity, 
walking, mood, sleep, work, relations with other persons, and enjoyment of 
life. Interference domains provide depth to the pain scores. 
The BPI has been used in more than 400 published studies in a variety of 
pain conditions including musculoskeletal and neuromuscular conditions. Tan 
and colleagues (Tan et al. 2004) validated the psychometric properties of BPI 
in chronic non-malignant pain population and found that the BPI scales show 
acceptable internal consistency for both intensity and interference items. They 
also found that BPI scales showed statistically significant improvement with 
treatment confirming the responsivity of BPI in detecting and reflecting 
improvement in pain over time. 
 
2. Upper Extremity Functional Index - UEFI (Stratford et al. 2001) 
 
This is a validated questionnaire (Stratford et al. 2001; Chesworth et al. 2014) 
for functional assessment of the upper limb. 20 domains are scored and each 
item uses a 5-point adjectival response scale to rate difficulty in performing 
Upper Extremity activities: 0 = extreme difficulty or unable to perform activity, 
1 = quite a bit of difficulty, 2 = moderate difficulty, 3 = a little bit of difficulty and 
4 = no difficulty. Summing the items yields a total score from 0 (worst) to 80 
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(best) points. This score has an error +/- 5, with both Minimally Detectable 
Change and Minimal Clinically Important Difference scores of 9 (90% 
confidence).  
 
3. Lower Extremity Functional Index - LEFI (Binkley et al. 1999) 
This is a validated questionnaire (Binkley et al. 1999) for functional 
assessment of the lower limb. 20 domains are scored from 0 (extreme 
difficulty or unable) to 4 (no difficulty) giving a total possible score 80. This 
score has an error +/- 5, with both Minimally Detectable Change and Minimal 
Clinically Important Difference scores of 9 (90% confidence). The LEFI is 
efficient to administer and score and is applicable for research purposes and 
clinical decision making for individual patients. 
4. Neglect-like Symptom Questionnaire - NLSQ (Galer & Jensen 
1999) 
This questionnaire reports on 5 domains scored 1-6 describing ‘body 
perception disturbance’ in patients with chronic pain (Galer & Jensen 1999; 
Frettlöh et al. 2006). It has been validated in a chronic pain cohort. Frettloh 
and colleagues (Frettlöh et al. 2006) in a study of CRPS patients (n=123) and  
chronic limb pain of other causes (n=117) found that the number of patients 
confirming such symptoms was significantly higher in the CRPS group, and 
moreover, these patients reported more severe symptoms. 
Body perception disturbance is more commonly used in the CRPS field in 
preference to ‘depersonalisation’(Lewis & McCabe 2010; Lewis et al. 2007) 
and this is discussed in detail in chapter 2 of this thesis.  Depersonalisation is 
defined as an alteration in the perception or experience of the self so that one 
feels detached from and as if one is an outside observer of one’s mental 
processes or body (Medford et al. 2005) and is described in neuropsychiatric 




5. Hospital Anxiety and Depression Scale - HADS (Zigmond & 
Snaith 1983; Snaith 2003) 
This widely used and well-validated questionnaire (Bjelland et al. 2002; Snaith 
2003) assesses anxiety and depression using 7 domains on each aspect. 
Each domain is scored 0-3 giving a total score of 21. Cut-off scores are 
available for quantification, for example, a score of 8 or more for anxiety has a 
specificity of 0.78 and sensitivity of 0.9, and for depression a specificity of 
0.79 and a sensitivity of 0.83. 
A score of 0 to 7 for either subscale is regarded as being in the normal range, 
a score of 11 or higher indicating probable presence ('caseness') of the mood 
disorder and a score of 8 to 10 being just suggestive of the presence of the 
respective state. Mild (8-10), moderate (11-14) and severe (15-21) cut-offs 
are defined for each aspect of anxiety and depression (Stern 2014). HADS 
has been shown to perform well in assessing the symptom severity and 
caseness of anxiety disorders and depression in both somatic, psychiatric and 
primary care patients and in the general population (Bjelland et al. 2002). 
 
The following clinical tests were performed 
1. Finger perception 
2. Hand laterality task 
3. Astereognosis 








3.3.6 Finger perception 
Finger perception was assessed bilaterally to allow intra-individual 
comparison between affected and unaffected sides. Ten touches were applied 
in a predefined order to the fingers of each hand. This allowed clear 
standardisation between observers. No contiguous finger was consecutively 
touched. Time was measured (using a stop watch) as the total time from 
when the first finger was touched to when the last answer was given after the 
10th touch. Regardless of the answer being correct or wrong for each touch, 
the next touch is applied as soon as the patient gives an answer. This 
continues till the 10 touches in total are applied per hand. If no answer was 
given, the test was finished after 60 seconds with the number of correct and 
incorrect answers recorded to give a percentage. Two outcome measures 
were generated: accuracy (%) and time (seconds). The test was administered 
in a stereotyped fashion and all the participants were given the following 
instruction: 
“I’d like to test the sensation in your fingers with your eyes shut. I’d like to call 
your thumb number 1, index finger number 2 and so on to the little finger and 
similarly on your other hand. Please place your hands on your lap. Do not 
move your fingers when I touch them, but simply tell me the number 
corresponding to the finger that I touch. I will first touch your [left / right] hand 
and then move on to the other. Do you have any questions to me? Thank you. 
Please close your eyes and we will start.” 
The administration of this test takes 2 minutes maximum and does not require 
any resources other than a stop watch. 
3.3.7 Hand laterality task 
A computer program was created in-house in the department of Medical 
Physics, University of Cambridge which presented 56 pre-loaded images in a 
random order. The patients and healthy controls were required to identify the 
presented image as a left or right hand by clicking the mouse and this would 
generate the next image. The process continues till all 56 images have been 
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presented. The program calculates the accuracy out of a total possible score 
of 56. The ‘time’ taken was measured (using a stop watch) as the total time in 
seconds from the first image shown to the last response clicked.  
           
Fig 3.1-3.3 (Hand laterality programme menu, hand recognition & an image of 
a hand) 
Stereotyped instruction was given as follows: “I would like to understand how 
quickly and reliably you can identify left and right hands presented to you 
using the computer programme. Please do not move your hand into the 
position shown but try to use mental imagery to decide whether the picture is 
of a left or right hand. Please select left or right using the mouse. We will time 
you and score how many you get right. Do you have any questions to me? 
Thank you.” 
The time taken to complete this task depends upon the patient but usually is 
around 3-5 minutes. The administration of this task requires a computer 
device with the program installed and a stop watch. 
3.3.8 Astereognosis 
Patients were asked to feel an object with their eyes closed and identify it by 
touch using only one hand. Three common objects were used for each hand. 
A penny, paperclip and key were used for right hand.  A ten pence coin, bull 
dog clip and micropore tape were used for left hand. Two outcomes were 
measured for each hand: accuracy (%) and time (s). 
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Stereotyped instruction was given as follows: “I would like to test whether you 
are able to identify different objects by touch only. I would like you to close 
your eyes and hold out your hand. I will put an object into the palm of your 
hand and I would like you to tell me what it is. You may move it around in your 
hand, but please don’t transfer it to the other hand. I will first test your left/right 
hand and then test the other side. Do you have any questions? Thank you.” 
The time taken to complete this task depends upon the patient but usually is 
around 1-2 minutes. The administration of this task requires the common 
objects used in the test and a stopwatch. 
 
3.3.9 Body scheme report  
Patients and healthy controls compared the sensations from left and right 
sides of their body while deprived of visual (eyes closed) and motor feedback 
(instructed not to move).  
21 areas were included: forehead; cheeks; chin; shoulders; upper arms; 
elbows; forearms; wrists; each digit; lower back; hips; thighs; knees; shins; 
ankles; big toes; other toes. If an asymmetry was perceived, subjects 
quantified the differences in size, length and heaviness, expressed as a 
percentage compared to the normal side.  
Stereotyped instruction was given as follows: “I would like to understand how 
you perceive your body with your eyes closed. I am going to ask you to close 
your eyes, keep your arms and legs still and describe how different parts of 
your body feel. I would like you to compare both sides in terms of size, weight 
and length as well as any other feelings you may be getting from those areas. 
I do not want you to move anything. We will start from your face and move 
down to your arms and legs. Do you have any questions to me? Thank you. 




An example is described below to explain in detail how the scoring was done 
for the body scheme report. Subject A is given the stereotyped instruction as 
above and is instructed to compare the left side to the right side starting at the 
forehead. They are then asked specifically 1) are the two sides same size? 2) 
same length? and 3) same weight?  If the answer is ‘same on both sides’ then 
they are asked to compare the next body area just below and the process 
repeated for all 21 body areas. If for example; they say their right wrist feels 
bigger or smaller than the left, they are asked to quantify the difference – ‘how 
much bigger/smaller than the left wrist in percentage’. If they say it feels 10 % 
bigger on the right wrist compared to left wrist, then this is documented in the 
excel spreadsheet as +10% for the right wrist and if they say it is 20% smaller, 
it is documented  as  -20% and so on. Please see appendix 5.6 for a sample 
data collection chart. The administration of the ‘body scheme report’ test takes 
around 10 minutes. 
All the investigators involved in data collection were given face to face training 
and were checked to make sure that they were administering the above tests 
in the correct and standardised fashion. 
‘Body Scheme Report’ is a novel test. We developed the test by piloting on 
healthy individuals and CRPS patients. We chose several dimensions of the 
test (size, length & weight) to be assessed. These were developed from 
clinical experience that when patients were describing, these were the areas 
of their body that did not feel the same, the descriptors that they used were 
those of size / length / weight. Size does include length but is a common 
characteristic described by patients in terms of the body part described as 
being ‘bigger’ or ‘smaller’. We decided to use percentages as a way of 
quantifying the changes after discussions within the research group. Previous 
public displays of distorted body scheme in patients with chronic pain 
(Wellcome portrait displays for example) support this approach to dividing 
subjective descriptions into these broad areas. We validated this in the 
healthy individuals and CRPS patients for intra-and inter-observer 




3.3.10 Defining a positive test  
 
Data in 60 healthy controls and 49 CRPS patients was taken to determine the 
optimum ‘cut off’ for all tests. The sensitivity was plotted against the 1-
specificity using every possible cut-off point of accuracy and time for Finger 
Perception (FP) and Hand Laterality (HL) and Receiver Operating 
Characteristic (ROC) curve analysis was performed (Figures 3.4 & 3.5). 
 
The optimum sensitivity and specificity for FP was determined to correspond 
to an accuracy of <10/10 OR a time of >20 seconds. For HL the cut off was 
determined to be an accuracy of <50/56 AND a time of >100 seconds. 
Astereognosis (AS) was considered positive if the accuracy was <3/3 OR the 
time was >30 seconds. Body Scheme (BS) was summarized as a composite 
score, where an abnormal perception of two contiguous areas ≥5% 
(e.g.shoulder and upper arm or ankle and lower leg) was regarded as a 
positive test result. For the ‘Body Scheme Report’, the expert statistical advice 
was that it was not appropriate to do a ROC analysis because the data was 
multi-dimensional and not on a continuous scale (i.e. often categorical). 
Therefore it made sense to reduce the dimensionality of the data by deriving a 
composite score. The changes refer to any of the three measurements of 
size, length and weight. We reflected following discussions within the 
research group and data analysis from preliminary data. We developed the 
cut off of 2 contiguous areas based on the data and putative underlying 
mechanism of this altered perception (i.e. cortical reorganisation) to maximise 
sensitivity/specificity. We decided on ≥5% change so that we were only 











Figure 3.4: Receiver Operating Characteristic (ROC) plot with data points 
representing the sensitivity and 1-specificity corresponding to every possible cut-off 
point combination of thresholds of time and accuracy for the finger perception test. 
This was constructed based on using the affected arm of CRPS patients and the non-
dominant hand of healthy controls. The optimum cut-off point combination is when 
Accuracy<10 or Time> 20 seconds indicates a positive test, corresponding to a 
sensitivity of 88% and specificity of 88%. 
                    
                           








Figure 3.5: Receiver Operating Characteristic (ROC) plot with data points 
representing the sensitivity and 1-specificity corresponding to every possible cut-off 
point combination of thresholds of time and accuracy when using the Hand laterality 
test to diagnose CRPS. The optimum cut-off point combination is when Accuracy<50 
and time>100 seconds indicates a positive test for CRPS, corresponding to a 
sensitivity of 69% and specificity of 70%. 
                        
                                                                                 






3.3.11 Inter-rater variability testing  
 
We established that there was no significant inter-rater variability in testing as 
follows. Five subjects were tested for novel clinical signs by four investigators 
separately during one session. Each investigator attended two 30-minute 
training sessions and was assessed that they were performing the clinical 
tests to the same standard. The results showed that there was a high inter-
rater agreement (Fleiss’ Kappa=0.84, SE=0.11, 95% CI= 0.6-1.0).  
 
 
3.3.12 Intra-rater variability testing 
 
We established that there was no significant intra-rater variability as follows: 
Nine subjects were tested on the novel signs on two separate occasions by 
the same investigator less than 4 weeks apart. There was a good strength of 
agreement between the results from 2 sessions (Cohen’s Kappa=0.65, 
SE=0.34, 95% CI= 0.02-1.0).  
 
3.3.13 Study outcomes 
 
The primary outcome measures were the sensitivity, specificity, positive 
predictive value, negative predictive value, positive likelihood ratio and 
negative likelihood ratio for the novel signs in the CRPS group compared to 
the Fracture group. The secondary outcome measures of the study were the 
prevalence of novel signs in different groups. 
 
3.3.14 Statistical analyses 
 
Sensitivity, specificity, positive predictive value, negative predictive value, 
positive likelihood ratio and negative likelihood ratio were calculated using 
MedCalc for Windows, version 12.7 (MedCalc Software, Ostend, Belgium). 
ROC curve analysis, ANOVA and Kappa testing were done using IBM SPSS 




The statistical tests used in this study are described in detail below (Bland 
2000; Lalkhen & McCluskey 2008; Altman 1991). 
 
The sensitivity of a clinical test refers to the ability of the test to correctly 
identify those patients with the disease. It is derived by the formula: true 
positives divided by the sum of true positives and false negatives. 
 
The specificity of a clinical test refers to the ability of the test to correctly 
identify those patients without the disease. It is derived by the formula: true 
negatives divided by the sum of true negatives and false positives. 
 
The Positive Predictive Value of a test is a proportion that answers the 
question: ‘How likely is it that this patient has the disease given that the test 
result is positive?’ It is derived by the formula: true positives divided by the 
sum of true positives and false positives. 
 
 The Negative Predictive Value of a test answers the question: ‘How likely is it 
that this patient does not have the disease given that the test result is 
negative?’ It is derived by the formula: true negatives divided by the sum of 
true negatives and false negatives. 
 
Positive likelihood ratio is the probability of a person who has the disease 
testing positive divided by the probability of a person who does not have the 
disease testing positive. It is derived by the formula: Sensitivity divided by (1-
Specificity). 
 
Negative likelihood ratio is the probability of a person who has the disease 
testing negative divided by the probability of a person who does not have the 
disease testing negative. It is derived by the formula: (1-sensitivity) divided by 
specificity. 
 
In a Receiver Operating Characteristic (ROC) curve, the true positive rate 
(Sensitivity) is plotted in function of the false positive rate (100-Specificity) for 
different cut-off points. Each point on the ROC curve represents a 
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sensitivity/specificity pair corresponding to a particular decision threshold. The 
area under this curve (AUC) represents the overall accuracy of a test, with a 
value approaching 1.0 indicating a high sensitivity and specificity. A test with 
perfect discrimination (no overlap in the two distributions) has a ROC curve 
that passes through the upper left corner (100% sensitivity, 100% specificity). 
Therefore the closer the ROC curve is to the upper left corner, the higher the 
overall accuracy of the test (Zweig & Campbell 1993).  
 
ANOVA (Analysis of Variance) is a statistical technique for testing whether 
different groups have different means on some metric variable. One-way (one 
independent variable) or two-way (2 independent variables) refers to the 
number of independent variables in the ANOVA test. Repeated measures 
analysis of variances (ANOVA) is used when the same parameter has been 
measured under different conditions on the same subjects. If the ANOVA test 
is positive (P less than the selected significance level) then a post hoc test 
(Tukey's) is used for pairwise comparison of subgroups (Altman 1991). 
 
Cohen’s kappa is a measure of the agreement between two raters who 
determine which category a finite number of subjects belong to whereby 
agreement due to chance is factored out. Cohen’s kappa takes into account 
disagreement between the two raters, but not the degree of disagreement. A 
weighted version of Cohen’s kappa can be used to take the degree of 
disagreement into account (Cohen 1968). Another modified version of 
Cohen’s kappa, called Fleiss’ kappa, is used where there are more than two 














3.4.1 Study population 
 
 
A total of 313 subjects (60 healthy controls and 253 patients) were recruited 
into the study from a single centre (Addenbrooke’s Hospital) between August 
2009 and August 2013. The patients were recruited from the five different 
groups of CRPS (n=49), FMS (n=50), RA (n=60), LBP (n=47) and fracture 
(n=47). In the CRPS group, 31 (63%) had an upper limb affected and 18 
(37%) had a lower limb affected. In the fracture group, 39 (83%) had upper 
limb fracture and eight (17%) had lower limb fracture. 
 
 The baseline characteristics of the subjects are documented in Table 3a.  
 
Single factor ANOVA revealed a significant difference between the mean 
ages of different groups, F (5, 307) = 15.88, p = <0.001. A Tukey post-hoc test 
revealed that there were no statistically significant differences between the 
ages of CRPS (43.6 ± 13.2 years) and healthy controls (36.1 ± 13.9 years, 
p=0.078), however the ages of healthy controls were lower than RA (56.0 ± 
14.4 years, p = <0.001), FMS (46.7 ± 13.5 years, p = 0.002), LBP (54.0 ± 13.8 
years, p = <0.001) and Fracture (53.5 ± 17.2 years, p = <0.001) subjects. The 
proportion of females in the study ranged from 55.3% in the fracture group to 
92% in the FMS group, reflecting the expected female preponderance. 
Majority of subjects in each group (ranging from 78.7% in the LBP group to 
89.3% in the fracture group) were right handed.  A small minority of subjects 
in each group had self-reported diagnosis of dyslexia (ranging from 6.1% in 
CRPS to 14.8% in LBP).  All patient groups had multiple co-morbidities and 
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*All fracture subjects had acute fractures of less than 2 weeks duration and 






3.4.2 Clinical Outcomes 
 
 
Table 3b demonstrates the prevalence of each of the signs across all of the 
groups. Abnormal BS had a very high prevalence in the CRPS group (93.9%) 
that was significant when compared to all of the other groups (23-50%). 
Abnormal FP was also significantly higher in the CRPS group (85.6%) when 
compared to the other groups (23-62%). Abnormal HL was very prevalent in 
all chronic pain groups – CRPS (69.4%), FMS (72%), RA (76.7%) and LBP 
(63.8%). AS had the lowest prevalence within each group (12-36%) and there 
were no significant differences between the groups. 
 
Individually, the tests did not appear to reliably distinguish patients with CRPS 
from other chronic pain conditions, although most patients with CRPS had 
abnormal finger perception and body scheme reports.  However, when we 
combined the two best performing tests in CRPS (finger perception and body 
scheme report) as a composite test and this still has a prevalence of 75.5% in 
the CRPS group while significantly decreasing the prevalence in all other 
groups compared to all four signs individually. There was no statistically 
significant difference in the number of positive signs between the upper and 
lower limb affected groups in either the CRPS group (p=0.15) or the fracture 















Table 3b: Prevalence of novel clinical signs in all groups 
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2-tailed p-values were calculated by Fisher’s exact test and represents the 


















The prevalence of the four novel signs is shown in Table 3c. 
35% of the healthy control did not have a single positive sign compared to at 
least one positive test in all 49 patients with chronic CRPS. Furthermore 9/16 
patients with four positive tests had a diagnosis of CRPS. 67.3% of the CRPS 
group had 3 or more signs, compared with 3.3% of the healthy control group 
and 13.3%; 21.3%; 27.7%; 32% in the RA; LBP; Fracture and FMS groups 
respectively. Of interest is that there was no significant difference in the 
prevalence of positive clinical signs in the CRPS group when comparing 
upper and lower limb involvement in either the CRPS group (p=0.15) or the 
fracture group (p=0.38). 
 
Table 3c: Prevalence of novel clinical signs 
 



















































































































































The clinical utility (sensitivity, specificity, positive predictive value, negative 
predictive value, positive likelihood ratio and negative likelihood ratio) of four 
clinical signs were calculated compared to the fracture group as this is the 
most relevant group in terms of being a risk factor for development of CRPS 
(Table 3d). 
BS had the highest sensitivity (93.9%) and specificity (72.3%). The absence 
of BS was clinically useful in being able to rule out CRPS (91.9% negative 
predictive value with a negative LR of 0.1). Combining the two best 
performing tests of FP & BS improves the specificity (85.1%) with a high 
positive predictive value (84.1%). 
 
Table 3d: Clinical utility of novel clinical signs (compared to fracture group) 
 

































































































































(Sn=Sensitivity, Sp=Specificity, PPV=Positive Predictive Value, NPV=Negative 
Predictive Value, PLR=Positive Likelihood Ratio, NLR=Negative Likelihood Ratio)  




3.4.3 Questionnaires results 
 
The data on pain severity, physical function, emotional state and 
depersonalisation were collected using five questionnaires – 
(Brief Pain Inventory (Cleeland & Ryan 1994), Upper Extremity Functional 
Index (Stratford et al. 2001), Lower Extremity Functional Index (Binkley et al. 
1999), Hospital Anxiety Depression score (Snaith 2003) and Neglect-like 
Symptom Questionnaire (Galer & Jensen 1999). (Table 3e) 
 
The subjects in the CRPS group had the highest pain, anxiety and depression 
scores and the lowest functional scores although these differences were not 
statistically significant. ANOVA revealed a significant difference between the 
mean NLSQ scores of different groups, F (4, 248) = 24.2, p = <0.001. A Tukey 
post-hoc test revealed that the average NLSQ scores were significantly higher 
in the CRPS group (4.21 ± 0.95, p=<0.001) compared to all other groups 
suggesting a significant degree of depersonalisation in CRPS. The scores on 
the questionnaire data did not correlate significantly (Spearman’s rho) with 










































(n=47)    
 
Maximum  Pain  
 
8 (1.68) 7.34 (1.25) 4.81 (2.6) 6.53 (2.02) 3.31 (2.61) 
Least Pain 
 
5.74 (2.29) 4.5 (2.62) 2.41 (1.91) 3.63 (2.42) 1.44 (2.03) 
Average Pain 
 
6.59 (1.86) 5.8 (1.78) 3.85 (1.92) 5.29 (1.66) 2.41 (2.18) 









































9.44 (4.66) 5.15 (3.55) 7.51 (5.11) 3.93 (3.17) 
NLSQ-Average 
 
4.21 (0.95) 2.88 (1.29) 2.36 (1.26) 2.32 (1.24) 2.17 (1.19) 
 
Mean scores for each group with standard deviations in brackets.  
 
3.4.4 Fracture follow-up  
 
20 subjects with fracture (n=14 upper limb & 6 lower limb) were re-tested for 
the novel clinical signs after six months of the plaster cast removal (Tables 3f 
& 3g).  
 
There was a statistically significant decrease in the average number of 
positive signs per subject from 1.55 to 1.0 in six months (paired t test, 
p=0.02). 50% (n=10) had finger misperception when in plaster cast, but this 
had resolved in 30% (n=3) of them at 6 months. 50% (n=10) had abnormal 
hand laterality at the onset but only 35% (n=7) at 6 months. The proportion of 
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subjects with astereognosis had also improved from 35% (n=7) to 10% (n=2). 
15% (n=3) were positive for the composite test of finger misperception and 
abnormal body scheme report initially but none were positive for this at 6 
months.  
 
The mean of the average pain score of the 20 subjects improved from 2.45 to 
1.4 (paired t test, p=0.01). There was also a statistically significant 
improvement in the Neglect like Symptom Questionnaire (NLSQ) score from 
2.35 to 1.58 (paired t test, p=0.01).  
 
We reviewed the electronic hospital records of all 47 fracture patients in the 
study to assess the clinical progress for a mean duration of 3.2 years (range 
1.5-5). 4/47 (8.5%) patients had persistent pain as documented by the clinical 
record. Out of 7 patients who were positive for both FP and BS report at initial 
testing, 3 had persistent pain with one having a formal diagnosis of CRPS. 
Another patient (who was negative for both finger perception and body 
scheme report) also had persistent pain but this was attributed to the severity 
of injury (i.e. not disproportionate pain) and there were no clinical signs of 
CRPS. There was no significant correlation between baseline pain report and 
the development of chronic pain. 
 
Table 3f: Prevalence of novel clinical signs: Fracture follow-up 
 











































































































































Previous studies have reported the presence of novel signs in CRPS (Galer et 
al. 1995);(Förderreuther et al. 2004);(Reinersmann et al. 2012). 
However, the clinical diagnostic utility of these signs in CRPS have not been 
established previously in a systematic fashion. 
We recruited a large cohort of patients (253 patients in five different groups of 
CRPS, FMS, RA, LBP and Fracture) and healthy controls (60 healthy) and 
objectively defined bedside tests for FP, HL, AS & BS.  
CRPS & Fracture patients were recruited with unilateral involvement only as 
comparisons could then be made between affected and unaffected sides in 
the same subject. Patients with other chronically painful conditions (for eg; 
RA, FMS & LBP) were also recruited to the study to assess the prevalence of 
novel signs in these groups. These groups are obviously clinically 
distinguishable and different to CRPS but were recruited as it would be 
scientifically insightful to see if novel signs are unique to CRPS.  
Carpal Tunnel Syndrome (or other painful mononeuropathy) would also have 
been a useful control group. This group was used in the original research 
studies to develop and validate the diagnostic criteria for CRPS (Harden et al. 
2007; Harden et al. 1999). However, we focused on control groups mainly 
seen at the Rheumatology clinics. In future studies, Carpal Tunnel Syndrome 
(or other painful mononeuropathy) is definitely worth considering as a control 
group as they provide a non-CRPS neuropathic pain group with objective 
diagnosis made by nerve conduction studies. 
We chose the 4 signs based on their relationship to body scheme and parietal 
function. We considered others such as Synchiria and Two-Point 
Discrimination. Synchiria is a phenomenon in which, although there is no 
apparent loss of sensation, stimulus applied to one side of the body is referred 
by the patient to both sides(Krämer et al. 2008). Dysynchiria is a term derived 
from synchiria and describes the phenomenon whereby stimulation of the 
intact limb elicits pain (brush-evoked allodynia) or paraesthesia at the 
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corresponding site on the affected limb, if the patient watches the stimulation 
in a mirror  (Krämer et al. 2008). This has been reported in CRPS patients 
(Moseley et al. 2014; Acerra & Moseley 2005).  
 
Impaired tactile acuity is reported in chronic pain patients including CRPS 
(Catley et al. 2014). Two-Point Discrimination (TPD) threshold is a 
quantitative measure of tactile acuity and is measured using calipers. Large 
variability in TPD measurements has been reported between subjects and 
across multiple body sites, suggesting random error. Therefore, although TPD 
may be reliable within a person, it may lack precision (Cashin & McAuley 
2017). We wanted to pick those signs that would be applicable with little 
specialist equipment and practical in a busy clinic or fracture room. Hence, we 
discarded synchiria and TPD as we thought they would be too complex. 
 
We wanted to develop a series of tests that can be applied in busy outpatient 
clinics. The Bath CRPS Body Perception Disturbance Scale may not be suited 
to this in our view. Further work can be established to assess the relationship 
between the CRPS BPDS and the body scheme test but these are not directly 
comparable as one is a paper-based questionnaire and the other 
phenomenological report. Although this would be an interesting comparison, it 
was not a relevant line of enquiry to our research in developing clinically 
useful bedside tests. 
 
We validated tests for FP, HL, AS & BS with a small number of assessors 
following a short training programme and the results showed that there was 
good intra- and inter-rater agreement. An ROC curve analysis was carried out 
to determine the cut-offs for optimum sensitivity and specificity. These were 
then used to calculate the prevalence of the novel signs in different groups. 
 
Förderreuther et al had reported that 48 % had impaired accuracy to identify 
fingers in the affected hand compared to contra-lateral hand in their study of 
73 CRPS patients (Förderreuther et al. 2004). However, this study did not 
take into account the time delay (latency) in responding to the touch. We used 
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both accuracy and time (latency) to define the cut-offs and we found that a 
higher proportion (85.6% of 49 patients) had finger misperception. 
Reinersmann et al reported delayed reaction time and reduced accuracy in 
limb laterality recognition in CRPS and Phantom limb pain patients compared 
to healthy controls (Reinersmann et al. 2010). However, this was a small 
study (n=12) and also did not assess the presence of this sign in other chronic 
pain conditions unlike our study.  
 
 
Our study found that the prevalence of abnormal body scheme report and 
finger misperception were significantly higher in the CRPS group compared to 
other chronically painful conditions. However, the prevalence of other two 
signs (abnormal hand laterality and astereognosis) was not significantly 
higher in the CRPS group. Hence, this study partially confirmed the central 
hypothesis – ‘’the prevalence of novel clinical signs will be significantly higher 
in patients with CRPS compared to patients with other chronic pain 
conditions’’. The higher prevalence of abnormal body scheme report and 
finger misperception in CRPS group suggests that body perception 
disturbance plays a significant role in CRPS and this is in keeping with 
findings from previous studies in CRPS(Lewis et al. 2007; Cohen et al. 2013). 
 
Our findings also demonstrate that the novel signs are not unique to patients 
with CRPS, but appear in all chronic pain groups. This suggests that some of 
the underlying mechanisms responsible for the novel signs are shared across 
the various chronically painful conditions. Further research is needed to 
establish the relevance of these findings in these groups and also to test 
whether these may be useful in stratifying a sub-group of patients (for eg; 
within RA patients) that may respond better to chronic pain management 
strategies rather than those focusing on inflammation control. 
 
There was no relationship between the presence of a positive test and self-
reported pain scores; anxiety and depression scores; nor functional scores. 
The absence of correlation between clinical tests and pain scores may also be 
a reflection of multiple factors underlying chronic pain and their complex 
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interactions. The study was also not powered to detect such differences 
however and further work is needed to explore any possible relationships. 
 
We calculated the diagnostic clinical utility (sensitivity, specificity, positive 
predictive value, negative predictive value, positive likelihood ratio and 
negative likelihood ratio) of novel signs in patients with CRPS. BS had the 
highest positive predictive value (78%) and the highest negative predictive 
value (91.9%). The diagnostic clinical utility was further increased by 
combining the two best performing tests of FP and BS as a composite test. 
There are many predictors of chronic pain following trauma. These include 
leaving education early; low self-efficacy scores; high baseline pain scores; 
high levels of sleep disturbance; and high levels of depression and anxiety 
(Castillo et al. 2006). None of these predictors perform well enough to predict 
persistent pain in the acute phase. 
 
Moseley et al report that a pain score of less than 5 rules out a diagnosis of 
CRPS (Moseley et al. 2014). 10/47 patients recorded a baseline pain VAS of 
5+ in our cohort and yet only 4 developed persistent pain of which 2/4 patients 
had a baseline average pain score of <5/10. We were therefore unable to 
replicate Moseley’s findings in our smaller cohort and it seems unlikely that 
using pain scores per se will be a sufficient marker to predict persistent post-
fracture pain. It’s possible that this difference reflects the timing of when the 
question was asked with Moseley’s cohort being asked within the first week, 
whereas patients in this cohort were captured within 4 weeks of the injury. 
 
Tests of altered body scheme are much more predictive. The absence of 
either abnormal finger perception or body scheme report was highly predictive 
of the absence of persistent pain. Their presence was associated with a 
significant increase in the presence of persistent pain. These findings support 
Moseley et al’s findings that dysynchiria (bilateral sensations when one limb is 
touched) is a strong predictor of CRPS when present. Assessing for 
dysynchiria takes 25 minutes and would not be practical in a clinical setting. 
Finger perception and abnormal body scheme assessments take less than 5 
minutes to perform. Using these tests will stratify patients rapidly into those ‘at 
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risk’ of developing persistent pain including CRPS; and those who are not. 
The prevalence of both signs together is 14.9% thus stratifying a manageable 
cohort in the Fracture clinic for targeted intervention, such as education, 
physiotherapy and analgesics. 
 
This is a single centre study and the numbers included are small. In this study 
the optimum cut-offs for each test were derived and then the prevalences of 
positive signs estimated using the same dataset. Validation of the optimum 
cut-offs is required in future studies using independent data. The healthy 
control group were importantly balanced in terms of age to the CRPS group, 
but were younger than the patient groups of LBP, FMS, RA and Fracture. This 
significant age difference is likely to under-estimate the predictive values. 
Patients with CRPS were more likely to be taking anti-neuropathic agents or 
anti-depressants. Both of these groups of drugs have cognitive side effects. 
It’s doubtful that these medications contribute significantly to the presence of 
signs as the RA and Fracture demonstrated a high prevalence of signs but 
very few patients took these medications. 
 
These bedside tests assess higher cognitive functions, known to be disrupted 
in some patients with CRPS and correlating to the size of mechanical 
allodynia (Cohen et al. 2013). FP did not correlate with the site of chronic pain 
suggesting that abnormal central processing is the dominant mechanism. 
Serial functional neuroimaging studies in these patient groups may provide 
further evidence and possible therapeutic targets in this regard. The pain 
phenotype may be better understood if future studies take into account 













 3.6 Conclusions 
 
 
Novel signs of FP, HL, BS, AS are present in CRPS patients and have 
significant clinical diagnostic utility. They are also present in other chronically 
painful conditions such as rheumatoid arthritis, fibromyalgia syndrome and 
low back pain. Combining FP and BS is helpful in stratifying a cohort of at risk 
patients post-fracture. It is a quick, simple and reliable test that can easily be 
taught. The pain phenotype may be better understood by assessing for 






































4.1 Definition and mechanisms 
 
The adult brain is plastic and maintains the ability to reorganise throughout 
life. Cortical reorganisation refers to structural and functional changes in the 
cerebral cortical properties. This has been reported in somatosensory 
(Merzenich et al. 1984; Pascual-Leone & Torres 1993; Maeda et al. 2014), 
motor (Giraux et al. 2001), auditory (Pape et al. 2014; Pantev et al. 1998) and 
visual (Darian-Smith & Gilbert 1994; Gilbert & Li 2012) cortices.  It is of major 
interest to both neuroscientists and clinicians as it is increasingly recognised 
to play an important role in learning and functional recovery after injury to the 
nervous system. 
 
Cortical reorganisation is caused by a combination of ‘unmasking’ of latent 
synaptic connectivity and formation of new functional connections through 
axonal sprouting. Activation of NMDA receptors, reduction of GABAergic 
inhibition, increased Brain-derived Neurotrophic Factor (BDNF) and 
downregulation of Nogo (Neurite outgrowth inhibitor) have been shown to be 
important underlying mechanisms (Endo et al. 2009). 
 
 
4.2 Measuring cortical reorganisation 
 
Researchers have used various modalities including microelectrodes, 
haemodynamic (PET, f-MRI) and electromagnetic (EEG, MEG) techniques to 
measure cortical reorganisation. The relative merits of these techniques with a 
special focus on EEG are discussed below. 
 
EEG (Electroencephalogram) measures the voltage fluctuations along the 
scalp through multiple surface electrodes placed on the scalp. There are 
mainly two types of electrical activity associated with neurons inside the brain, 
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namely action potential and post-synaptic potentials (Olejniczak 2006). Action 
potentials are discrete voltage spikes lasting about a millisecond, and travel 
from axon cell body to terminals resulting in release of neurotransmitters. The 
surface electrodes cannot usually detect them as they tend to cancel each 
other out in different axons. Post-synaptic potentials are generated when 
neurotransmitters bind to receptors causing opening or closing of ion 
channels resulting in a transmembrane potential. These are confined to the 
cell body and dendrites rather than travelling down the axon at a fixed rate. 
They last tens to hundreds of milliseconds and under certain conditions 
summate allowing us to record them at the scalp using EEG (Luck 2005).  
 
Hans Berger, a German neuro-psychiatrist is credited with the first recording 
of human EEG in 1924. He used silver foil electrodes attached to the head by 
rubber band and recorded the electric voltages by a galvanometer (Berger 
1969).  
 





Fig 4.2: One of the first EEG recordings by Berger 
Top trace is the EEG and the bottom trace is a 10 Hz 




In clinical contexts, EEG usually refers to measuring spontaneous electrical 
activity of brain and is used in the diagnosis of various clinical conditions 
including epilepsy, encephalopathies and sleep disorders (Noachtar & Remi 
2009; Kaplan & Rosetti 2011; Arriaga & Paiva 1990). EEG is a coarse 
measure of brain activity and represents a myriad collection of numerous 
different sources of neural activity. However, averaging techniques can be 
used to extract specific neural responses to sensory, cognitive and motor 
events which are embedded within the whole EEG. These specific responses 
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are called Event Related Potentials (ERP) as they are electric potentials that 
display stable time relationships to specific definable events. ERP measures 
averaged EEG signals time-locked to complex processing of stimuli. Analysis 
of ERP waveforms can yield information on cortical structure and function, 
and they are used in various fields of neuroscience research(Luck 2005). 
 
ERP provides a continuous measure of processing between a stimulus and a 
response and this helps to study the effect of experimental manipulations on 
different stages of processing. They also provide information on processing of 
stimuli even in the absence of a behavioural response(Blackwood & Muir 
1990; Luck 2005). The functional significance of an ERP component may be 
difficult to interpret compared to a behavioural measure. The other 
disadvantage of ERP technique is that large numbers of trials are necessary 
per subject in each condition to measure the ERPs accurately as they are 
small amplitude signals (Beres 2017; Luck 2005).  
 
Grand average ERP waveforms are created by averaging together the 
averaged waveforms of individual subjects in a study. This masks the 
individual variability across subjects which is useful in studying similarities but 
has the disadvantage that the grand average may not be a true reflection of 
individual patterns (Luck 2005).  One of the factors responsible for the 
between-subject variation is the idiosyncratic folding pattern of cortex which 
influences the ERP waveforms. Medications, age and psychopathology are 
other factors that affect the shape of waveforms (Blume 2006; Polich 1997; 
Nuwer 2012). 
 
ERP waveforms will have positive and negative deflections called peaks or 
components which are labelled P1, N1, P2, N2, P3 etc. P refers to positive 
and N refers to negative, and the numbers refer to the peak’s position within 
the waveform  (Luck 2005). It is also common to give a precise latency in 
milliseconds (ms) such as P300 as the P3 wave had a peak latency of around 
300 ms in the original experiment. However, this can be misleading as the 
latency can vary widely. For example, P300 usually peaks anywhere between 
250 to 500 ms and not at 300 ms (Polich 2009). 
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The somatosensory ERP begins with a rare ERP component that reflects 
action potential from peripheral nerves followed by a set of sub-cortical 
components (10-20 ms) and short and medium latency cortical components 
(20-100 ms).  Classically, an N1 wave is observed at approximately 150 ms 
followed by a P2 wave at approximately 200 ms (Luck 2005).  
 
P3 or P300 refers to the positive peak seen between 250 and 500 ms after 
stimulus onset. This is an endogenous potential as it does not depend upon 
the physical attributes of the external stimulus but on the person’s reaction to 
the stimulus. This has two components, P3a (also called novelty P3, between 
250 & 280 ms) and P3b (also called classic P3). P3a originates from stimulus 
driven frontal attention mechanisms during task processing, whereas P3b 
originates from temporo-parietal activity associated with attention and appears 
related to subsequent memory processing (Polich 2009). The hallmark of P3 
is its sensitivity to target probability. Discriminating the target from the 
standard stimulus produces a robust P300 that increases in amplitude as the 
target’s global and local sequence probability decreases (Duncan-Johnson & 
Dunchin 1977). 
 
In addition to analysing the amplitude and latency of ERP voltage waveforms, 
Global Field Power (GFP), which is a single, reference independent measure 
of response strength, is often used in neuroimaging studies. The concept of 
GFP was first introduced by Lehman & Skrandies (Lehmann & Skrandies 
1980). GFP is defined as the root mean square (RMS) across the average-
referenced electrode values at a given instant in time. In the case of ERPs, 
the resultant GFP waveform is a measure of potential as a function of time. 
However, as GFP is a non-linear transformation, the GFP of the group-
average ERP is not equivalent to the mean GFP of the single-subject ERPs 








Table 4a: Comparison of different neurophysiology measurement techniques; 

















































EEG, MEG and f-MRI are non-invasive and involve no radiation exposure 
making it possible to collect large amount of data from each subject. 
Microelectrode measures are extremely invasive and PET scan involves 
radiation exposure making both of these techniques less suitable in human 
subjects.  
 
EEG and MEG have excellent temporal resolution of around 1 millisecond 
whereas the haemodynamic measures of PET and f-MRI have a limited 
resolution of several seconds. However, the haemodynamic measures have 
an excellent spatial resolution in the millimetre range which EEG cannot 








4.3 Somatosensory cortical reorganisation 
 
 
The somatosensory system detects peripheral sensations and conveys them 
via pathways through the spinal cord, brainstem, and thalamus to the sensory 
cortex in the parietal lobe (Brodal 1969). 
 
Aδ and C fibres carry noxious sensory information and Aβ fibres carry non-
noxious stimuli from the periphery. Aβ fibres are highly myelinated and of 
large diameter, therefore allowing rapid signal conduction (Conduction 
velocity >40 m/s). They have a low activation threshold and usually respond to 
light touch and transmit non-noxious stimuli. Aδ fibres are lightly myelinated 
and smaller diameter, and hence conduct more slowly than Aβ fibres 
(Conduction velocity 5-15 m/s). They respond to mechanical and thermal 
stimuli. They carry rapid, sharp pain and are responsible for the initial reflex 
response to acute pain. C fibres are unmyelinated and are also the smallest 
type of primary afferent fibre. Hence they demonstrate the slowest conduction 
(Conduction velocity <2 m/s). C fibres are polymodal, responding to chemical, 
mechanical and thermal stimuli and their activation leads to slow, burning pain 
(Waxman 1980; Krarup & Buchthal 1985; Rivner et al. 2001). 
 
The sensations are transmitted via the peripheral nerves to the dorsal root 
ganglion, which houses the first-order neuron for the somatosensory system. 
The fibres split into 2 functional groups: a lateral group (or anterolateral 
system) that carries pain and temperature sensations; and a medial group (or 
dorsal column-medial lemniscal system) that carries proprioceptive impulses. 
The sensation of touch is mediated by both systems (Parent 1996; Brodal 
1969). 
 
The lateral group of fibres enters the spinal cord, then ascend or descend 
approximately 2 spinal cord segments to terminate on the substantia 
gelatinosa and the nucleus proprius, where the second-order neurons are 
housed. These neurons have projections that cross over to the contralateral 
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side via a tract called the anterior white commissure. Fibres then ascend via 
the brainstem to the thalamus in the spinothalamic tracts. Two primary 
spinothalamic tracts exist: the lateral spinothalamic tract, which conveys pain 
and temperature information, and the anterior spinothalamic tract, which 
conveys pain and poorly localizable touch sensation (Brodal 1969; Parent 
1996).  
 
The medial group also sends its fibres into the posterior spinal cord; however, 
upon reaching it, most fibres ascend to the dorsal column nuclei in the 
medulla and synapse there. These tracts synapse on a second-order neuron 
in the nucleus gracilis and cuneatus, which are located in the medulla. Their 
axons then decussate (via internal arcuate fibres) and form a bundle known 
as the medial lemniscus. Fibres of the posterior columns and medial 
lemniscus are concerned primarily with position sense and fine discriminative 
touch (Parent 1996; Brodal 1969). 
 
The third-order neurons then project, via the posterior limb of the internal 
capsule, to the primary somatosensory cortex (S1), which is located in the 
postcentral gyrus of the parietal lobe (Parent 1996). Primary somatosensory 
cortex serves to integrate sensory information. It also receives connections 
from the motor cortex, somatosensory association cortex, and the 
contralateral primary somatosensory cortex. S1 representation refers to the 
pattern of neuronal activity that is evoked when a body part is stimulated. This 
is generally in keeping with the topographic ‘homunculus’ model proposed by 
Wilder Penfield (Penfield & Boldrey 1937). Genital and leg fibres are located 
medially, whereas arm, hand, face, and tongue fibres are on the lateral 
surface of the somatosensory area. Body areas particularly important to the 
sensory system (for example the face, lips, and hand) are given larger 











4.3.1 Animal studies 
 
Merzenich et al used microelectrode mapping techniques to show that digit 
amputation in adult monkeys resulted in increased cortical representation of 
the 4 adjacent digits. They found that within two months the area of cortex 
corresponding to amputated digit started to respond to touch stimuli delivered 
to adjacent digits, i.e.; this area was ‘taken over’ by sensory input from 
adjacent digits (Merzenich et al. 1984). 
Jenkins et al in a related experiment using normal adult monkeys showed that 
behaviourally controlled tactile stimulation produced an expansion of cortical 
representation zone in trained fingers (Jenkins et al. 1990). 
 
 
4.3.2 Human studies (other than CRPS) 
 
Elbert et al in a magnetic source imaging study showed that cortical 
representation of the digits of the left hand of string players (violinist, cellists, 
guitarists) was larger compared to controls. No such differences were 
observed for the right hand digits. Moreover, the amount of cortical 
reorganization in the representation of the fingering digits was correlated with 
the age at which the person had begun to play (Elbert et al. 1995). 
 
Pascual-Leone et al reported increased cortical representation for the index 
finger used in reading by blind Braille readers. They studied organisation of 
somatosensory cortex in 15 proficient Braille readers (10 using 
Somatosensory evoked potential elicited by electrical stimuli to the index 
finger and 5 using transcranial magnetic stimulation) and compared them to 
the control group of 15 non-blind non-Braille readers. The scalp areas from 
which they recorded N20 and P22 components of somatosensory evoked 
potential were significantly larger in the reading fingers compared to the non-
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reading fingers of the braille readers as well as both left and right hand fingers 
of the control subjects (Pascual-Leone & Torres 1993). 
 
Reversible cortical reorganisation has been reported in phantom limb pain. 
MEG (magnetic encephalogram) source imaging showed that the mouth area 
of S1 shifted into that of the former hand and the extent of this shift highly 
correlated with the intensity of pain (Flor et al. 1995). Behaviourally relevant 
sensory discrimination training in the stump area reduced the cortical 





             4.4 CRPS neuroimaging studies 
 
 
Investigators have used several functional neuroimaging techniques such as 
electroencephalography (EEG), magneto-encephalography (MEG), functional 
magnetic resonance imaging (f-MRI), and positron emission tomography 
(PET) to study changes within the somatosensory and motor cortices in 
patients with CRPS.  
 
 
4.4.1 Somatosensory Cortex  
The main studies investigating the somatosensory cortex function in CRPS 






Pleger and colleagues(Pleger et al. 2004), using 32 channel EEG, performed 
somatosensory evoked potential (SSEP) mapping with non-painful electrical 
stimulation of median and ulnar nerve in seven CRPS patients and compared 
them to healthy controls. They performed source reconstruction for the N20 
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SSEP component based on a single rotating dipole model in a spherical 
volume conductor. The polar angle difference between the N20 dipoles after 
median and ulnar nerve stimulation was used as a parameter to describe the 
dimension of the cortical hand representation. The dipole co-ordinates were 
therefore projected onto an adjusted 3D co-ordinate system (y-axis: joined 
acoustic meati of both ears; x-axis: joined centre point of y-axis and origin of 
nasion; z-axis: joined centre point and vertex). The polar angle of each nerve 
representation was calculated by referring the connection between dipole 
position and y-axis to z-axis. The results of somatosensory potential 
measurement in all seven patients showed latencies and amplitudes of the 
N20 component without any side-to-side differences.  
However, the differences between the polar angles of the N20-dipole 
locations of both nerve representations were significantly smaller on the 
CRPS-associated hemisphere. 
 [median nerve N20-dipole: 27°±4° (“CRPS hemi- sphere”) vs 28°±5° (“healthy 
hemisphere”); ulnar nerve N20-dipole: 27°±2° (“CRPS hemisphere”) vs 26°±2° 
(“healthy hemisphere”); difference between the median and ulnar nerve polar 
angle: 1.1°±1° (“CRPS hemisphere”) vs 3.2°±1° (“healthy hemisphere”); 
Z=−2.36, p=0.018;Wilcoxon signed rank test] 
 
     
Fig 4.3: The cortical representations of the median (red) and ulnar nerve (green) were 
projected onto a coronal magnetic resonance imaging slice. The average positions of the 
N20-dipoles are given by the polar angles showing a larger hand representation on the 




In the control group, they found no significant differences between dominant 
left and non-dominant right hemisphere (difference between the median and 
the ulnar nerve polar angle: dominant hemisphere: 2.7°±1.3°; non-dominant 
hemisphere: 2.9°±1.4°; Wilcoxon signed rank test: Z −0.69, p=0.5). Non-
parametric analysis (Kendall’s tau-b and Spearman’s rho) further revealed 
that the observed reduction in the CRPS-associated hemisphere significantly 
correlated with the degree of the CRPS-induced pain experienced 
continuously for the 4-week period before SSEP measurement. Accordingly, 
low pain levels were associated with small changes in SI, whereas subjects 
with higher pain intensity levels exhibited a marked asymmetry of SI, 
indicating a higher degree of cortical reorganization. 
van Rijn and colleagues (van Rijn et al. 2009) investigated spatiotemporal 
integration of sensory stimuli in an EEG study of 33 CRPS patients with 
dystonia and 19 healthy controls.  N9, N14, N20 and N35 amplitudes were 
recorded after paired electrical stimulation of median and ulnar nerves 
(‘‘spatial’’) and after stimulation of both nerves with single stimuli and with 
interstimulus intervals of 20 and 40 ms (‘‘temporal’’ stimulation). Finally, both 
methods were integrated resulting in spatiotemporal stimulation. 
Somatosensory evoked potentials were recorded using a four electrode 
system: Erb’s point, cervical lead aimed at N14 and other two recording 
ipsilateral & contralateral cortical activity.  Statistical testing was performed 
using linear mixed model analysis of variance. SSEP amplitudes were 
significantly suppressed after spatial and temporal stimulation. No difference 
was observed between patients and healthy controls. Spatio-temporal 
stimulation did not show an additional suppressive effect in any group. This 
study concluded that central sensory integration of proprioceptive afferent 
input is normal in patients with CRPS-related dystonia. 
 
Lenz and colleagues (Lenz et al. 2011) measured paired pulse suppression of 
somatosensory evoked potential in 21 CRPS patients with unilateral 
involvement of hand. The control groups were 11 patients with non-
neuropathic pain and 21 healthy controls. Innocuous electrical stimulations 
were administered to median nerve at the affected and unaffected hands in 
the patient groups. Somatosensory evoked potentials were measured using a 
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three electrode array: two electrodes C3’ and C4’ over left and right primary 
somatosensory cortex and a reference electrode over the midfront position 
(FZ). They analyzed peak-to-peak amplitudes of the cortical N20–P25 
response component for the first and second paired-pulse stimulus.  
ANOVA revealed no significant difference between the patients’ affected 
(mean amplitude ratio ±SE; CRPS group = 0.96 ±0.09, control group = 0.74 ± 
0.06) and clinically unaffected side (mean amplitude ratio ± SE; CRPS group 
= 0.95±0.07, control group = 0.71±0.06; F=0.311, p=0.581). In contrast, 
ANOVA revealed increased amplitude ratios in patients with CRPS compared 
with patients with non-neuropathic pain (CRPS group vs control group; F= 
5.622, p=0.024). The ANOVA result was confirmed by post hoc t-tests 
(affected hand CRPS vs control group, p=0.045; unaffected hand CRPS vs 
control group, p=0.006). This finding of significant reduction of paired pulse 
suppression of both sides in the CRPS group compared to both the control 
groups, supports the hypothesis that complex impairment of central sensory 
integration or cortical disinhibition plays a role in CRPS. This is in contrast to 
the study by van Rijn and colleagues (van Rijn et al. 2009) described before 






Juottonen and colleagues (Juottonen et al. 2002) investigated central tactile 
processing in CRPS by recording somatosensory evoked fields  in six patients 
with CRPS and six matched controls, using a 306-channel whole-head 
neuromagnetometer. Non-painful tactile stimuli were delivered to the fingertips 
of thumb, index, and little fingers (D1, D2, and D5) of the left and right hand 
with balloon diaphragms driven by compressed air. Stimulus-related reactivity 
of the 10-Hz (originating predominantly from somatosensory cortex) and 20-
Hz (originating predominantly from primary motor cortex) sensorimotor 
rhythms was quantified and statistically analysed using Student’s paired two-
tailed t-test. They found that in the whole patient group the SI responses were 
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25–55% stronger for stimulation of the affected than the healthy side; this 
difference was observed regardless of the side of pain (P = 0.03).  
The contralateral SII response was also stronger to stimulation of the painful 
side but this difference did not reach statistical significance. The amplitude of 
the SI response showed a statistically non-significant trend for positive 
correlation with the intensity of pain evaluated by VAS scale, at the level of 
r=0.60, but it did not correlate with duration of pain or tactile sensitivity.  
The SI responses peaked at the same time regardless of the side of 
stimulation. The mean source strengths to the healthy side stimulation of the 
patients did not differ from the source strengths of the control subjects. In the 
control group, the amplitudes and latencies of SI and contralateral SII 
responses did not differ between right and left-sided stimulation. The SI 
responses to thumb vs. little finger were 40% closer to each other in the SI 
cortex corresponding to the painful hand than the other hand so that in 
patients with severe pain, the distance between finger representations was 
shorter. There was no significant correlation between the distance and the 
level of pain (measured with VAS) or the duration of pain. 
 
Maihöfner and colleagues (Maihöfner et al. 2003) recorded somatosensory 
evoked magnetic fields  of 12 patients with CRPS after non-painful stimulation 
of their thumb (D1), little finger (D5) and lower lip with air-puff derived tactile 
stimulator. Cortical responses were recorded by using a 37-channel 
neuromagnetometer in a magnetically shielded room. To visualize results with 
respect to brain anatomy, the dipole locations were superimposed on MR 
images. No significant difference was found in the peak latencies of affected 
and unaffected sides. However, the mean strengths of the magnetic fields for 
D1/D5 were significantly increased on the CRPS side compared to the 
unaffected side and this increase on the painful side was independent of the 
side of pain (left or right) or patient handedness. They also found that this 
increase in dipole moment was significantly correlated with the intensity of 
spontaneous pain at the moment of the MEG recordings but had no 
correlation with other clinical signs and symptoms. They found a significant 
shrinkage of the extent of the cortical hand representation for the CRPS 
affected side. The centre of the hand was shifted toward the cortical 
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representation of the lip. The cortical reorganization correlated with the 
amount of CRPS pain (r = 0.792), as measured by the McGill questionnaire, 
and the extent of mechanical hyperalgesia (r = 0.860). Using multiple 
regression analysis, the best predictor for the plastic changes was found to be 
mechanical hyperalgesia. 
 
Maihöfner and colleagues (Maihöfner et al. 2004) did a follow up study of 10 
out of the 12 patients from the previous study a year after treatment to assess 
potential changes in cortical representation. The patients all had significant 
improvement in their symptoms with treatment. There were no statistically 
significant differences in the peak latencies or magnetic field strengths 
between sides this time. However, the cortical reorganisation had reversed in 












Fig 4.4 (A): Projection of the equivalent current dipole (ECD) localizations for D1 (filed circle) 
and D5 (open circle) onto individual MRI slices. There was a reduction of the hand extension 
from 1.42 cm (unaffected side) to 0.8 cm (CRPS-affected side) during acute CRPS. After the 
follow-up time of 62 months, the distance between D1 and D5 increased to 1.45 cm on the 
affected side, whereas the corresponding distance on the unaffected side remained 
unchanged (1.43 cm).  
 (B): Projection of the ECDs for the center of the hand (open squares) and the lower lip (filled 
squares) onto individual MRI slices. The distance between the center of the hand and the 
lower lip increased from 2.05 cm to 2.92 cm following therapy on the CRPS-affected side, 
whereas the respective ECD localizations for the unaffected side remained unchanged 
(distance hand–lip 2.92 vs 3.01 cm, before and after treatment). 
 
 
Sinis and colleagues (Sinis et al. 2007) studied the effect of N-methyl-D-
aspartate receptor antagonist memantine in six patients with CRPS of one 
upper extremity . In one of these six patients, somatosensory evoked fields 
were recorded after pneumatic stimulation of thumb and little finger using a 
whole head MEG with 151 first-order gradiometers. The functional 
organization of S1 was determined by dipole analysis of the first prominent 
peak of the magnetic brain response. The localization was represented in a 3 
dimensional grid and was expressed as the angle ‘‘θ’’ between Cz and a 
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direct line from the middle of the sphere to the dipole localization. Cortical 
reorganization was expressed as the difference between the ‘‘θ’’ angle of the 
cortical distance DI/D5 of the affected side mirrored in the unaffected side in 
S1. This difference was seen in the S1 cortex of the affected limb unlike the 
contralateral unaffected limb (difference ‘‘θ’’ angle = 11 degrees). These 
changes returned to a cortical pattern comparable to the unaffected side after 
treatment with memantine for eight weeks. 
 
Vartiainen and colleagues (Vartiainen et al. 2008) recorded somatosensory 
evoked fields in 8 CRPS patients and 9 healthy controls using MEG after 
delivering non-painful tactile stimuli to thumb (D1), index finger (D2) and little 
finger (D5) using diaphragms driven by compressed air. The size of the hand 
representation area in the SI cortex was estimated by calculating the distance 
(in xyz-space) between D1 and D5 sources. The peak amplitude of the 
equivalent current dipole waveform was considered to reflect the strength of 
the source. The strengths and peak latencies of the sources were compared 
between the groups and between the painful and healthy hands with a two-
tailed t-test. Pearson’s correlation coefficients were calculated to correlate the 
source strengths with the stimulation energy and intensity of perceived pain. 
In all subjects, the earliest cortical responses to tactile stimuli peaked at about 
54–58 ms at the contralateral parietal cortex. The source of the response was 
identified in all subjects in the posterior wall of the central fissure, in the SI 
cortex. Longer-latency responses peaked bilaterally at 99–105 ms in the 
temporo-parietal regions. These responses were generated in the upper lip of 
the Sylvian fissure in the secondary somatosensory (SII) cortex. A later 
response peaked at the contralateral parietal cortex at 95–152 ms, and it was 
generated in the bottom of the post-central fissure in the posterior parietal 
cortex (PPC). At group level, the SI sources were 33% stronger (P = 0.05) to 
the stimulation of the painful than that of the healthy hand in the patients, 
whereas no such side difference was observed in the control group.  
The strengths and latencies of the SII sources did not differ between the 
groups or between the sides in either group. PPC was activated in all control 
subjects but only in three CRPS patients. The mean (±SEM) PPC source 
strength was weaker in the CRPS patients than in the control subjects. 
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The PPC source strength did not correlate with the tactile sensitivity or dis- 
crimination in the patients. At group level, the D1–D5 distance was statistically 
significantly shorter for the painful than the healthy hand (mean ± SEM; 6 ± 
2mm vs. 10 ± 2 mm, P = 0.02). In the control subjects, the distance was 
similar in both hemispheres (10 ± 2mm vs. 12 ± 1 mm, n.s.). 
 
Functional MRI studies 
 
Forster and colleagues (Forster et al. 2000) used f-MRI to identify the 
activated brain regions in 7 CRPS patients and 7 healthy controls. The 
different stimuli conditions were finger tapping, impact pain, tonic pain (using 
a mechanical pneumatic device) and light touch. They found that in both 
healthy and CRPS group there were activations in primary and secondary 
somatosensory cortices, insula and anterior cingulate cortex (ACC). In 
addition, there was activation in motor (primary and supplementary) and 
frontal areas. There was no significant difference in activation between the 
two groups. However, in one CRPS patient with strong mechanical 
hyperalgesia, even light touch stimuli caused activation of ACC which was not 
seen in any of the healthy subjects with non-painful stimuli.  
 
Maihöfner and colleagues (Maihöfner et al. 2005) studied brain processing in 
mechanical hyperalgesia in 12 CRPS patients (control=unaffected side) using 
f-MRI. They found mechanical stimuli using von-Frey filaments in the 
unaffected side (non-painful) led to activations in contralateral primary 
somatosensory cortex, insula and bilateral secondary somatosensory 
cortices. Stimuli in the affected hand (perceived as painful due to 
hyperalgesia) revealed activations in additional areas of anterior cingulate 
cortex and frontal cortex. Maihöfner and colleagues (Maihöfner et al. 2006) in 
a related study (n=12 CRPS patients, control=unaffected side) also showed 
that a complex cortical network is involved in allodynia similar to that in 
mechanical hyperalgesia. 
 
Pleger and colleagues (Pleger et al. 2005) subjected 6 CRPS patients to          
f-MRI imaging during non-painful electrical stimulation to index finger before 
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and after 1-6 months of graded sensorimotor training. They showed that 
shrinkage of cortical maps of primary (S1) and secondary (S2) somatosensory 
cortex contralateral to the affected side was reversible and associated with a 
decrease in pain intensity and improvement in two-point discrimination. In a 
subsequent larger study (Pleger et al. 2006) of 17 patients (which included the 
six from previous study) they confirmed the findings that patterns of cortical 
reorganization in SI and SII seem to parallel impaired tactile discrimination. 
 
Freund and colleagues (Freund et al. 2010) reported that there was increased 
activation of posterior cingulate cortex and decreased opercular activation 
compared to healthy controls in a f-MRI study where they delivered graded 
electrical painful stimulation to index fingers of both hands of 10 CRPS 
patients. These changes were not limited to the affected side and may be a 
reflection of generalised motor inhibition and decreased sensory 
discrimination in these patients. In a follow up study of the same patient group 
(Freund et al. 2011), they reported that there was less activation of 
periaqueductal gray and cingulate cortex during a pain suppression task 
suggesting impairment of descending opioid pain suppression pathway. 
 
Di Pietro and colleagues (Di Pietro et al. 2015) compared the S1 spatial 
representation of the hand in 16 patients with upper-limb CRPS to 16 healthy 
controls, using functional MRI. Innocuous vibration was delivered to digits one 
(D1) and five (D5) in a block design. Distance between D1 and D5 activation 
maxima, calculated for both hands, was used as a measure of S1 
representation. Analyses were blinded to group and hand. In patients, S1 
representation was smaller for the affected hand than it was for the healthy 
hand. However, S1 representation of the affected hand was no different to 
that of either hand in controls. S1 representation of the healthy hand of 
patients was larger than that of controls’ hands. This study suggests that 
CRPS seems to be associated with an enlarged representation of the healthy 
hand, not a smaller representation of the affected hand unlike previous 
studies. This study addressed various methodological limitations of previous 
studies such as unblinded data analysis and failure to report on healthy 
controls.  Further exploration (Di Pietro et al. 2016) using the f-MRI data from 
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the same study, did not show any relationship between the size of the healthy 
hand representation in S1 and the severity of functional impairment of the 
CRPS-affected hand or pain duration. This suggests that the enlarged S1 






Shiraishi and colleagues (Shiraishi et al. 2006) used 18 F-fluorodeoxyglucose 
PET scanning in 18 CRPS patients and 13 age-matched healthy controls and 
found that the cerebral glucose metabolism was elevated bilaterally in the 
areas concerned with somatosensory perception such as anterior cingulate 
cortex, posterior parietal cortex, secondary somatosensory cortex, insula and 
cerebellum. In contrast, the glucose metabolism was reduced in the 
contralateral pre-frontal cortex and primary motor cortex. The changes in the 
anterior cingulate cortex, posterior cingulate cortex and posterior parietal 




A systematic review and meta-analysis by Di Pietro and colleagues (Di Pietro 
et al. 2013b) came to the following conclusions regarding primary 
somatosensory cortex changes in CRPS  : 
1. S1 spatial representation was found to be reduced on the affected 
hand compared to the unaffected hand in CRPS in the meta-analysis of 
pooled data from four MEG studies (Juottonen et al. 2002; Maihöfner et 
al. 2003; Sinis et al. 2007; Vartiainen et al. 2008) and one EEG study 
(Pleger et al. 2004). Data available from two studies (Pleger et al. 
2004; Vartiainen et al. 2008) reporting on healthy controls indicated 
that the representation size of the affected hand in CRPS patients was 
smaller than that of healthy controls. 
87 
 
2. There was no difference in the activation strength in S1 comparing 
hemispheres in CRPS patients or comparing CRPS patients with non-
CRPS controls. 
3. There were no significant differences in S1 peak latency after 
stimulation of CRPS-affected and unaffected hands or comparing 
CRPS patients with non-CRPS controls. 
4. Contrasting data on cortical disinhibition:   One study (Lenz et al. 2011) 
found bilateral S1 cortical disinhibition in CRPS patients compared to 
non-CRPS controls; whereas another study (van Rijn et al. 2009) found 
no evidence of cortical disinhibition.  
5. There was an overall high risk of bias in the included studies 
introduced by non-consecutive sampling, unblinded assessment of 









Stimulation/         
Paradigm 
Outcomes      
Assessed 
Condition & Comparison   
[Study size (M/F)                 
Age in years] 
Main Results 
 




Electrical stimulation to median 
and ulnar nerves—affected and 
unaffected sides 
                                  
Cortical SSEPs to 
determine- Hand 
representation size; S1 
activation strength& latency  
 
CRPS :  n=7 (4/3); age=40 
(19–64); Healthy Controls :              
n=7 (1/6); age=28 (20–45) 
Unaffected side 
 
Differences between the polar angles of the N20-dipole 
locations of both nerve representations were significantly 
smaller on the CRPS-associated hemisphere. 
No difference between hemispheres in N20 latency or 
amplitude 
 




Electrical stimuli to median and 
ulnar nerves of both wrists; 
right arm in control group 
 
Cortical (N20 and N35) 
amplitudes and latencies to 
determine:  S1 activation 
strength& latency 
 
CRPS : n=33 (1/32) ; age=39.7 
±10.9 (SD); Healthy Controls:              
n=19 (0/19); age=40.2 (23–55)  
 
No difference between patient and control groups in 
suppression of SSEP after spatio-temporal stimulation 
 
(Lenz et al. 
2011)       
EEG 
 
Paired-pulse stimulation to 
median nerve                                   
 
Paired-pulse suppression 
to determine strength of S1 
activation  
 
CRPS:  n=21 (9/12) ; 51± 10.8 
(SD); Healthy Controls :                
n=21 (9/12) ; 51.3 ± 10.9 (SD) 
 
Significant reduction of paired pulse suppression of both 
sides in the CRPS group compared to the control group.   








stimulation to D1, D2 and D5 of 
both hands 
 
Cortical SEFs to determine:                   
Hand representation size;  
S1 activation strength& 
latency 
 
CRPS : n= 6 (0/6); age=45.4 
(33-54); Healthy controls:                   
n= 6 (0/6); age=45.1 (34-55) 
Unaffected side 
 
Significantly stronger response in the contralateral S1 in 
affected hand compared to unaffected. 
Distance between the S1 representations of the 
D1 and D5 of the affected hand significantly shorter 







Air-puff stimulation to D1,D5 
and lower lip on both sides 
 
Cortical ECDs to 
determine:                   
Hand representation size;  
S1 activation strength& 
latency 
 
CRPS : n=12 (3/9); 57.4±18.7 
(SEM)   
Unaffected side  
 
Increased strength of magnetic fields and a reduced 
distance between D1 and D5 representation in S1 
contralateral to the affected hand. 
S1 representation of the affected hand shifted toward the 
lip representation. 
Amount of cortical reorganization correlates with the 
intensity of CRPS pain and the extent of mechanical 
hyperalgesia 









Air-puff stimulation to D1,D5 
and lower lip on both sides 
 
Cortical ECDs to 
determine:  Hand 
representation size;  S1 
activation strength& latency 
 
CRPS : n=10 out of the 12 
patients from the previous 
study in 2003 
 
Cortical reorganisation noted in the initial study in 2003 
had reversed in parallel to clinical improvement 
 




Pneumatic stimulation to D1 
and D5 both hands 
 




CRPS: n=1 male, age=59   
Unaffected side 
 
Cortical representation decreased in affected hand 







Compressed- air tactile 
stimulation of D1, D2 and D5 of 
both hands 
 
Cortical ECDs to 
determine:  Hand 
representation size;  S1 
activation strength& latency 
 
CRPS : n= 8 (0/8) ; age=45.5 
(26–57); Healthy controls                   
n= 9 (0/9) ; age=46 (28–57) 
Unaffected side 
 
SI sources significantly stronger to the stimulation of 
affected compared to unaffected hand. 
Significantly shorter D1-D5 distance in affected compared 
to unaffected hand 
 




Finger tapping, Impact pain, 
Tonic pain, Light Touch. 
Stimulated D2 and D3.  
 
S1 signal change  
 
 
CRPS  : n= 7 (1/6) ; age =27–
68;  Healthy Controls                  
n= 7 (7/0) ; age =22–55  
 
Bilateral activation of S1, S2, insula and ACC in both 
groups by painful stimuli.     







Painful pin-prick stimulation to 
affected limb; pin-prick to 
corresponding site on 
unaffected limb 
 
S1 signal change  :           




CRPS :  n=12 (4/8) ; 45.3± 3.5 
(SEM); Unaffected side  
 
Pinprick stimulation to unaffected side caused activation in 
contralateral S1, bilateral S2 and insula. 
Pinprick stimulation of affected side (perceived as painful 
due to hyperalgesia) caused significantly increased 
activation in S1, bilateral insula, S2 and additional 
activation in ACC and frontal cortex 
 




Electrical stimulation to D2    on 
both hands 
 
S1 activation level :          
To assess possible 
alterations in cortical maps 
before & after sensori-
motor training program 
 
CRPS  : 6 (gender & age not 
reported)  Unaffected side 
 
Shrinkage of cortical maps of S1 and S2 contralateral to 
the affected side was reversible and associated with a 




Abbreviations: T, Tesla; SEM, standard error of the mean; SEFs, somatosensory-evoked fields; SD, standard deviation; ECDs, equivalent 
current dipoles. NOTE. All stimulation paradigms were non-painful unless otherwise stated.   






Brush-evoked allodynia to 
affected side; brushing of the 
corresponding site on 
unaffected limb 
 
S1 signal change:            
To explore allodynia related 
brain areas acti-vations and 
deactivations  
 
CRPS: n= 12 (5/7); 47.5 ± 3.1 
(SEM); Unaffected side 
 
A complex cortical network is involved in allodynia similar 
to that in mechanical hyperalgesia 
 
 




Electrical stimulation to D2 on 
both hands. 
 
S1 signal change      
 
 
CRPS  :  n=17 (7/10); 
age=40.1 ± 9.5 (SD);                               
Healthy Controls: n=17 
(7/10);  age=40.2 ± 10 (SD)                            
Unaffected Side                                            
 
Patterns of cortical reorganization in SI and SII seem to 
parallel impaired tactile discrimination 
 




Graded electrical  non-painful 
and  painful stimulation to D2 
both hands  
 
S1 signal change-                
To investigate for a  
generalized change  in pain 
processing   
 
CRPS:                                  
n=10 (5/5); age=45 (28–61)     
Healthy Controls:                  
n=15 (10/5); age= 35.5 (25-64)  
 
Increased activation of posterior cingulate cortex and 
decreased opercular activation in CRPS compared to 
healthy controls  
 




Tonic painful electrical 
stimulation to D2 of both hands 
 
S1 signal change-            
To investigate for dys-
function  in the descending 
opioid pain system  
 
CRPS  : n=10 (5/5) ; age=45 
(28-61);  Healthy Controls :                 
n=15 (10/5) ;age= 35.5 (25-64) 
 
Less activation of Periaqueductal gray and cingulate 
cortex during a pain suppression task 
 
 





Vibration stimuli to D1 & D5 of 
both hands 
 
S1 signal change 
 
CRPS  : n=16 (5/11) ; 
age=48.9 ± 13.9);  Healthy 
Controls :  n=16 (5/11) ; 
age=43.9 ± 11.7) 
 
In patients, S1 smaller in affected side compared to 
unaffected side. S1 representation of healthy hand in 







Identification of active brain 




CRPS : n= 8 (10/8) ;age=40.7 
(21–59) ; Healthy Controls                 
n=13(11/2) ; age=38.7 (27–58) 
 
Elevated glucose metabolism bilaterally in ACC, posterior 
parietal cortex, S2, insula and cerebellum 
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4.4.2 Motor cortex 
 
The main studies investigating the motor cortex function in CRPS are 
discussed in detail below and summarised in Table 4c. 
 
Functional MRI Studies 
 
Maihofner and colleagues (Maihöfner et al. 2007) studied cortical activations 
during finger tapping (n=12 CRPS Right arm affected, 12 age & sex matched 
controls) using f-MRI. They found increased activation in the primary motor 
cortex in both hemispheres on finger tapping of the CRPS affected side 
compared to the unaffected side (difference in cluster size in contralateral M1: 
3142, P < .0001; ipsilateral M1: 554,P=.0001) and the right hand in controls 
(difference in contralateral M1: 1769, P = .0002; ipsilateral M1: 3250, P = 
.0003).  
 
Gieteling and colleagues (Gieteling et al. 2008) studied cerebral activations 
during imagined and actual hand movements in CRPS patients with dystonia 
(n=8 CRPS, 17 age-matched healthy controls). Compared with controls, 
imaginary movement of the affected hand in patients showed reduced 
activation ipsilaterally in the premotor and adjacent prefrontal cortex (P 
corrected-cluster-level 0.030, cluster size 186 voxels), and in the anterior part 
of the insular cortex and the superior temporal gyrus (P corrected-cluster-level 
0.010, cluster size 242 voxels). Contralaterally, reduced activation was seen 
in the inferior parietal and adjacent primary sensory cortex (P corrected-
cluster-level 0.030, cluster size 186 voxels). There were no differences 
between patients and controls when they executed movements, nor when 






Fig 4.5:  Areas of activation in controls (n = 17) and patients (n = 8). Four different tasks 
compared with rest condition, projected on a template rendered brain image. P, uncorrected 




Transcranial Magnetic Stimulation Studies 
 
Schwenkreis and colleagues (Schwenkreis et al. 2003) studied 25 CRPS 
patients (all unilateral upper limb affected) and 20 healthy controls using 
paired pulse paradigm and found significant reduction in intracortical inhibition 
on both sides of patients but no significant change in intracortical facilitation or 
motor threshold compared to the healthy. There was no significant difference 
between the affected and unaffected side in the patient group.  
 
Eisenberg and colleagues (Eisenberg et al. 2005) delivered TMS (Magstim 
200, figure of eight coil) to the motor cortex of subjects (6 upper limb CRPS 
and 6 Lower Limb CRPS, 14 age & sex matched healthy control) and 
measured the motor evoked potential using surface EMG from APB muscles 
of both wrists. A significant reduction in the short intracortical inhibition 
associated with a significant increase of the I-wave facilitation was found in 
the hemisphere contralateral to the affected side in the upper-limb CRPS 
group (paired t-test, p<0.05). No significant inter-hemispheric asymmetry 
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between the affected and the non-affected sides was revealed in the lower-
limb CRPS group.  
 
Krause and colleagues (Krause et al. 2005) recorded the cortical and spinal 
motor evoked potentials (c-MEP and s-MEP), and the contralateral and 
ipsilateral cortical silent period (c-CSP and i-CSP) in subjects (12 patients with 
CRPS type I and 10 healthy controls) before and after conditioning repetitive 
magnetic stimulation, applied at cervical nerve roots innervating affected 
muscles. The silent period, the time between the stimulus delivery and the 
return of voluntary activity, is a reflection of inhibitory mechanisms at the 
motor cortex. They reported no difference in c-CSP and i-CSP between CRPS 
and healthy controls. The c-MEP but not s-MEP was significantly smaller in 
both hemispheres in CRPS group. 
 
In a subsequent TMS experiment, Krause and colleagues (Krause et al. 2006) 
found a significant interhemispheric asymmetry between the motor cortical 
representation of affected and unaffected hand muscles in a group of CRPS I 
patients (n=14 CRPS, 10 Healthy). The cortical representation (size, Motor 
Evoked Potential, and calculated volumes) was significantly larger for the 
unaffected hand than for the affected hand. This asymmetry was not found in 
the control group of healthy subjects. 
 
Turton and colleagues (Turton et al. 2007) coupled TMS with peripheral 
median nerve stimulation to evaluate sensorimotor interaction in CRPS (n=8 
CRPS Type 1, 8 age and sex-matched healthy controls). They reported no 
difference in MEP suppression (patients, 52.2 ± 20.1% vs controls, 53.7 ± 
16.5%), thus demonstrating no evidence of abnormal interaction of sensory 
pathways with motor cortex in CRPS compared with healthy controls. 
 
 
Van Velzen and colleagues (Van Velzen et al. 2015) used TMS to measure 
corticospinal excitability at rest and during motor imagery (explicit motor task) 
and motor observation (implicit motor task) in a study of 12 CRPS patients, 12 
healthy controls & 6 patients with hand immobilisation due to scaphoid bone 
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fracture (SBF). Weightlifting of 2 distinct weights (heavy/1 kg and light 
weight/50 gram) was used for both motor imagery and motor observation 
tasks. Motor corticospinal excitation measured at rest and during implicit and 
explicit motor tasks was similar for CRPS patients and healthy controls. 
Patients with an immobilized hand showed an absence of motor cortical 
excitation of the corresponding hemisphere during motor imagery of tasks 
involving the immobilized hand, but not during motor observation. This study 
suggests that the nature of motor dysfunction in CRPS patients differs from 







Juottonen and colleagues (Juottonen et al. 2002) in the study previously 
discussed in the somatosensory section of this review also reported on the 20 
Hz motor cortex rhythm and its reactivity to tactile stimuli. There was no 
difference between hemispheres or groups in the resting peak amplitude of 
the 20-Hz rhythm before stimulation or for the average rebound amplitude 
after stimulation. The 20-Hz rebound duration was significantly shorter in 
patients than healthy controls (P < .03), although there was no difference 
between hemispheres. 
 
Kirveskari and colleagues (Kirveskari et al. 2010) recorded whole scalp MEG 
during noxious laser stimulation of dorsum of hands (n=8 CRPS Type 1 
patients and 8 age & sex-matched healthy controls) to study the reactivity of 
20 Hz motor cortex rhythm. They defined reactivity as the sum of stimulus 
induced suppression of 20 Hz rhythm and subsequent rebound. The reactivity 
of the 20-Hz rhythm in the hemisphere contralateral to the painful hand in the 
patient group was significantly weaker than in control subjects. The reactivity 
correlated with the mean level of the spontaneous pain (r=0.64, P= 0.04). 
Suppression of the 20-Hz rhythm correlated with the grip strength in the 
painful hand (r= 0.66, P= 0.04). There were no differences between 






Shiraishi and colleagues (Shiraishi et al. 2006) in the previously discussed 
study in this review reported decreased glucose metabolism in the 





A systematic review and meta-analysis of studies investigating primary motor 
cortex function in adult CRPS by di Pietro and colleagues (Di Pietro et al. 
2013a) found that the risk of bias across studies was high, mainly due to 
missing data and unblinded assessment of outcomes. Apart from a limited 
evidence for bilateral M1 disinhibition in CRPS of the upper limb, they could 
not draw any definitive conclusions regarding M1 spatial representation, 
reactivity, or glucose metabolism in CRPS.  
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Study/Modality Stimulation/Paradigm Outcomes Condition & Comparison  Main Results 
(Maihöfner et al. 
2007)                         
f-MRI 
Finger-tapping task at 
1-Hz frequency 
Detection of activation 
within the motor 
system during motor 
performance 
CRPS  :  n=12 (2/10); age= 41.2 ± 8.7; 
Health Controls : n=12 (2/10); age= 
43.2 ± 8.7 ; Unaffected Side 
Increased activation in M1 in both hemispheres 
affected side compared to the unaffected side 
 
(Gieteling et al. 
2008)                        
f-MRI 
Execution (painful) &  
imagined movement of wrist 
flexion/extension, both hands 
Detection of activation 
in regions supporting 
primary motor function 
and higher-order motor 
control 
CRPS : n=8 (1/7); age= 46.4 ±6.0; 
Healthy Controls: n=17 (2/15); age= 
42.9 ± 9.2 
Compared with controls, imaginary movement 
of the affected hand in patients showed reduced 
activation ipsilaterally in the premotor and 
adjacent prefrontal cortex &  in the anterior part 
of the insula & the superior temporal gyrus 
 
(Schwenkreis et al. 
2003)                   
TMS 
TMS applied over the vertex. 
MEPs recorded with surface 
EMG from FDI; Use of a 
single- and paired pulse 
paradigm 
MT, MEP, ICI, ICF CRPS: n=25 (9/16); age= 29-80 
(range); Healthy Controls: n=20 
(10/10); age=20-79 (range) 
Unaffected Side 
Significant reduction in intra-cortical inhibition on 
both sides of patients compared to healthy.      
No significant difference between the affected 
and unaffected side in the patient group 
 
(Eisenberg et al. 
2005)                   
TMS 
TMS applied to optimal scalp 
position M1. MEPs recorded 
with surface EMG from APB 
muscles of both wrists. Use of 
a single- and paired pulse 
paradigm 
rMT; aMT;          
MEP/M-wave 
amplitude ratio; 
CMCT; ICF; SICI;LICI; 
I-wave facilitation 
CRPS: n= 12 (3/9); age= 32±9; 
Healthy Controls: n= 14 (10/4); age= 
30.9 ±12.7; Unaffected Side 
Significant reduction in short intra-cortical 
inhibition & a significant increase of the I-wave 
facilitation in the hemisphere contralateral to the 
affected side in the upper-limb CRPS group.     
No significant difference in lower-limb CRPS. 
 
(Krause et al. 2005) 
TMS 
TMS applied to optimal scalp 
position M1. MEPs recorded 
with surface EMG from long 
extensor muscles of forearms 
MEP; iCSP; cCSP  
(before and after a 
conditioning repetitive 
magnetic stimulation) 
CRPS: n=12 (2/10); age= 48.2 ±15.6 
Healthy Controls: n=10 (gender not 
reported); age=42.4 (only mean given) 
;Unaffected Side 
No difference in c-CSP and i-CSP between 
CRPS & healthy controls. c-MEP but not s-MEP 
smaller in both hemispheres in CRPS 
 
Table 4c: Neuroimaging studies investigating motor cortex function in CRPS 
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(Krause et al. 2006) 
TMS 
TMS applied to hot spot 
on the motor cortex 
MEPs recorded with 
EMG from long extensor 
muscles of both forearms 
Spatial representation 
in M1 (i.e., size, 
volume); MEP; MT 
CRPS : n=13 (4/9); age= 37 (18–72); 
Healthy Controls : n=10 (4/6); age= 
38 (24–63);Unaffected Side 
Significant interhemispheric asymmetry 
between the motor cortical representation of 
affected and unaffected sides. Cortical 
representation (size, Motor Evoked Potential, 
and calculated volumes) significantly larger for 
the unaffected hand than the affected hand 
 
(Turton et al. 2007) 
TMS 
TMS applied to optimal scalp 
position M1. MEPs recorded 
with surface EMG from APB 
muscle on affected side in 
patients; matching side in 
controls. Recording EMG 
response to median nerve 
stimuli paired with subsequent 
TMS. Compared paired 
stimulation with TMS alone 
Modulation of EMG 





CRPS: n=8 (1/7); age= 45 ± 13; 
Healthy Controls: n=8 (1/7); age= 45 
± 13 
No difference in MEP suppression (no evidence 
of abnormal interaction of sensory pathways 




(Van Velzen et al. 
2015) 
TMS 
TMS applied to hot spot on the 
motor cortex. MEPs recorded 
from 1
st
 dorsal interosseous 
muscle of both hands. Motor 
threshold, Motor imagery & 
motor observation 
(weightlifting of heavy & light 
weights) measurements done. 
MEP amplitudes CRPS: n=12 (2/10); age=51±  9.5; 
Healthy Controls : n=12 (1/11); age: 
52±13.0 
Scaphoid Bone Fracture patients: 
n=6 (5/1); age: 24 (20.5–33.5) 
Normal motor cortex activation at rest and 
similar motor cortex excitation in Motor Imagery 
and Motor Observation in compared to healthy 
controls. Patients with an immobilized hand due 
to scaphoid bone fracture showed an absence 
of motor cortical excitation of the corresponding 
hemisphere during motor imagery of tasks 
involving the immobilized hand, but not during 
motor observation. 
 
(Juottonen et al. 
2002)                  
MEG 
Compressed-air-driven 
tactile stimulation to index 
finger of both hands. 
 
Reactivity of the 
20-Hz motor cortex 
rhythm (amplitude 
and duration of 
rebound) at rest 
and to tactile 
stimulation 
CRPS :n=6 (0/6); age= 45.4 ± 8.4 ; 
Healthy Controls : n= 6 (0/6); age= 
45.1,(34–55)(range); Unaffected Side 
No difference between hemispheres or groups 
in the resting peak amplitude of the 20-Hz 
rhythm before stimulation or for the average 
rebound amplitude after stimulation. 20-Hz 
rebound duration was significantly shorter in 
patients than healthy controls, although there 




(Kirveskari et al. 
2010)                  
MEG 
Single-pulse painful laser 
stimulation to the dorsum of 
both hands 
Reactivity of the 20-Hz 
motor cortex rhythm 
(amplitude and 
duration of rebound 
and suppression) at 
rest and to painful 
stimulation 
CRPS: n=8 (0/8); age= 45.5 ± 10.5 ; 
Healthy Controls : n= 8 (0/8); age= 
46.3 (28–52)(range) ; Unaffected Side 
Reactivity of the 20-Hz rhythm in the 
hemisphere contralateral to the painful hand in 
the patient group was significantly weaker than 
in control subjects. No differences between 
hemispheres either in the patient or healthy 
control groups 
 
(Shiraishi et al. 




Identification of active 
brain areas via glucose 
metabolism 
CRPS :  n=18(10/8); age=40.7 (21–59)                                 
Healthy Controls:  n=13(11/2) ; 
age=38.7 (27–58) 
Decreased glucose metabolism in the 
contralateral primary cortex in CRPS patients 
compared to healthy controls 
 
 
Abbreviations: EMG, electromyography; APB, abductor pollicis brevis muscle; rMT, resting motor threshold; aMT, active motor threshold; 
CMCT, central motor conduction time; ICI, intracortical inhibition; ICF, intracortical facilitation; SICI, short-interval intracortical inhibition; LICI, 
long-interval intracortical inhibition; f-MRI, functional MRI; FDI, first dorsal interosseous muscle; SAI:short-latency afferent inhibition; iCSP, 
ipsilateral cortical silent period; cCSP, contralateral cortical silent period; COG, center of gravity;  MEP, motor evoked potential. 
 
NOTE. All data reported as mean and standard deviation unless otherwise stated. All stimulation paradigms were non-painful unless otherwise 
stated. Table adapted from (Di Pietro et al. 2013a).
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4.4.3 Functional Connectivity 
 
Default Mode Network (DMN) is a resting state brain network characterized by 
balanced positive and negative correlations between activities in the dorsal 
and ventral medial prefrontal cortex, the medial parietal cortex and the inferior 
parietal cortex. Bolwerk and colleagues (Bolwerk et al. 2013) found that 
functional DMN connectivity was significantly reduced in patients compared to 
controls in an f-MRI study (n=12 CRPS patients and 12 age & sex-matched 
healthy controls). They also reported that functional connectivity maps of 
sensorimotor cortex (S1/M1) and intra-parietal sulcus (IPS) in patients 
revealed greater and more diffuse connectivity with other brain regions, 
mainly with the cingulate cortex, precuneus, thalamus, and prefrontal cortex. 
In contrast, controls showed greater intraregional connectivity in S1/M1 and 
IPS. These spatial alterations in functional connectivity in CRPS also showed 
a trend towards correlation to the intensity of pain. 
 
 
Fig 4.6: Functional connectivity map of DMN. (A) DMN Controls (B) DMN 
Patients  
Abbreviations: DLPFC, Dorsolateral Prefrontal Cortex; MPFC, Medial 
Prefrontal Cortex; Th, Thalamus; IPL, Inferior Parietal Lobule; PCC/preCUN, 
Posterior Cingulate Cortex/pre Cuneate. 
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Kim and colleagues (Kim et al. 2017) in a f-MRI study of 25 patients with 
CRPS and 25 matched healthy controls, found that the functional connectivity 
of the anterior and posterior insular cortices with the postcentral and inferior 
frontal gyri, cingulate and dorsomedial prefrontal cortices was reduced in 
patients with CRPS. They also found that a reduced functional connectivity 
between the anterior insula and right postcentral gyrus was associated with 
increased perception of severe pain in patients with CRPS. This suggests that 
a disconnection between the somatosensory cortical function of perception 
and insular function of awareness or regulation may play a significant role in 
persistent pain in CRPS. 
 
Kim and colleagues (Kim et al. 2018) investigated the role of the attention 
network and its dynamic interactions with other pain-related networks of the 
brain in a f-MRI study of 21 CRPS patients and 49 healthy controls. CRPS-
related reduction in intra-network functional connectivity was found in the 
attention network. CRPS patients had greater inter-network connectivities 
between the attention and salience networks as compared with healthy 
controls. They also found that individuals within the CRPS group with high 
levels of pain catastrophizing showed greater inter-network connectivities 
between the attention and salience networks. These findings suggest that 
altered connectivities may be potentially associated with the maladaptive pain 
coping in CRPS patients. 
 
4.4.4 Summary of appraised literature and justification for undertaking 
high density EEG study 
 
Cortical reorganisation in both somatosensory and motor cortices in CRPS 
has been investigated using various neuroimaging techniques including 
functional MRI, MEG, PET and high density EEG. Most compelling evidence 
is for reduction of S1 spatial representation on the affected hand compared to 
the unaffected hand in CRPS as shown by the findings of a meta-analysis (Di 
Pietro et al. 2013b) of pooled data from four MEG studies (Juottonen et al. 
2002; Maihöfner et al. 2003; Sinis et al. 2007; Vartiainen et al. 2008) and one 
EEG study (Pleger et al. 2004); Two studies (Pleger et al. 2004; Vartiainen et 
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al. 2008) reporting on healthy controls indicated that the representation size of 
the affected hand in CRPS patients was smaller than that of healthy controls. 
However, a more recent study (Di Pietro et al. 2015) which addressed some 
of the methodological limitations of previous studies such as unblinded data 
analysis and failure to report on healthy controls reported that CRPS seems to 
be associated with an enlarged representation of the healthy hand, not a 
smaller representation of the affected hand unlike previous studies.  
Studies also suggest that there was no difference in the activation strength in 
S1 comparing hemispheres in CRPS patients or comparing CRPS patients 
with non-CRPS controls. There were also no significant differences in S1 
peak latency after stimulation of CRPS-affected and unaffected hands or 
comparing CRPS patients with non-CRPS controls. There is some evidence 
for bilateral M1 disinhibition in CRPS of the upper limb but no other definitive 
conclusions can be drawn regarding the motor cortex changes. 
 
Many studies have overall high risk of bias introduced by non-consecutive 
sampling, unblinded assessment of outcomes and unclear or selective 
reporting of outcomes (Di Pietro et al. 2013b; Di Pietro et al. 2013a). There is 
clearly a need for further well designed studies of cortical reorganisation in 
CRPS. Previously there are no published studies of CRPS specifically 
investigating neuro-imaging markers of cognitive dysfunction in CRPS. 
Hence, we decided to undertake this study (described in detail in chapter 5 of 
this thesis) to investigate the cortical changes in CRPS and also to explore 













Chapter 5: Cortical reorganisation in CRPS and digit 
misperception- a high density EEG Study 
 
 
             5.1 Introduction 
 
We used high density EEG to investigate the cortical changes in CRPS 
patients by studying the somatosensory ERPs (Event Related Potentials) 
elicited on painless finger stimulation. We also examined whether the EEG 
parameters correlated with the behavioural variables such as finger 
misperception and pain severity in CRPS. 
 
High-density EEG provides excellent temporal resolution of the order of a few 
milliseconds and hence provides an excellent tool for studying the functional 
changes within the somatosensory cortex (Luck 2005). Cortical reorganization 
can manifest both spatially and temporally. While f-MRI would be a preferred 
tool to assess spatial reorganization of S1 given the better spatial resolution, 
we were interested in temporal aspects of somatosensory processing (latency 
and/or amplitude of early responses). It is also non-invasive, well-tolerated by 
patients and relatively inexpensive (Luck 2005). Hence we decided to use this 
rather than other modalities such as f-MRI (expensive and poor temporal 
resolution) or PET scan (risk of radiation exposure) in our exploratory study.  
 
 
             5.2 Central hypothesis and objectives 
 
The central hypothesis of the study was that the ‘’cortical reorganisation’’ as 
defined by EEG parameters will correlate significantly with finger 
misperception in CRPS. The primary objective was to determine whether 
cortical reorganisation in CRPS correlates with finger misperception. The 
secondary objective was to determine whether cortical reorganisation in 
CRPS correlates with pain severity.  
103 
 
The central hypothesis was developed based on the results from previous 
research studies which suggest that cognitive dysfunctions including finger 
misperception in CRPS may arise from cortical reorganisation. It would then 
be reasonable to hypothesise that the EEG parameters of cortical 
reorganisation would correlate with finger misperception. We were also 
interested in exploring the complex link of pain severity with markers of 
cortical re-organisation. 
 
       
 
           5.3 Methods 
 
5.3.1 Study design 
This was an experimental case-control study.  
 
5.3.2 Study setting 
The study was done in the EEG lab in Herschel Smith Building for Brain and 
Mind Sciences, University of Cambridge, UK between March 2013 and July 
2013. 
 
5.3.3 Inclusion criteria 
Participant is willing and able to give informed consent for participation in the 
study; Male or Female, aged 18-80 years; Right handed; Able to 
communicate fluently in English; Healthy controls or Patients diagnosed with 
unilateral upper or lower limb Complex Regional Pain Syndrome according to 
modified Budapest Research Criteria (Harden et al. 2007) given below: 
  
1. Continuing pain, which is disproportionate to any inciting event  







Table 5A: Symptom categories in CRPS 
Sensory Reports of hyperesthesia and/or allodynia 
Vasomotor Reports of temperature asymmetry and/or skin colour changes and/or   
skin colour asymmetry 
Sudomotor/ 
Oedema 
Reports of oedema and/or sweating changes and/or sweating asymmetry 
Motor/Trophic Reports of decreased range of motion and/or motor dysfunction 
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
 
3. Must display at least 1 sign at time of evaluation in ≥2 categories in Table 
5B 
Table 5B: Signs categories in CRPS 
Sensory Evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch 
and/or temperature sensation and/or deep somatic pressure and/or joint 
movement) 




Evidence of oedema and/or sweating changes and/or sweating asymmetry 
Motor/Trophic Evidence of decreased range of motion and/or motor dysfunction 
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
 
4. There is no other diagnosis that better explains the signs and symptoms 
 
 
5.3.4 Exclusion Criteria 
 
The participant may NOT enter the study if ANY of the following apply: 
Previous or current diagnosis of peripheral neuropathy, stroke, Transient 
Ischemic Attack, multiple sclerosis, malignancy or seizure disorder; Unable to 




  5.3.5 Sample Size 
 
At the stage of study design and conduct, tools were not available for 
powering EEG studies for group contrasts using contemporary statistical 
methods for EEG as used in this report. Reporting of sample size calculations 
in the EEG/ERP literature is estimated to be extremely uncommon for this and 
a number of other likely reasons (Larson & Carbine 2017). 
The aim was therefore to recruit as many as possible/practical with the 
available resources bearing in mind that many published EEG studies of 
CRPS report on around 10 subjects. Our aim was to recruit 20 patients, half of 
whom we expected (based on past literature (Förderreuther et al. 2004)) to 
show signs of digit misperception, and an equal number of healthy control 
participants.  
 
5.3.6 Study Procedure 
 
Potential participants were identified from the CRPS UK registry and were 
approached for taking part in the study. The total number of potentially eligible 
CRPS patients contacted (who lived locally) was 30; 25 of these were 
confirmed eligible, of which 16 patients were able to be recruited before the 
recruitment period of the study ended. Data from 3 patients were excluded 
from the study analysis: one did not complete the study, and in the other two 
patients, data quality was extremely poor due to extreme movement artefact 
that could not be corrected or removed.  
 
Also recruited were 13 age-and-sex frequency-matched healthy (pain-free) 
controls, recruited by advertising the study using posters in Addenbrooke’s 
hospital.  
 
Detailed written information leaflets for participants were provided in advance. 
Informed consent was taken and all the participants signed a consent form 
prior to taking part. It was stressed in the information sheet and at the time of 
taking consent that should a patient wish to withdraw their informed consent 




The participants were required to refrain from consuming alcohol or smoking 
tobacco for 24 hours and caffeine for 12 hours prior to the study. During the 
study visit, CRPS subjects (but not healthy controls) completed five 
questionnaires assessing pain severity, physical function, depersonalisation 
and emotional state: Brief Pain Inventory (Cleeland & Ryan 1994), Upper 
Extremity Functional Index (Stratford et al. 2001), Lower Extremity Functional 
Index (Binkley et al. 1999), Neglect-like Symptom Questionnaire (Galer & 
Jensen 1999), Hospital Anxiety and Depression Score (Snaith 2003). 
 
Standardised clinical tests for finger perception, astereognosis, hand laterality 
and body scheme were then administered on the same day as the EEG 
testing. These were the same tests as described in detail for the study ‘Novel 
clinical signs and their clinical utility in CRPS- an observational cohort 
study’(Kuttikat et al. 2017). They then underwent EEG testing according to the 
standardised protocol given below. 
 
5.3.7 EEG Protocol  
 
 
Participants were sat in a comfortable chair in an acoustically and electrically 
shielded room. The room was air conditioned and temperature of the room 
kept constant within the limits of 18 - 22°C. Adjacent to the testing room was a 
connected investigator room, where we observed and listened to the 
participants using a headphone and video monitoring system.  
 
Participants were fitted with the EGI electrolyte cap with 128 channels (see 
figures 5.1 & 5.2). The correct size of the cap for the individual participant was 
determined by measuring the head circumference. The cap was soaked in a 
solution of water and potassium hydrochloride for 10 minutes before fitting on 
the participant. The salt-water solution was pipetted into sponges of 






Figure 5.1: EGI 128 channel hydrocel sensor net   
 
Figure 5.2: Sensor lay out for 128 channels 
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We instructed the participants to keep their eyes closed and head still as 
much as possible during the testing to minimise eye blink and muscle 
movement artifacts. We also provided the participants with soft ear plugs to 
block out any extraneous auditory input so that they can focus on the tactile 
stimuli. 
 
Soft touch stimuli were delivered to the fingertips by using custom made 
handboxes (one for each hand) which were calibrated to deliver non-painful 
stimuli with the same force (See Figures 5.3 & 5.4 below). The participants 
were advised to report immediately if the sensation was uncomfortable or 
painful. The fingertips were also checked after each session to check for any 
redness of the skin. 
 
         
Figure 5.3: Handbox used to deliver soft touch stimuli                        
 
 






We carried out two experiments as described below. 
 
5.3.8 Experiment 1 
 
The main aim of Experiment 1 was to record (i) behavioural accuracy and 
response time for identification of each digit stimulated, (ii) SEPs related to 
task-relevant and spatially probabilistic tactile processing. 
We instructed the participant to place one hand on the handbox. The fingers 
were numbered consecutively from one to five starting with thumb (i.e.; 
thumb=1, index finger=2, middle finger =3, ring finger=4 and little finger=5). 
The participants had to respond to a stimulus by saying out loud the number 
corresponding to the finger which received the stimulus. 
 
Each trial consisted of the following: The subject receives a stimulus in one 
finger and responds which finger is touched by saying out loud the number 
corresponding to that finger. We record the answer manually by typing the 
number on the computer. This triggered the next stimulus. We used a 
microphone attached to the EMG leads on the polygraph input box to capture 
the participant’s response. The reaction time was measured from the delivery 
of the stimulus to the start of the voice deflection on the EMG lead recording. 
We did 80 trials per block and four blocks per hand. We tested only one hand 
in a block and alternated the hands after each block. We set a maximum time 
lock of three seconds per trial. The 80 trials were split into 30 each for thumb 
(Digit 1) and little finger (Digit 5) and the remaining 20 split between the 
remaining three fingers (Figure 5.5). The randomisation was done using 
MATLAB code which mixed up the order of the trials before presentation 
without changing the proportion stimulating each finger. The trials were 
weighted towards D1 & D5 and the 3 middle digits on each hand were 
stimulated rarely compared with the outer digits to assess the effects of 
spatial probability. This resulted in a significantly higher probability of digits 1 
and 5 (37.5% of the time for each, or 75% in total) being stimulated compared 
to digits 2, 3 and 4 (8.3% each, or 25% in total). Over the 4 blocks, 80 trials 
were presented for the total of the middle three digits (D2-D4) and 120 for 
each of the little finger and thumb; this provided more than enough data for 
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robust measurement of the P300 potential, thought to require a minimum of 
36 clean trials (Duncan et al. 2009). 
 
Figure 5.5 Number of stimuli delivered to each digit (randomised) and the number 
assignment to each digit that the subject used to respond as to which digit was stimulated. 
 
The clinical finger misperception test as used in the first study - ‘Novel signs in 
CRPS’ - was designed specifically as an easy and practical test to do in the 
clinic setting.  The second study utilised a more sophisticated method and a 
handbox to deliver exact same stimuli each time at a pre-defined frequency. 
Both tests are painless and can be used to elicit the finger misperception. The 
second method using handbox delivers precise calibrated stimuli and this is 
essential in generating robust somatosensory Event Related Potentials. The 
main limitation of this method is that this requires additional equipment and 
may not be practical in a clinic setting. 
 
5.3.9 Experiment 2 
 
The main aim of the Experiment 2 was to study group differences in sensory 
Event Related Potential (ERP) in the absence of cognitive task demands. We 
instructed the participants to sit relaxed with their eyes closed and head still. 
We delivered random stimuli to all fingers, one finger at a time, at a 
predefined frequency of 1 stimulus per second. The stimulus duration was 
0.05 seconds; interstimulus interval was 0.95 seconds with a 10 seconds 
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break after every 50 stimuli. In total 100 stimuli were delivered per finger of 
each hand generating 1000 trials in total in 20 minutes. We tested one hand 
at a time for five minutes and alternated the hand after every five minutes so 
that each hand would get a break improving participant comfort. Unlike in 
Experiment 1; they did not have to respond to the stimuli. 
 
 
5.3.10 EEG data acquisition and pre-processing 
 
During the experiment, 128-channel high-density EEG data in microvolts (μV), 
sampled at 250 Hz and referenced to the vertex, were collected using the Net 
Amps 300 amplifier (Electrical Geodesics Inc., Oregon, USA).  
Due to the use of naturalistic touch stimuli with relatively long stimulus 
durations (compared to electrical stimuli, for example), early components (e.g. 
<100ms) were expected to be difficult to detect, and as our main interest was 
long-latency components, the sampling rate was set at 250 Hz. 
Data from 92 channels over the scalp surface (at locations shown in figure 5.6 
below) were retained for further analysis. Channels on the neck, cheeks and 
forehead, which mostly contributed more movement related noise than signal 







Figure 5.6: Locations of 92 channels selected for analysis 
 
EEG data for the experiments were high pass filtered at 0.5 Hz, low pass 
filtered at 30Hz and segmented into epochs with the criteria of taking the 200 
ms preceding the stimulus and 800 ms after the stimulus. Data containing 
excessive eye movement or muscular artefact were rejected by a quasi-
automated procedure: noisy channels and epochs were identified by 
calculating their normalised variance and then manually rejected or retained 
by visual confirmation. Independent component analysis (ICA) based on the 
Infomax ICA algorithm (Bell & Sejnowski 1995) was run on the clean data 
excluding bad channels using ‘runica’ programme on MATLAB. ICA 
components were visually inspected and bad components rejected to further 
prune the dataset. Bad channels previously identified by visual inspection 
were then rejected and replaced by channels interpolated using spherical 
spline interpolation of the voltages from the neighbouring electrodes.  Data 
was then re-referenced to the average of 92 channels. These processing 
steps were implemented using custom MATLAB scripts based on EEGLAB 
(Delorme & Makeig 2004). 
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5.3.11 Statistical Methods 
            
We analysed behavioural data using IBM SPSS (Statistical Package for 
Social Sciences) software version 21(IBM 2012). Paired and independent 
samples t-tests were used for comparisons of reaction times in healthy and 
patient groups. Data for accuracy and response times were not normally 
distributed, especially in the CRPS group. Hence, non-parametric tests were 
performed to investigate overall group differences averaged over all 
conditions (Mann-Whitney U test), and to investigate within-subject condition 
effects in each group separately (Wilcoxon signed rank tests). Spearman’s rho 
(non-parametric) was used for correlation analyses. 
 
We used FieldTrip, an open-source software developed at the Donders 
Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 
The Netherlands (Oostenveld et al. 2011) for analysis of EEG data.  
FieldTrip is implemented as a MATLAB toolbox and has algorithms to perform 
time-frequency analysis, source reconstruction, connectivity analysis, and 
non-parametric statistical permutation tests at the channel and source level. 
 
Two major approaches to study cortical reorganisation in CRPS are (a) 
source reconstruction, and (b) event-related potential analysis. Regarding (a), 
EEG is inferior compared to other methods (MEG, TMS, fMRI), plus we did 
not have MRI images of patients that would facilitate source reconstruction. 
Hence, we decided to focus on (b), which could be divided into temporal-
spatial ERP (classical ERP studies) and temporal ERP, which is GFP. We 
initially aimed to use temporal-spatial ERP, but due to heterogeneity of 
patients, spatial distributions of individual ERP were rather different among 
patients, making the dataset set very noisy. Hence, we opted for GFP, which 
reduces space-time dimensions to a time vector. The strength of this 
approach is that it is relatively easy to elicit in an experimental setting, and 
hence provides a robust marker. Weakness is that exact identification of the 





Brain electric field data (EEG and ERP) recorded simultaneously from multiple 
channels can be viewed as a series of maps of the momentary spatial 
distributions of electric potential. Global Field Power is a measure of map 
strength computed as standard deviation of the momentary potential values 
(Lehmann & Skrandies 1980). 
 
Epochs from an experimental condition and its own baseline period, or pairs 
of conditions of interest, were compared using a non-parametric t-test based 
on that employed in the FieldTrip toolbox. This test identified temporal clusters 
of statistically significant differences between the Global Field Power (GFP) of 
the ERPs in the two conditions using a Monte Carlo procedure for estimating 
p-values. 
To elaborate, we first calculated ERPs by separately averaging epochs (for 
single-subject analysis) or subject-wise averages (for group analysis) included 
in each condition. The difference between the GFP time courses of the two 
ERPs was then tested for statistical significance using a randomisation testing 
procedure. To do this, the original epochs/subject-wise averages were mixed 
together and separated into two new sets that contained random samples 
from the original conditions. These sets were again separately averaged to 
calculate new ERPs and GFP difference time course. This randomised 
resampling step was repeated 1000 times, to generate as many GFP 
difference time courses. The original GFP difference at each time point within 
a time window of interest was then compared to the maximum GFP 
differences obtained within that time window over the randomisation 
iterations, to calculate a time point-wise t-value and p-value. Significant time 
points with p-values <0.05 were clustered together based on temporal 
contiguity, and the cluster with the largest sum of constituent t-values, the 
cluster-level t-value, was retained. This procedure was then repeated for the 
GFP differences generated in every randomisation iteration, to identify the 
largest such cluster generated in each iteration. Finally, the cluster-level t-
value generated with the original GFP difference was compared to the 
distribution of cluster-level t-values generated by the randomisation iterations, 
to calculate a non-parametric p-value. This represented the Monte Carlo 
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estimate of the level of statistical significance of the cluster identified in the 
original GFP.  
As shown by  (Maris & Oostenveld 2007), this comparison of the original GFP 
difference at each time point to the maximal GFP difference obtained in each 
iteration, followed by temporal clustering of time points, effectively and 
sensitively controls for family wise error (Type 1 error) and multiple 
comparisons. 
        
  





There were 13 patients with unilateral upper or lower limb CRPS of which 11 
were females and two males. 9 had left sided CRPS and 4 had right sided 
CRPS. 4 had left arm affected, 2 had right arm affected, 5 had left leg affected 
and 2 had right leg affected. There were 13 age and sex matched healthy 
controls. All subjects (patients & healthy) were right handed. The baseline 


















Table 5C: Summary of baseline characteristics of study subjects  
Characteristics CRPS (n=13) Healthy (n=13) 
Age in years 





Female sex (%) 
 
11 (84.6) 11 (84.6) 
Right handed (%) 
 




Disease duration in 
years  Mean (range) 
 
5.3 (1-14) Not applicable 
Past Medical History Depression/Anxiety 7 (53.8) 
Other psychiatric 0 
IBS 0 
Asthma/COPD 6 (46.2) 
Migraines 2 (15.8) 




Medications at the 
time of study (%) 
 
 
Paracetamol 10 (76.9) 
NSAIDs 4 (30.8) 
Weak opioids 5 (38.5) 
Strong opioids 2 (15.4) 
Anti-depressants 7 (53.8) 
Anti-convulsants 6 (46.2) 













































P1 34 F Right  
leg 
1  Raynaud’s 
phenomenon 
Amitriptyline, Pregabalin, 
Paracetamol, Tramadol  
P2 59 F Left 
 leg 
8  Osteoarthritis 
Migraine, Cervical 
spondylosis 





P3 63 F Left  
arm 
8 none Pregabalin, Paracetamol 
Tramadol, Lidocaine patch 
P4 42 F Right 
arm 
5 Rotator cuff 
Tendinopathy 
Ibuprofen, Paracetamol , 
Tramadol  











Tramadol, Adcal D3,QVAR 
GTN spray, Omeprazole  
P6 20 F Left  
leg 
5 Depression Amitriptyline, Oxynorm, 
Paracetamol, Fluoxetine, 
Carbemazepine, Oxycontin 








Amitriptyline, Pregabalin  
MST continus, Ramipril,  
Lactulose, Mebeverine  
Diazepam, Fluoxetine  
Furosemide,  Naratriptan  
Symbicort 
P8 52 F Right 
 leg 
4 Adhesive capsulitis, 
Asthma, Anxiety 
Naproxen , Paracetamol  







Paracetamol, Tramadol  
Fluoxetine  
P10 59 M Left leg 5 Anxiety Amitriptyline  
P11 29 M Left  
arm 
3 Adhesive capsulitis Amitriptyline, Ibuprofen,  
Gabapentin, Adcal D3  




Symbicort, Naproxen  
Pregabalin, Paracetamol  
Adcal D3, Sertraline, 
Zopiclone  
P13 43 F Left 
hand 
5 Asthma Beclomethasone,  
Buprenorphine patch  
Gabapentin, Paracetamol, 






5.4.2 Results-Behavioural data 
 
Reaction Times 
The average reaction times (in milliseconds) of the healthy controls (left and 
right hands) and patients (affected and unaffected hands) are tabulated below 
in table 5E. 
 
Table 5E: Average reaction times (milliseconds) of individual study subjects 










1 746.6 716.2 1871.7 2014.3 
2 963.6 1013.7 955.5 973.4 
3 1401.6 1432.3 995.6 1097.6 
4 875.9 862.0 1285.5 2193.3 
5 953.4 1024.3 993.5 931.2 
6 893.4 912.1 1236.7 1631.2 
7 1096.9 1216.1 1473.6 1627.8 
8 927.5 895.8 1157.4 1271.0 
9 963.1 1056.7 1110.3 1331.5 
10 520.2 520.4 1519.7 1866.1 
11 941.5 957.1 1086.8 1262.0 
12 867.5 827.9 732.8 717.0 
13 1160.6 1146.8 2016.3 1992.0 
 
 
Figure 5.7: Graphical representation of mean reaction time (RT) of different 

























Mean Reaction Time (+/- 1 S.D.) 
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H1 637.8 612.9 795.5 749.1 782.7 728.2 783.8 786.9 732.9 703.8 
H2 815.2 798.0 984.2 1054.8 1066.3 1104.7 1065.9 1201.2 886.4 909.9 
H3 1209.1 1058.2 1227.6 1370.0 1728.3 1758.1 1562.3 1745.7 1280.5 1229.7 
H4 774.6 806.8 871.1 954.2 995.3 907.2 904.3 845.2 834.1 796.5 
H5 846.7 839.9 948.7 1053.3 1056.2 1133.1 1054.4 1194.3 860.9 900.7 
H6 724.9 728.8 902.1 969.3 986.7 946.8 1061.1 1112.4 792.1 803.1 
H7 1078.8 1067.8 1054.9 1131.7 1069.1 1343.7 1163.7 1358.4 1118.3 1178.7 
H8 737.2 713.8 1012.6 976.3 1028.7 983.3 1037.7 1032.3 821.4 773.6 
H9 787.9 779.0 1032.2 1122.9 1083.2 1306.3 1033.1 1214.5 879.2 861.1 
H10 515.3 547.3 525.0 526.4 514.3 512.0 524.0 504.0 522.5 512.2 
H11 795.5 788.9 975.5 994.1 1073.4 1086.9 1052.7 1098.4 810.3 817.3 
H12 622.4 645.3 942.1 835.6 1038.4 1056.0 1032.2 987.9 702.3 614.9 
H13 1010.0 1010.8 1231.5 1207.8 1215.1 1180.8 1270.4 1278.5 1075.8 1056.0 
 
 
Table 5G: Average reaction time (milliseconds) of individual fingers in patients 
 
Un D1 Af D1 Un D2 Af D2 Un D3 Af D3 Un D4 Af D4 Un D5 Af D5 
P1 1200.2 1180.2 1931.4 2262.0 2611.2 2733.1 2218.0 2551.1 1397.9 1345.3 
P2 638.4 718.8 1232.7 1138.1 966.2 955.1 1178.3 1216.3 761.9 838.8 
P3 896.9 863.6 963.5 1378.5 1082.3 1048.4 1113.2 1089.3 921.9 1108.1 
P4 1002.6 1407.4 1415.7 2450.4 1362.1 2913.6 1459.4 2698.2 1187.9 1496.8 
P5 810.0 773.6 976.3 850.0 1236.5 1138.8 1074.6 991.5 870.2 901.9 
P6 776.2 934.7 1159.0 1878.5 1481.0 1942.3 1630.9 2060.3 1136.4 1340.1 
P7 961.5 899.2 2118.3 1761.2 1457.2 1643.6 1743.3 2752.0 1087.9 1082.9 
P8 954.5 931.1 1298.4 1527.5 1165.4 1251.4 1310.9 1486.3 1057.9 1158.7 
P9 1004.5 1086.0 1258.0 1503.8 1166.8 1432.9 1167.3 1431.7 955.1 1203.3 
P10 1002.9 1101.5 1622.3 1656.3 1614.0 1859.8 2240.0 2493.0 1119.2 2220.1 
P11 835.3 930.3 1097.6 1183.9 1132.9 1238.4 1229.7 1532.3 1138.6 1425.2 
P12 590.7 591.0 755.0 694.0 829.2 886.5 860.4 789.8 628.8 623.8 
P13 1509.2 1894.0 2357.1 2170.9 2014.1 2233.6 2144.0 2294.0 2057.3 1367.3 
 









Figure 5.8: Graphical representation of mean reaction time (RT) of individual 
fingers (D1 to D5, Thumb to Little finger) in healthy subjects with standard 
deviation error bars.  
 
 
Figure 5.9: Graphical representation of mean reaction time (RT) of individual 
fingers (D1 to D5, Thumb to Little finger) in patients with standard deviation 























































Healthy- Mean Reaction Time 





























Patients- Mean Reaction Time 
 (+/- 1 S.D.) 
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1. On average, healthy controls had similar reaction times in the left hand (M = 
947.1 ms, SE = 57.31) and in the right hand (M = 967.8 ms, SE = 63.31, t (12) 
= -1.49, two-tailed p = 0.18). 
 
2. Within the same hand in healthy controls, on average, the reaction times were 
significantly longer in the little finger compared to the thumb in both left and 
right sides. 
Left little finger (M=870.5 ms, SE=53.94) and left thumb (M=811.9 ms, 
SE=53.05, t (12) =7.02, two-tailed p = 0.00001). 
Right little finger (M= 858.3 ms, SE= 56.77) and right thumb (M= 799.8ms, 
SE= 45.32, t (12) = 3.53, two-tailed p = 0.004). 
 
3. On average, patients had significantly longer reaction times in the affected 
hand (M = 1454.5 ms, SE = 130.12), than in the unaffected hand (M = 1264.3 
ms, SE = 102.37, t (12) = 2.68, two-tailed p = 0.02). 
 
4. There was a statistically significant difference (longer) in the average reaction 
times of patients’ affected hand (M = 1454.5 ms, SE = 130.12) than to the 
healthy left hand (M = 947.1 ms, SE = 57.31, t = 3.12, two-tailed p = 0.009).  
 
5. There was a statistically significant difference (longer) in the average reaction 
times of patients’ affected hand (M = 1454.5 ms, SE = 130.12) than to the 
healthy right hand (M = 967.8 ms, SE = 63.31, t = 2.97, two-tailed p = 0.012). 
 
6. There was a statistically significant difference (longer) in the average reaction 
times of patients’ unaffected hand (M = 1264.3 ms, SE = 102.37) than to the 
healthy left hand (M = 947.1 ms, SE = 57.31, t = 2.32, two-tailed p = 0.038).  
 
7. There was a statistically significant difference (longer) in the average reaction 
times of patients’ unaffected hand (M = 1264.3 ms, SE = 102.37) than to the 







The average accuracy (in percentage) of patients (affected and unaffected 
hands) and the healthy controls (left and right hands) are tabulated below in 
Table 5H.  











1 99.83 98.79 95.74 88.86 
2 96.33 98.95 91.21 73.69 
3 97.31 97.58 99.33 95.79 
4 96.24 98.06 96.41 83.93 
5 95.55 94.98 66.64 47.11 
6 98.90 95.66 99.00 91.66 
7 97.40 97.26 81.48 60.86 
8 97.47 96.99 97.17 73.61 
9 97.20 98.08 96.50 68.37 
10 98.88 99.83 94.41 91.04 
11 85.11 97.98 83.77 51.20 
12 94.43 96.00 98.62 97.83 
13 99.33 99.50 86.15 32.90 
 
 
Figure 5.10: Graphical representation of mean accuracy (%) of different study 

























Mean Accuracy (+/- 1 S.D) 
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H1 100.00 100.00 100.00 100.00 100.00 100.00 100.00 96.43 99.17 97.50 
H2 98.33 98.33 100.00 100.00 91.67 100.00 95.83 96.43 95.83 100.00 
H3 96.67 100.00 100.00 100.00 96.43 96.43 96.77 92.31 96.67 99.17 
H4 95.00 97.50 96.55 96.67 96.15 100.00 96.00 96.15 97.50 100.00 
H5 96.67 97.50 93.94 89.29 100.00 96.43 88.00 91.67 99.17 100.00 
H6 98.33 91.67 100.00 100.00 100.00 96.15 96.15 95.45 100.00 95.00 
H7 98.33 95.83 100.00 100.00 94.74 96.67 96.43 95.45 97.50 98.33 
H8 99.17 99.17 96.88 100.00 91.30 94.29 100.00 92.31 100.00 99.17 
H9 97.50 98.33 95.83 100.00 100.00 93.75 96.00 100.00 96.67 98.33 
H10 100.00 100.00 100.00 100.00 100.00 100.00 95.24 100.00 99.17 99.17 
H11 89.17 99.17 87.50 96.97 82.61 95.45 78.79 100.00 87.50 98.33 
H12 99.17 100.00 96.00 100.00 93.94 100.00 86.36 80.00 96.67 100.00 
H13 99.17 100.00 100.00 100.00 100.00 100.00 100.00 100.00 97.50 97.50 
 
D1 to D5= Thumb to Little finger consecutively 
 
Table 5J: Average accuracy (%) of individual fingers in patients 
 
  Un D1 Af D1 Un D2 Af D2 Un D3 Af D3 Un D4 Af D4 Un D5 Af D5 
P1 94.17 92.50 100.00 96.15 100.00 93.75 92.86 72.73 91.67 89.17 
P2 86.67 71.67 100.00 62.96 85.00 95.45 93.55 74.19 90.83 64.17 
P3 96.67 98.33 100.00 89.47 100.00 100.00 100.00 92.00 100.00 99.17 
P4 100.00 99.17 95.83 76.67 100.00 80.00 96.77 68.00 99.17 95.83 
P5 67.50 50.00 78.26 52.94 56.00 39.13 65.63 43.48 65.83 50.00 
P6 100.00 99.17 95.83 67.65 100.00 100.00 100.00 95.65 99.17 95.83 
P7 95.83 96.67 73.45 27.27 71.43 77.42 70.00 6.25 96.67 96.67 
P8 97.50 74.17 97.06 70.37 95.45 75.00 95.83 76.00 100.00 72.50 
P9 95.83 77.33 100.00 64.10 100.00 85.00 86.67 38.10 100.00 77.33 
P10 95.00 94.17 90.91 96.43 100.00 96.00 89.47 77.78 96.67 90.83 
P11 97.50 98.33 78.95 43.33 86.67 92.59 77.42 21.74 78.33 0.00 
P12 99.17 100.00 100.00 100.00 100.00 90.00 93.94 100.00 100.00 99.17 
P13 98.33 75.83 89.05 17.39 84.54 42.86 83.85 27.59 75.00 0.83 
 









Figure 5.11: Graphical representation of mean accuracy (%) of individual 





Figure 5.12: Graphical representation of mean accuracy (%) of individual 







































































Mean Accuracy-Patients (+/- 1 S.D.) 
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1. Healthy controls, on average, had similar accuracy in the left hand (M = 
96.46 %, SE = 1.03) compared to the right hand (M = 97.67%, SE = 0.41, 
Wilcoxon Signed Rank test,   z= -1.08, p = 0.28). 
 
2. Healthy controls, on average, had similar accuracy in the left little finger (M 
= 97.18 %, SE = 0.89) compared to the left thumb (M = 97.5%, SE = 0.80, 
Wilcoxon Signed Rank test,   z= -0.26, p = 0.53). 
 
3. Healthy controls, on average, had similar accuracy in the right little finger 
(M = 98.65 %, SE = 0.39) compared to the right thumb (M = 98.27%, SE = 
0.66, Wilcoxon Signed Rank test,   z= -0.76, p = 0.45). 
 
4. Patients, on average, had statistically significant lower accuracy in the 
affected hand (M = 75.17 %, SE = 6.09) than in the unaffected hand (M = 
91.26 %, SE = 2.63, Wilcoxon Signed Rank test, z= -2.97, p = 0.003). 
 
5. Patients had statistically significant lower accuracy in the affected hand (M 
= 75.17 %, SE = 6.09) compared to the left hand in healthy (M = 96.46 %, SE 
= 1.03, Mann-Whitney-U test, Z score= -3.03, U= 25, p = 0.002).  
 
6. Patients had statistically significant lower accuracy in the affected hand (M 
= 75.17 %, SE = 6.09) compared to the right hand in healthy (M = 97.67%, SE 
= 0.41, Mann-Whitney-U test, Z score= -3.44, U= 17, p = 0.0006). 
 
7. Patients had lower accuracy (but not reaching statistical significance) in the 
unaffected hand (M = 91.26 %, SE = 2.63) compared to the left hand in 
healthy (M = 96.46 %, SE = 1.03, Mann-Whitney-U test, Z score= -1.62, U= 
52.5, p = 0.11). 
 
8. Patients had statistically significant lower accuracy in the unaffected hand 
(M = 91.26 %, SE = 2.63) compared to the right hand in healthy (M = 97.67%, 






Was there a difference in reaction times and accuracy between right 
side affected and left side affected CRPS patients? 
 
There were four patients who had CRPS clinically affecting their right side and 
nine patients with left side affected. We were interested to see if the affected 
side (left or right) had a bearing on the reaction times or the accuracy rates.  
 
There was a statistically significant difference in the average reaction times of 
patients’ affected hand in right sided (n=4) CRPS (M = 1869.52 ms, SE = 
145.50) compared to the left sided (n=9) CRPS (M = 1311.33 ms, SE = 
145.96, t = 2.71, two-tailed p = 0.02). However, there was no statistically 
significant difference in the average reaction times of patients’ unaffected 
hand in right sided (n=4) CRPS (M = 1447.08 ms, SE = 155.73) compared to 
the left sided (n=9) CRPS (M = 1183.04 ms, SE = 126.42, t = 1.32, two-tailed 
p = 0.23). 
 
There was no statistically significant difference in the average accuracy of 
patients’ affected hand in right sided (n=4) CRPS (M = 76.81%, SE = 6.20) 
compared to the left sided (n=9) CRPS (M = 72.18%, SE = 7.98, t = 0.46, two-
tailed p = 0.66). Similarly, there was no statistically significant difference in the 
average accuracy of patients’ unaffected hand in right sided (n=4) CRPS (M = 
93.18%, SE = 3.94) compared to the left sided (n=9) CRPS (M = 90.63%, SE 
= 3.54, t = 0.48, two-tailed p = 0.64).  
 
The numbers in the groups used in subgroup testing are small and hence the 
results have to be interpreted with caution. Results are not always 
generalizable to larger samples. Small sample sizes may not be sufficient to 
pick up significant differences even if they exist and that is a limitation of this 
particular analysis. 
 
NB: t-tests with independent samples and assuming unequal variances were used for 
both reaction times and accuracy as Mann-Whitney U-test statistic will be highly 




Was there a difference in reaction times and accuracy between upper 
and lower limb affected patients? 
 
There were six patients with upper limb clinically affected with CRPS and 
seven with lower limb affected. We were interested to see if the affected limb 
(upper or lower) had a bearing on the reaction times or accuracy scores. 
 
There was no statistically significant difference in the average reaction times 
of patients’ hand on the affected side in upper limb (n=6) CRPS (M = 1584.03 
ms, SE = 177.35) compared to the lower limb (n=7) CRPS (M = 1343.47 ms, 
SE = 189.66, t = 0.93, two-tailed p = 0.37). 
 
There was no statistically significant difference in the average reaction times 
of patients’ hand on the unaffected side in upper limb (n=6) CRPS (M = 
1328.04 ms, SE = 154.15) compared to the lower limb (n=7) CRPS (M = 
1209.63 ms, SE = 144.47, t = 0.56, two-tailed p = 0.59). 
 
There was no statistically significant difference in the average accuracy of 
patients’ hand on the affected side in upper limb (n=6) CRPS (M = 65.51%, 
SE = 9.23) compared to the lower limb (n=7) CRPS (M = 80.54%, SE = 6.57, t 
= -1.33, two-tailed p = 0.22). 
 
There was no statistically significant difference in the average accuracy of 
patients’ hand on the unaffected side in upper limb (n=6) CRPS (M = 90.61%, 
SE = 3.13) compared to the lower limb (n=7) CRPS (M = 91.83%, SE = 4.32, t 














5.4.3 Results-Experiment 1 Global Field Power (GFP) analysis 
 
 
Group level  
1. No statistically significant difference between Left & Right hand stimulations in 
healthy controls (Figures 5.13 & 5.14).  
 





Figure 5.14: Time course of GFP of ERP grand average of healthy left (blue 
line) and right (green line). The vertical red dashed line indicates the time 
point within the cluster at which GFP difference was maximal, and the upper 







2. No significant difference between affected & unaffected hand stimulations in 
patients (Figures 5.15 & 5.16). 
 
Figure 5.15: Affected and unaffected side hand stimulations - grand average 




Figure 5.16: Time course of GFP of ERP grand average of patient unaffected 
(blue line) and affected (green line). The vertical red dashed line indicates the 
time point within the cluster at which GFP difference was maximal, and the 
upper half of the panel plots the scalp topography of the ERP (condition 1) at 











3. No significant difference between Right hand stimulations in healthy controls 
compared to unaffected hand stimulation in patients (Figures 5.17 & 5.18). 
 
 
Figure 5.17: Healthy right hand and patient unaffected side hand stimulations 





Figure 5.18: Time course of GFP of ERP grand average of healthy right (blue 
line) and patient unaffected (green line). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of the ERP (condition 1) 







4. Statistically significant difference (p=0.003) between healthy left compared to 
affected hand in patients in the time segment 200 -400 ms but not between 0-
200 ms (Figures 5.19 & 5.20). 
 
Figure 5.19: Healthy left hand and patient affected side hand stimulations - 




Figure 5.20: Time course of GFP of ERP grand average of healthy left (blue 
line) and patient affected (green line). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of ERP (condition 1) at 
this time point. The horizontal thick red line indicates the temporal extent of a 
statistically significant cluster of contiguous time points where GFP was 
greater in patients affected side than healthy left. 
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5. Statistically significant difference (p=0.008) between healthy (Left and right 
combined) compared to patients (affected and unaffected combined) in the 
time segment 200 -400 ms but not between 0-200 ms (Figures 5.21 & 5.22).  
 
Figure 5.21: Healthy and patients both hand stimulations combined - grand average 
of ERPs of all subjects. 
 
 
Figure 5.22: Time course of GFP of ERP grand average of hands combined, 
healthy (blue line) and patients (green line). The vertical red dashed line indicates the 
time point within the cluster at which GFP difference was maximal, and the upper half 
of the panel plots the scalp topography of the ERP (condition 1) at this time point. 
The horizontal thick red line indicates the temporal extent of a statistically significant 
cluster of contiguous time points where GFP was greater in patients (both hands) 








Individual level (focus on the time segment 200-400 ms to capture P300 
effects)  
1. No statistically significant difference between left or right hand in any of the 
healthy controls (Figures 5.23 & 5.24).  
 




Figure 5.24: Time course of GFP of ERP average of a single healthy subject, 
left hand (blue) and right hand (green). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 




2. Statistically significant difference between affected and unaffected hands in 
four of the 13 patients. In three of those four, GFP on the affected side was 
higher than the unaffected side (shaded yellow) whereas in one, the reverse 
was true (shaded green in the Table 5K). The individual ERP plots and GFP 
time course of these 4 patients are detailed in figures 5.25-5.32 
 
Table 5K:  
Patient 
identifier 
Age, sex, affected 
limb 





P4 42,F,Right arm 272 ms 754.2 0.001 
P5 53,F,Left leg 376 ms 268.1 0.006 
P8 52,F,Right leg 320 ms 400.9 0.002 











Figure 5.26: Time course of GFP of ERP average of a single patient (P4), 
affected hand (blue) and unaffected hand (green). The vertical red dashed 
line indicates the time point within the cluster at which GFP (condition 1) was 
maximal, and the upper half of the panel plots the scalp topography of the 
ERP (condition 1) at this time point. The horizontal thick blue line indicates the 
temporal extent of a statistically significant cluster of contiguous time points 












Figure 5.28: Time course of GFP of ERP average of a single patient (P5), 
affected hand (blue) and unaffected hand (green). The vertical red dashed 
line indicates the time point within the cluster at which GFP difference was 
maximal, and the upper half of the panel plots the scalp topography of the 
ERP (condition 1) at this time point. The horizontal thick blue line indicates the 
temporal extent of a statistically significant cluster of contiguous time points 















Figure 5.30: Time course of GFP of ERP average of a single patient (P8), 
affected hand (blue) and unaffected hand (green). The vertical red dashed 
line indicates the time point within the cluster at which GFP difference was 
maximal, and the upper half of the panel plots the scalp topography of the 
ERP (condition 1) at this time point. The horizontal thick blue line indicates the 
temporal extent of a statistically significant cluster of contiguous time points 















Figure 5.32: Time course of GFP of ERP average of a single patient (P3), 
affected hand (blue) and unaffected hand (green). The vertical red dashed 
line indicates the time point within the cluster at which GFP difference was 
maximal, and the upper half of the panel plots the scalp topography of the 
ERP (condition 1) at this time point. The horizontal thick red line indicates the 
temporal extent of a statistically significant cluster of contiguous time points 





























5.4.4 Results-Experiment 2 Global Field Power (GFP) analysis 
Group level  
1. No significant difference between Healthy Left & Right stimulations (Figures 
5.33 & 5.34).  
 




Figure 5.34: Time course of GFP of ERP grand average of healthy left (blue 
line) and right (green line). The vertical red dashed line indicates the time 
point within the cluster at which GFP difference was maximal, and the upper 




2. No significant difference between Patient affected and unaffected (Figures 
5.35 & 5.36). 
 
Figure 5.35: Affected and unaffected hand stimulations-grand average of 




Figure 5.36: Time course of GFP of ERP grand average of patients affected 
(blue line) and unaffected (green line). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of the ERP (condition 1) 





3. No significant difference between healthy Left and Patient affected (Figures 
5.37 & 5.38). 
 
Figure 5.37: Healthy Left and patient affected hand stimulations-grand 




Figure 5.38: Time course of GFP of ERP grand average of healthy left (blue 
line) and patients affected (green line). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of the ERP (condition 1) 






4. No significant difference between healthy Right and Patient unaffected 
(Figures 5.39 & 5.40)  
 
Figure 5.39: Healthy right and patient unaffected hand stimulations-grand 
average of ERPs of all subjects 
 
 
Figure 5.40: Time course of GFP of ERP grand average of healthy right (blue 
line) and patient unaffected (green line). The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of the ERP (condition 1) 







5. No significant difference between healthy and patients, both hands combined 
(Figures 5.41 & 5.42). 
 
Figure 5.41: Healthy and patient both hands combined -grand average of 
ERPs of all subjects. 
 
 
Figure 5.42: Time course of GFP of ERP grand average of both hands 
combined, healthy (blue line) and patient (green line). The vertical red dashed 
line indicates the time point within the cluster at which GFP difference was 
maximal, and the upper half of the panel plots the scalp topography of the 










1. No statistically significant difference between left or right hand in any of the 
healthy controls (Figures 5.43 & 5.44)  
 




Figure 5.44: Time course of GFP of ERP average of a single healthy control, 
left hand (blue) and right hand (green).  The vertical red dashed line indicates 
the time point within the cluster at which GFP difference was maximal, and 
the upper half of the panel plots the scalp topography of the ERP (condition 1) 




2. No statistically significant difference between affected or unaffected hand in 
any of the patients (Figures 5.45 & 5.46). 
 





Figure 5.46: Time course of GFP of ERP average of a single patient, affected 
hand (blue) and unaffected hand (green). The vertical red dashed line 
indicates the time point within the cluster at which GFP difference was 
maximal, and the upper half of the panel plots the scalp topography of the 






5.4.5 Results- Variability analysis  
 
We graphically represented the variability of GFP and latency in both healthy 
and patient groups using spider plots as below (Figures 5.46-5.54) and also 
formally tested the homogeneity of variances in the patient and healthy 
groups using Levene’s test. The GFP score and the latency are from 200-400 
ms segment in experiment 2.  
 
 
Figure 5.47: GFP variability in Healthy Left (blue) Vs Healthy Right (red). 
The spokes 1 to 13 represent the 13 individual subjects. The GFP score (0 






Figure 5.48: GFP variability in Patients affected (blue) Vs unaffected (red). 
The spokes 1 to 13 represent the 13 individual subjects. The GFP score (0 













































Figure 5.49: GFP variability in Healthy Left (blue) Vs Patient affected 
(red). The spokes 1 to 13 represent the 13 individual subjects. The GFP 






Figure 5.50: GFP variability in Healthy Right (blue) Vs Patient unaffected 
(red). The spokes 1 to 13 represent the 13 individual subjects. The GFP 






















































Figure 5.51: Latency variability in Healthy Left (blue) Vs Right (red). The 
spokes 1 to 13 represent the 13 individual subjects. The latency (0 to 300 






Figure 5.52: Latency variability in Patients affected (blue) Vs unaffected 
(red). The spokes 1 to 13 represent the 13 individual subjects. The latency 













































Figure 5.53: Latency variability in Healthy Left (blue) Vs Patient affected 
(red). The spokes 1 to 13 represent the 13 individual subjects. The latency 





Figure 5.54: Latency variability in Healthy Right (blue) Vs Patient 
unaffected (red). The spokes 1 to 13 represent the 13 individual subjects. 















































Figure 5.55: Composite spider plot of GFP and Latency variability in 
Healthy and Patients. The spokes 1 to 13 represent the 13 individual 
subjects.  
The GFP score (Blue = Healthy left, Red=Patient affected) is in microvolts. 






The above spider plots illustrate two main points: 
 
1. Significant variability in the patient group compared to the healthy 
group in terms of GFP score for both affected (Levene’s test, one-tailed 
p=0.03) and unaffected (Levene’s test, one-tailed p=0.045) sides. 
2. No significant variability in the patient group compared to the healthy 































5.4.6 Results - Correlations 
 
Correlation analyses were done using GFP & Behavioural variables described 
below:  
GFP variables (calculated over the time period of 200-400 ms): Peak latency, 
peak amplitude and mean amplitude 
Behavioural variables: Average Reaction Time, average accuracy, BPI pain 
scores, HAD Anxiety & Depression Scores, NLSQ (Neglect-Like Symptom 
Questionnaire) and Hand Laterality (accuracy & time). Pain severity was 
derived from the Brief Pain Inventory and included the ‘worst’ pain and 
‘average’ pain in the last 24 hours as well as the ‘current’ pain. Pain 
interference was scored as the mean of the seven interference items. 
 
Hand laterality time showed significant correlation (after Bonferroni correction 
for multiple comparisons) with mean GFP amplitude of affected hand. (Figure 
5.55). None of the other behavioural variables including pain severity 




Figure 5.56: HL Time & mean GFP amplitude (affected hand), Spearman’s 






We recruited 13 CRPS patients (11 females, mean age=46.8 years) and 13 
age-and- sex matched healthy controls. In the CRPS group, 4 had left arm, 2 
had right arm, 5 had left leg and 2 had right leg affected respectively. The 
mean disease duration was 5.3 years (range 1-14). 
 
On average, healthy controls had similar reaction times in the left and right 
hands, while the patients had significantly longer reaction times in the affected 
hand compared to the unaffected hand. The average reaction times of 
patients affected as well as unaffected hands were significantly longer than 
both the left and right hands of healthy controls. 
 
Healthy controls, on average, had similar accuracy in the left and right hands. 
In contrast the patients, on average, had statistically significant lower 
accuracy in the affected hand than in the unaffected hand. Patients had 
statistically significant lower accuracy in the affected hand compared to either 
the left or right hand in healthy controls. In the unaffected hand, patients had a 
lower accuracy (but not reaching statistical significance) compared to the left 
hand in the healthy controls and statistically significant lower accuracy 
compared to the right hand in the healthy controls.  
 
The average reaction times of patients’ affected hand in right sided (n=4) 
CRPS was significantly longer compared to the left sided (n=9) CRPS. 
However, there was no statistically significant difference in the average 
reaction times of patients’ unaffected hand in right sided CRPS compared to 
the left sided CRPS. There was no statistically significant difference in the 
average accuracy of patients’ affected or unaffected hands in right sided 
CRPS compared to the left sided CRPS. 
 
There was no statistically significant difference in the average reaction times 
of patients’ hand on the affected or unaffected side in upper limb (n=6) CRPS 
compared to the lower limb (n=7) CRPS. Similarly, there was no statistically 
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significant difference in the average accuracy of patients’ hand on the affected 
or unaffected side in upper limb CRPS compared to the lower limb (n=7) 
CRPS. 
 
All patients and healthy volunteers were right handed and there were no 
statistically significant differences between healthy left and healthy right hands 
on GFP analysis. Hence we could have used either healthy left or healthy 
right as comparator group to the patient group.  We compared healthy left to 
patient affected and healthy right to unaffected group. We also compared 
combined left and right hands in healthy to combined affected and unaffected 
hand in patients. 
 
In the Experiment 1 designed to elicit P300 responses (where the patients 
had to behaviourally respond to the stimuli), we noted interesting differences 
in the GFP in 200-400 ms segment.  
 
At the group level, there was a statistically significant difference (p=0.003) 
with the GFP score in the affected hand in patients being higher compared to 
healthy left in the time segment 200-400 ms but not between 0-200 ms. There 
was also a statistically significant difference (p=0.008) between healthy (left 
and right combined) compared to patients (affected and unaffected combined) 
in the time segment 200 -400 ms but not between 0-200 ms. 
 
There was no significant difference between right hand stimulations in healthy 
controls compared to unaffected hand stimulation in patients. There were no 
statistically significant differences either between left and right hand 
stimulations in healthy subjects or between affected & unaffected hand 
stimulations in patients. We also ran an ANOVA to test the interaction 
between left & right hands in healthy and affected & unaffected hands in 






At the individual level, there were no statistically significant differences 
between left or right hand in any of the healthy controls. In contrast, 
statistically significant differences between affected and unaffected hands 
were noted in four of the 13 patients. In three of these 4, GFP on the affected 
side was higher than the unaffected side whereas in one, the reverse was 
true. 
 
There was significant variability within the patient group compared to the 
healthy group in terms of GFP score for both affected (Levene’s test, one-
tailed p=0.03) and unaffected (Levene’s test, one-tailed p=0.045) sides. There 
was no significant variability in the patient group compared to the healthy 
group in terms of peak latency.  
 
In the Experiment 2 designed to study the somatosensory ERPs, GFP 
analysis revealed no statistically significant differences between left and right 
hand stimulations in the healthy controls either at the group or the individual 
level. There were also no statistically significant differences between the 
affected and unaffected sides in the patients either at the group or the 
individual level. Comparisons between the healthy and the patient groups also 
failed to reveal any statistically significant differences in the somatosensory 
ERPs. 
 
Our finding of no significant differences in the GFP analysis in both the time 
segment of 0-200 ms in the Experiment 1 as well as the Experiment 2 suggest 
that there was no impairment of somatosensory conduction from the periphery 
to the somatosensory cortex in the CRPS patients in this study. This is in 
keeping with the finding of a systematic review and meta-analysis of 
somatosensory cortex function in CRPS (Di Pietro et al. 2013b).  
 
Despite the somatosensory signals apparently reaching the cortex normally, 
the patients took significantly longer to respond to stimuli and also had lower 
accuracy rate compared to healthy controls. This suggests a higher cognitive 
dysfunction in the way signals are processed in the cerebral cortex which may 
be a result of structural or functional cortical reorganisation. This altered 
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cognitive processing during tactile perceptual decision-making is likely 
downstream of early-latency somatotopic mapping. 
 
P300 (positive peak seen usually between 200 and 400 ms after stimulus 
onset) has been studied as a marker of cognitive dysfunction in a variety of 
clinical contexts including chronic headache (DeMirci & Savas 2002), chronic 
lower back pain (Tandon et al. 1997; D. S. Veldhuijzen et al. 2006), phantom 
limb pain (Karl et al. 2004), schizophrenia (Ford 1999) and dementia (Parra et 
al. 2012).  
P300 is an endogenous potential which does not depend upon the physical 
attributes of the external stimulus but on the person’s reaction to the stimulus. 
Some experts have further classified P300 into two components, P3a (also 
called novelty P3) and P3b (also called classic P3). P3a originates from 
stimulus driven frontal attention mechanisms during task processing, whereas 
P3b originates from temporo-parietal activity associated with attention and 
appears related to subsequent memory processing (Polich 2009; Linden 
2005).  
 
Previous studies have provided inconsistent results on the P300 latency and 
amplitude in chronic pain conditions as discussed below. 
 
Increase in P300 latency was reported in chronic back pain patients 
compared to healthy adults in a study using visual odd-ball paradigm (Tandon 
& Kumar 1993). Another visual ERP study (n=12) reported that improvement 
in pain scores in chronic back pain patients with treatment (epidural steroid 
injection) was associated with parallel decrease in the baseline P300 latency 
(Tandon et al. 1997).   
 
An auditory ERP study (n=23 chronic back pain, 23 episodic tension-type 
headache & 23 age-and-sex matched healthy controls) did not find any 





A visual ERP study on chronic non-malignant pain patients (n=14 patients, 30 
healthy) also found no differences in P300 latency or amplitude between 
patient and healthy groups in the primary task. However with increasing task 
difficulty, in contrast to the healthy, the patients did not show a decrease in 
P300 amplitude(D. S. Veldhuijzen et al. 2006). 
 
A visual ERP study on phantom pain patients (n= 5 upper limb amputees 
without pain, 5 upper limb amputees with phantom pain & 10 age-and-sex 
matched healthy controls) found that P300 amplitude was higher and latency 
was longer in the phantom pain group compared to the other groups. They 
also reported that the pain severity correlated with the P300 amplitude (Karl et 
al. 2004).  
 
We did not find any significant differences in the latency between patient and 
healthy groups in our study in line with some previous studies (DeMirci & 
Savas 2002; D. S. Veldhuijzen et al. 2006) and in contrast to others (Karl et 
al. 2004; Tandon et al. 1997; Tandon & Kumar 1993).  
 
We found that at the group level the P300 amplitude was increased in the 
affected side of the patient group compared to the healthy group. However 
there were no statistically significant differences between affected and 
unaffected sides in the patient group. This was broadly in line with other 
studies (Karl et al. 2004) and may reflect increased allocation of resources in 
terms of attention and perceptual sensitivity.  
 
Additional analyses (collaborative work with Dr Chris Brown; (Kuttikat et al. 
2018) ) were carried out considering 3 factors: digit type, side affected (by 
CRPS), and group (CRPS, Healthy Control). These analyses focused on EEG 
source analysis and were done using SPM12 (www.fil.ion.ucl.ac.uk/spm) and 
showed augmented P300-like responses in supplementary motor area (SMA), 
positively correlating with longer response times in CRPS patients. The 
response was also observed in Experiment 2, but was substantially 
diminished (indicating sensitivity to task demands) and there was no group 
difference. This suggests that the augmented response was due to the need 
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for greater attentional resources to perform the task in this group. 
Interestingly, the magnitude of the P300 activity in CRPS patients predicted 
better limb functioning, suggesting it compensates to the disease rather than 
directly marking disease pathology. 
 
Our study findings did not support our central hypothesis that EEG markers of 
cortical reorganisation will correlate significantly with finger misperception. We 
also did not find any correlation between cortical reorganisation in CRPS and 
pain severity. 
 
Patients were on medications that may affect neural responses as described 
below. A study of intravenous Tramadol in the anaesthetic setting has been 
reported to show activation of EEG variables including power frequency, 
spectral edge, Delta Power and Alpha/Delta ratio but no significant change in 
amplitudes or latencies (Vaughan et al. 2000). 
A study of fluoxetine and amitriptyline in depressed patients showed a 
significant decrease in the amount of beta activity but no EEG evidence of 
drowsiness or epileptiform activity (Tarn et al. 1993). Another study found that 
amitriptyline increased reaction times after acute but not after sub-chronic 
administration. ERP analyses showed that P300 amplitudes to the task stimuli 
were not affected by amitriptyline (Veldhuijzen et al. 2006). Sertraline can 
cause augmentation and acceleration of alpha activity and attenuation and 
acceleration of delta activity (Saletu et al. 1986). 
Gabapentin and Carbamazepine can slow the alpha rhythm and median EEG 
frequency, and increased the percentage of theta and delta power (Salinsky 
et al. 2002). Pregabalin has been shown to decrease alpha and beta band 
power during NREM sleep and increase the delta band power (Wilson et al. 
2011). 
Morphine is known to increase alpha and theta power, and decrease delta 
power (Phillips et al. 1994). Diazepam can decrease theta and alpha activity 
and increases beta activity (Montagu 1972).  
Patients in our study have been on stable medications and it is difficult to be 
certain what effects these had on the EEG findings. Medication use raises a 
complex confound in that certain medications (such as opioids) may reduce 
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cognitive performance, but also more severely affected patients are more 
likely to be prescribed such medication; establishing cause and effect is 
impossible from cross-sectional data. 
 
There was variability within the patient group in terms of clinical 
characteristics. The disease duration ranged from 1 year to 14 years and 
some had upper limb affected while others had lower limb affected. In addition 
to this clinical heterogeneity, another limitation of the study was the small 
sample size which can impact on the robustness and generalisability of the 
findings. General limitations of EEG technique such as low spatial resolution 
also make it difficult to draw any strong conclusions about the structural 
reorganisation within the cerebral cortex. 
 
Future studies with larger sample sizes can allow clustering into 
mechanistically homogeneous patient sub-groups and these are necessary to 
further characterise the cortical changes in CRPS. Follow up studies will help 
us delineate the neural cortical changes in the patient group that may 
fluctuate with the clinical course of the disease. Spatial localisation studies 
using f-MRI and functional connectivity studies to assess the spectral 
signatures of cognition may provide objective biomarkers that are clinically 





In our case control design study, CRPS patients had significantly reduced 
accuracy and prolonged reaction time in the affected side compared to the 
unaffected side in the behavioural task of identifying the finger stimulated by a 
handbox. They also had significantly reduced accuracy and prolonged 
reaction time in both hands when compared to the age-and-sex matched 
healthy subjects. There was also high variability in the tactile discrimination 




There was no significant difference in the GFP latency in the patient group 
compared to healthy subjects. There was also no difference between affected 
and unaffected sides of the patient group suggesting there was no impairment 
of somatosensory conduction from the periphery to the somatosensory cortex.  
However, GFP amplitude corresponding to P300 was significantly higher in 
the patient affected side compared to the healthy controls suggesting 
cognitive dysfunction possibly related to increased allocation of attentional 
resources.  
Our study did not find any correlation between cortical reorganisation in CRPS 
and either finger misperception or pain severity. 
Additional collaborative work (EEG source analysis) revealed augmented 
P300–like response in SMA in CRPS patients that was positively correlating 
























Chapter 6: Overall Conclusions 
 
6.1 Background and hypotheses explored 
 
Delays in diagnosis occur in CRPS adversely affecting patient outcomes. 
The first research project in this thesis, ‘Novel Signs in CRPS and their 
Diagnostic Clinical Utility’ was a prospective observational cohort study which 
defined the four novel signs  of finger misperception, abnormal hand laterality, 
astereognosis and abnormal body scheme report in CRPS, examined their 
prevalence in CRPS and other chronic pain conditions and assessed their 
diagnostic utility (Sensitivity, Specificity, Predictive values and Likelihood 
ratios) for identifying patients at risk of CRPS within a Fracture cohort.  The 
main hypotheses explored in this study were that the prevalence of novel 
signs in CRPS will be higher compared to other chronic pain conditions and 
also that these signs will have significant diagnostic clinical utility in 
diagnosing CRPS compared to a group of fracture patients.  
 
Cortical reorganisation, defined as structural and functional changes within 
the cerebral cortex, is implicated in many chronic pain conditions including 
CRPS.  The second research project in this thesis ‘Cortical Reorganisation 
and Finger Misperception in CRPS- a High Density Electroencephalogram 
Study’ was a prospective case control design study which investigated the 
EEG parameters suggestive of cortical reorganisation in CRPS patients by 
studying the somatosensory ERPs (Event Related Potentials) elicited on 
painless finger stimulation. The central hypothesis of this study was that the 
‘’cortical reorganisation’’ as defined by EEG parameters will correlate 
significantly with finger misperception in CRPS.  
 
6.2 Diagnostic utility of novel clinical signs 
 
We demonstrate that novel signs are present in the majority of CRPS patients 
and can be reliably detected following simple training. They are practical and 
have significant clinical utility in diagnosing persistent pain in a fracture group 
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thereby allowing targeted intervention. They are also present in other 
chronically painful conditions such as RA, FMS, and LBP. 
Finger misperception (FP) and abnormal body scheme report (BS) were the 
best performing tests and by combining them the diagnostic utility can be 
further improved. Prospective monitoring of fracture patients showed that out 
of 7 fracture patients (total n=47) who had both finger misperception and 
abnormal BS report at initial testing, 3 developed persistent pain with 1 having 
a formal diagnosis of CRPS.  
 
6.3 P300 as a high density EEG marker of cognitive 
dysfunction 
 
Our study confirmed that CRPS patients had altered cognitive processing of 
tactile stimuli. During a task to discriminate the digit simulated, patients 
(compared to controls) had significantly lower accuracy and slowed response 
times but with high between-subject variability.  
In our study, there was no significant difference in the GFP (Global Field 
Power) latency in the patient group compared to healthy subjects or between 
affected and unaffected sides of the patient group suggesting there was no 
impairment of somatosensory conduction from the periphery to the 
somatosensory cortex. However, GFP amplitude corresponding to P300 was 
significantly higher in the patient affected side compared to the healthy 
subjects suggesting cognitive dysfunction possibly related to increased 
allocation of attentional resources. Additional source analysis showed 
augmented P300-like response under task demands that localised to 
supplementary motor area (SMA). Source activity in SMA correlated with 
slowed response times, while its scalp representation correlated with better 
functioning of the affected limb, suggesting a compensatory mechanism. Our 
study did not find evidence to support our hypothesis that cortical 







6.4 Clinical Relevance 
 
The two research studies described in this thesis are complementary to each 
other. The first study sets out the diagnostic utility of clinical signs in 
diagnosing CRPS and the second study explored the high density EEG 
markers of cortical reorganisation in CRPS.  
 
Clinical tests in the first study were designed to be used in a practical clinic 
setting with minimal equipment and hence are simple and time efficient. 
Behavioural test for finger misperception in the second study was robust and 
elaborate but requires additional equipment (eg; handbox) and hence may not 
be practical in a busy clinic setting. However, this study also established the 
presence of finger misperception in a significant proportion of CRPS patients 
and thus provides further validation for this study. 
 
The tests for finger misperception and abnormal body scheme performed well 
in the study but the tests for astereognosis and abnormal hand laterality did 
not. Some modifications in these tests such as increasing the number and 
complexity of objects used in astereognosis test and the images in hand 
laterality test may improve their diagnostic utility and this possibility merits 
further exploration in future studies. 
 
The clinical tests presented in this thesis potentially add value over the 
modified Budapest criteria as they test for facets of body perception 
disturbance not included in the formal criteria. Patients may not also fulfil the 
strict ‘modified Budapest criteria’ due to variability of their clinical features. 
Therapeutic strategies targeting cortical reorganisation such as graded motor 
imagery training, tactile discrimination training, electrical sensory 
discrimination therapy and neurofeedback  have been used in CRPS patients 
(Bowering et al. 2013; Moseley & Wiech 2009; Bailey et al. 2013). 
Comprehensive Graded Motor Imagery training incorporates 3 components 
namely - 1) Left/Right laterality judgements, 2) Motor Imagery and 3) Mirror 
Visual Feedback (Bowering et al. 2013).  Mirror Visual Feedback is often used 
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as a stand-alone therapy without the previous two stages. It provides a visual 
illusion whereby the reflection of the unaffected limb is superimposed on the 
affected limb. This can reduce pain levels by providing corrective sensory 
feedback which reduces sensorimotor conflict (Bailey et al. 2013). 
Tactile discrimination training can increase tactile acuity and decrease pain in 
CRPS patients (Moseley & Wiech 2009). Electrical Sensory Discrimination 
Training involves application of electrodes around the painful area and 
participants then choose which electrodes to be stimulated. Feedback is given 
after each electrode is stimulated and the participants progress through a 
hierarchy of training levels. Early pilot work suggests that this is safely 
tolerated and in CRPS patients and improves two-point discrimination 
(McCabe et al. 2011). 
 
Our study provides evidence for altered neurocognitive processing of tactile 
stimuli in CRPS and thus offers mechanistic reasons why these treatment 
strategies that target cortical reorganisation may be useful. The tests that we 
describe in our study may also allow us to stratify a sub-group of patients who 




6.5 Future directions 
 
The work presented in this thesis has the potential to alter clinical practice in 
terms of using the novel clinical signs to identify high risk patients from a 
fracture cohort. However, longer term prospective follow up of a larger cohort 
of fracture patients are necessary to confirm the diagnostic utility in some of 
these patients who may eventually develop CRPS. Importantly, our study also 
reveals that novel signs are present in other pain conditions including 
inflammatory conditions such as rheumatoid arthritis. This raises the intriguing 
possibility that some of these patients may have common underlying 
mechanistic reasons for developing chronic pain. This is an area for further 
explorative research which has significant implications in optimising 
management of these patients.  
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We have shown that somatosensory ERPs recorded using high density EEG 
can be useful to study the cortical changes in CRPS. In particular, mid-to-late 
latency responses (corresponding to P300) could potentially provide 
convenient and robust biomarkers of abnormal perceptual decision-making 
mechanisms in CRPS to aid in clinical detection and treatment. Future 
research should investigate the clinical utility of these putative markers of 
tactile decision-making mechanisms in CRPS. 
   
Novel therapeutic strategies targeting cortical reorganisation are being trialled 
and developed in CRPS. It will be of great clinical utility to develop objective 
functional and structural neuro-imaging biomarkers that help identify sub-
groups of patients that are more likely to respond to these interventions. 
 
Larger studies will allow clustering of patients into more homogeneous sub-
groups and these are necessary to overcome the challenge of significant 
clinical and mechanistic heterogeneity in CRPS. Follow up studies are 
required to delineate the neural cortical changes in the patient group that may 
fluctuate with the clinical course of the disease. Spatial localisation studies 
using f-MRI and functional connectivity studies to assess the spectral 
signatures of cognition may provide objective biomarkers that are clinically 
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 Study 1:  Clinical utility of novel clinical signs in patients with CRPS 
Funding source:  BMA Doris Hillier Award & Cambridge Arthritis Research 
Endeavour (CARE)  
NIHR CRN (National Institute of Health Research, Clinical Research Network) 
portfolio adopted study (Ref No: 11545)  
Ethics: Approved by the Research Ethics Committee, East of England-Essex 
(REC Ref No: 09/H0302/83) 
 
Study 2: Cortical reorganisation in CRPS and digit misperception-             
A high density Electroencephalogram Study 
Funding source: Cambridge Arthritis Research Endeavour (CARE) 
Ethics: Approved by the Research Ethics Committee, East of England-South 
Cambridge (REC Ref No: 12/EE/0305) 
 
Appendix 2: Location of Research 
 
All research was carried out in Addenbrooke’s hospital, Cambridge University 
Hospital NHS Foundation Trust and Herchel Smith building for brain and mind 
sciences, Cambridge. 
 
Appendix 3: Personal contribution to research 
 
I recruited the subjects, administered the tests for novel clinical signs, 
collected and analysed the data for the study ‘Novel clinical signs and their 
diagnostic clinical utility in CRPS’. I successfully applied for the inclusion of 
this study into the NIHR portfolio. 
I prepared the study protocol and successfully applied for ethics approval for 
the study, ‘Cortical reorganisation in CRPS and digit misperception-A high 
density EEG study’. I helped design the handbox used in the study to deliver 
somatosensory stimuli. I recruited subjects, administered the tests and 
collected high density EEG data from the subjects. I pre-processed the EEG 
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data using custom MATLAB scripts based on EEGLAB. I analysed the EEG 
data using FieldTrip, open source software implemented as a MATLAB 
toolbox. I also analysed the behavioural data using IBM SPSS. 
 
The following contributions have been made by others: 
Dr. Nicholas Shenker and Dr. Maliha Shaikh prepared the study protocol and 
obtained funding and ethics approval for the study, ‘Novel signs and their 
clinical diagnostic utility in CRPS’. Research nurses, Ms. Yin Fan and Ms. 
Alison Mitchell helped with patient recruitment and data collection for this 
study. Mr. Richard Parker and Prof Toby Prevost provided guidance on the 
statistical analyses. 
Dr. Tristan Bekinschtein and Dr. Valdas Noreika helped with the 
conceptualisation and preparation of study protocol for the study, ‘Cortical 
reorganisation in CRPS and digit misperception-A high density EEG study’ 
and also trained me in acquisition, pre-processing and analysis of the EEG 
data.  Dr. Srivas Chennu provided the scripts used in running the experiments 
and data analysis and also trained me in EEG data analysis. Dr Christopher 
Brown did additional analyses (including source analysis) on the EEG data. 
 
 
Appendix 4: Supervision 
 
Prof Hill Gaston, Professor of Rheumatology, University of Cambridge and Dr 
Nicholas Shenker, Consultant Rheumatologist, Addenbrooke’s hospital 
provided overall supervision for my MD. 
Dr. Nicholas Shenker supervised the study ‘Novel clinical signs and their 
diagnostic clinical utility in CRPS’. Dr. Nicholas Shenker and Dr. Tristan 
Bekinschtein supervised the study ‘Cortical reorganisation in CRPS and digit 






Appendix 5: Questionnaires used  
 
5.1 Brief pain inventory 
1. Throughout our lives, most of us have had pain from time to time (such as minor 
headaches, sprains, and toothaches). Have you had pain other than these everyday 
kinds of pain today?  
Yes No 
 
2. On the diagram, shade in the areas where you feel pain. Put an X on the area that 
hurts the most.      Front    Back 
    
 
3. Please rate your pain by circling the number that best describes your pain at its 
worst in the last 24 hours.  
0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
 Pain as bad 
as you can 
imagine 
 
4. Please rate your pain by circling the number that best describes your pain at its 
least in the last 24 hours.  
0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
 Pain as bad 





5. Please rate your pain by circling the number that best describes your pain on the 
average.  
0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
 Pain as bad 
as you can 
imagine 
 
6. Please rate your pain by circling the number that tells how much pain you have 
right now.  
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0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
 Pain as bad 
as you can 
imagine 




8. In the last 24 hours, how much relief have pain treatments or medications  
 
 
8. In the last 24 hours, how much relief have pain treatments or medications 
provided? Please circle below the percentage that most shows how much relief you 
have received.  
0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
 Pain as bad 
as you can 
imagine  
9. Circle the number beside the number that describes how, during the past 24 
hours, pain has interfered with your:  
 
A. General Activity  







B. Mood  







C. Walking ability  








D. Normal Work (includes both work outside the home and housework)  







E. Relations with other people  










F. Sleep  







G. Enjoyment of life  













































5.2 Upper extremity functional index (UEFI) 
We are interested in knowing whether you are having any difficulty at all with 
the activities listed below because of your arm problem. Please circle a 



























Any of your usual work, housework, or 
school activities 
0 1 2 3 4 
Your usual hobbies, recreational or 
sporting activities 
0 1 2 3 4 
Lifting a bag of groceries to waist level 0 1 2 3 4 
Lifting a bag of groceries above your 
head 
0 1 2 3 4 
Grooming your hair 0 1 2 3 4 
Pushing up on your hands (e.g. from 
bathtub or chair) 
0 1 2 3 4 
Preparing food (e.g. peeling, cutting) 0 1 2 3 4 
Driving 0 1 2 3 4 
Vacuuming, sweeping or raking 0 1 2 3 4 
Dressing 0 1 2 3 4 
Doing up buttons 0 1 2 3 4 
Using tools or appliances 0 1 2 3 4 
Opening doors 0 1 2 3 4 
Cleaning 0 1 2 3 4 
Tying or lacing shoes 0 1 2 3 4 
Sleeping 0 1 2 3 4 
Laundering clothes(e.g. washing, ironing, 
folding) 
0 1 2 3 4 
Opening a jar 0 1 2 3 4 
Throwing a ball 0 1 2 3 4 
Carrying a small suitcase with your 
affected limb 
0 1 2 3 4 
Column Totals:      
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5.3 Lower extremity functional index (LEFI)  
 
We are interested in knowing whether you are having any difficulty at all with 
the activities listed below because of your leg problem. Please circle a 
number for each activity. Today, do you or would you have any difficulty at all 
with:  
 
Activities Extreme   
Difficulty/ 
unable 









Any of your usual work, 
housework, or school 
activities 
0 1 2 3 4 
Your usual hobbies, 
recreational or sporting 
activities 
0 1 2 3 4 
Getting into or out of 
the bath 
0 1 2 3 4 
Walking between rooms 0 1 2 3 4 
Putting on your shoes or 
socks 
0 1 2 3 4 
Squatting 0 1 2 3 4 
Lifting an object, like a 
bag of groceries from 
the floor 
0 1 2 3 4 
Performing light 
activities around home 
0 1 2 3 4 
Performing heavy 
activities around home 
0 1 2 3 4 
Getting into or out of a 
car 
0 1 2 3 4 
Walking 2 blocks 0 1 2 3 4 
Walking a mile 0 1 2 3 4 
Going up or down 10 
stairs  











Standing for 1 hour 0 1 2 3 4 
Sitting for 1 hour 0 1 2 3 4 
Running on even ground 0 1 2 3 4 
Running on uneven 
ground 
0 1 2 3 4 
Making sharp turns 
while running fast 
0 1 2 3 4 
Hopping 0 1 2 3 4 
Rolling over in bed 0 1 2 3 4 






5.4 Neglect-like Symptom Questionnaire 
Painful limbs can sometimes feel alien due to nervous system changes. For 
each of the five items, please circle the statement with which you most 
strongly agree. 
 
1. If I don’t focus my attention on my painful limb it would lie still, like a dead 
weight. 
 
Never - Very rarely - Rarely - Occasionally - Very frequently - Always 
     
 
2. My painful limb feels as though it is not part of the rest of my body. 
 
Never - Very rarely - Rarely - Occasionally - Very frequently - Always 
     
 
3. I need to focus all of my attention on my painful limb to make it move 
 
Never - Very rarely - Rarely - Occasionally - Very frequently - Always 
     
 
4. My painful limb sometimes moves involuntarily, without my control. 
 
Never - Very rarely - Rarely - Occasionally - Very frequently - Always 
     
 
5. My painful limb feels dead to me. 
 























5.5 Hospital anxiety and depression score  
Doctors are aware that emotions play an important part in most illnesses. If 
your doctor knows about these feelings he will be able to help you more. This 
questionnaire is designed to help your doctor to know how you feel. Please 
read each item and circle the reply which comes closest to how you have 
been feeling in the last week. Don’t take too long over your replies; your 
immediate reaction to each item will probably be more accurate than a 
thought out response. 
 















Not quite  
so much 





3. I get a sort of frightened feeling as if something awful is about to happen 
 
Very definitely  
and quite badly 
Yes, but not  
so badly 
A little but it  




4. I can laugh and see the funny side of things 
 
As much as I  
always could 
Not quite as  
much now 
Definitely not  




5. Worrying thoughts go through my mind 
 
A great deal  
of the time 
A lot of 
the time 
From time to time  








Not often Sometimes Most of the time 
 
7. I can sit at ease and relax 
 
Definitely Usually Not often Not at 
all 
 
8. I feel as if I am slowed down 
 
Nearly all of 
the time 














10. I have lost interest in my appearance 
 
Definitely I don’t have as 
much care as I 
should 
I may not take 
quite as much 
care 
I take as much 
care as ever 
 
11. I feel restless as if I have to be on the move 
 









12. I look forward with enjoyment to things 
 
As much as  
I ever did 
Rather less  
than I used to 
Definitely less  




13. I get sudden feelings of panic 
 









14. I can enjoy a good book or radio/TV programme 
 



















































Appendix 6: Relevant publications of Dr Kuttikat related to the MD thesis 
 
 
1. Kuttikat A, Noreika V, Chennu S, Shenker N, Bekinschtein T, Brown 
CA. Altered cognitive processing of tactile stimuli in patients with Complex 
Regional Pain Syndrome (CRPS). J Pain. 2018 Apr; 19(4):395-409. 
 
2. Kuttikat A, Shaikh M, Oomatia A, Parker R, Shenker N. Novel signs 
and their clinical utility in diagnosing Complex Regional Pain Syndrome 
(CRPS): A prospective observational cohort study. Clin J Pain. 2017 Jun; 
33(6):496-502. 
 
3. Kuttikat A, Noreika V, Shenker N, Chennu S, Bekinschtein T, Brown 
CA. Neurocognitive and neuroplastic mechanisms of novel clinical signs in 
CRPS. Front Hum Neurosci. 2016 Jan 27; 10:16. 
 
4. Dubuis E, Thompson V, Leite MI, Blaes F, Maihöfner C, Greensmith D, 
Vincent A, Shenker N, Kuttikat A, Leuwer M, Goebel A. Longstanding 
Complex Regional Pain Syndrome is associated with activating 
autoantibodies against alpha-1a adrenoceptors. Pain. 2014 Nov; 
155(11):2408-17. 
 
5. Kuttikat A, Shenker N. ‘Fibromyalgia & diffuse pain syndromes: Adult 
onset.’ Oxford Textbook of Rheumatology.  4th Ed. 2013. 
 
6. Kuttikat A, Shenker N. ‘Chronic Pain in RA-Is it mediated by cortical 
reorganisation?’ Rheumatology 2013:52(1):i122. 
 
7. Kuttikat A, Shenker N. ‘Pharmacological modulation of central 
nociception in the management of chronic musculoskeletal pain.’ Pain 
Management’ 2011; 1 (6): 549-556. 
